1 | Cord Tissue | Allogeneic - Related | Chronic renal disease | Endocrinology | 2025 | Experimental Therapy | Romania | 50 |
2 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2025 | Experimental Therapy | Romania | 6 |
3 | Cord Tissue | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Romania | 6 |
4 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2025 | Experimental Therapy | Poland | 57,2 |
5 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3,1 |
6 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 3,4 |
7 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 2,8 |
8 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5,9 |
9 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 11,9 |
10 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 54,2 |
11 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 78,4 |
12 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 6,8 |
13 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedics | 2025 | Experimental Therapy | Poland | 58,2 |
14 | Cord Tissue | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
15 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
16 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 4,1 |
17 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Poland | 7,9 |
18 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7,8 |
19 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2025 | Experimental Therapy | Poland | 25,8 |
20 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 5,9 |
21 | Cord Blood | Autologous | Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 2 |
22 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 6,8 |
23 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2025 | Experimental Therapy | Portugal | 1 year and 8 months |
24 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Romania | 5 |
25 | Cord Blood | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2025 | Standard Therapy | Poland | 13 |
26 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 5 ,5 |
27 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 7,2 |
28 | Cord Blood | Allogeneic | Thalassemia Major | Hematology | 2025 | Standard Therapy | Turkey | 10,9 |
29 | Cord Blood | Autologous | Autism | Neurology | 2025 | Experimental Therapy | Poland | 4,1 |
30 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Poland | 71 |
31 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 72 |
32 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 47 |
33 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Ukraine | 43 |
34 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 49 |
35 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 51 |
36 | Bone Marrow Family | Allogeneic | Philadelphia - positive Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 61 |
37 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 58 |
38 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | NETHERLANDS | 63 |
39 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
40 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | France | 63 |
41 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 68 |
42 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | France | 71 |
43 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Russia | 51 |
44 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
45 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Czechia | 54 |
46 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | United Kingdom | 16 |
47 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 61 |
48 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 61 |
49 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2025 | Standard Therapy | Spain | 15 |
50 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Norway | 55 |
51 | Bone Marrow | Allogeneic | Inherited Immune System Disorder | Hematology | 2025 | Standard Therapy | France | 3 |
52 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 7 |
53 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Ukraine | 36 |
54 | Bone Marrow | Allogeneic | Inherited Immune System Disorder | Hematology | 2025 | Standard Therapy | France | 10 |
55 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 76 |
56 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 39 |
57 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | South Africa | 6 |
58 | Bone Marrow | Allogeneic | Wiskott-Aldrich syndrome | Hematology | 2025 | Standard Therapy | Turkey | 6 |
59 | Bone Marrow | Allogeneic | Combined immnunodeficiency | Hematology | 2025 | Standard Therapy | Ukraine | 3 months |
60 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2025 | Standard Therapy | Poland | 3 |
61 | Bone Marrow | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2025 | Standard Therapy | Poland | 13 |
62 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 7 |
63 | Bone Marrow | Allogeneic | B-cell precursor Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 56 |
64 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 43 |
65 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 19 |
66 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 12 |
67 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 5 |
68 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 10 months |
69 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 6 |
70 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 44 |
71 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2025 | Standard Therapy | Poland | 25 |
72 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 4 |
73 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | USA | 21 |
74 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 12 |
75 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Hungary | 10 |
76 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Czechia | 68 |
77 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2025 | Standard Therapy | Poland | 53 |
78 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Germany | 4 |
79 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | France | 4 |
80 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2025 | Standard Therapy | Norway | 18 |
81 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Spain | 24 |
82 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Belarus | 5 |
83 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Germany | 53 |
84 | Bone Marrow | Allogeneic | diamond-Balckfan anemia | Hematology | 2025 | Standard Therapy | Germany | 11 |
85 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 57 |
86 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 61 |
87 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 58 |
88 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 34 |
89 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 61 |
90 | Apheresis | Allogeneic | Myelodysplastic Syndrome/Myeloproliferative neoplasm | Hematology | 2025 | Standard Therapy | NETHERLANDS | 62 |
91 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Austria | 68 |
92 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 70 |
93 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 66 |
94 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 77 |
95 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 12 |
96 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 58 |
97 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 67 |
98 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 4 |
99 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | USA | 73 |
100 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 56 |
101 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 50 |
102 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 39 |
103 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Lithuania | 43 |
104 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 66 |
105 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2025 | Standard Therapy | USA | 61 |
106 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Austria | 55 |
107 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 69 |
108 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Denmark | 67 |
109 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | United Kingdom | 75 |
110 | Apheresis | Allogeneic | T - cell Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 24 |
111 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Belgium | 68 |
112 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 42 |
113 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 50 |
114 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2025 | Standard Therapy | USA | 62 |
115 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | United Kingdom | 62 |
116 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | USA | 69 |
117 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 85 |
118 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 54 |
119 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | USA | 39 |
120 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 45 |
121 | Apheresis | Autologous | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 59 |
122 | Apheresis | Allogeneic | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 68 |
123 | Apheresis | Allogeneic | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 68 |
124 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 73 |
125 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 66 |
126 | Apheresis | Autologous | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 69 |
127 | Apheresis | Autologous | Hodgkin lymphoma | Hematology | 2025 | Standard Therapy | Germany | 38 |
128 | Apheresis | Allogeneic | Tcell acute leukemia | Hematology | 2025 | Standard Therapy | Romania | 31 |
129 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Italy | 37 |
130 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Sweden | 69 |
131 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 55 |
132 | Apheresis | Allogeneic | Fanconi's Anemia | Hematology | 2025 | Standard Therapy | Russia | 14 |
133 | Apheresis | Allogeneic | Peripheral T-cell Lymphoma not otherwise specified | Hematology | 2025 | Standard Therapy | Germany | 54 |
134 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 63 |
135 | Apheresis | Allogeneic | Myeloid Sarcoma | Hematology | 2025 | Standard Therapy | Poland | 48 |
136 | Apheresis | Allogeneic | Other Myelofibrosis/Myelosclerosis | Hematology | 2025 | Standard Therapy | USA | 72 |
137 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Germany | 11 |
138 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 37 |
139 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Australia | 59 |
140 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 35 |
141 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 51 |
142 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 59 |
143 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 70 |
144 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 70 |
145 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 66 |
146 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 63 |
147 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 66 |
148 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Italy | 61 |
149 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 71 |
150 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2025 | Standard Therapy | Czechia | 45 |
151 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Brazil | 61 |
152 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Hungary | 35 |
153 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | NETHERLANDS | 48 |
154 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2025 | Standard Therapy | Ireland | 62 |
155 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 62 |
156 | Apheresis | Allogeneic | Acute Myeloid Leukemia, Myelodysplasia-Related | Hematology | 2025 | Standard Therapy | Russia | 53 |
157 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 56 |
158 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | USA | 68 |
159 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 70 |
160 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
161 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 53 |
162 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 52 |
163 | Apheresis | Autologous | Diffuse large B-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 63 |
164 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 72 |
165 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
166 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 74 |
167 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 65 |
168 | Apheresis | Allogeneic | T-cell prolymphocytic leukemia | Hematology | 2025 | Standard Therapy | Germany | 53 |
169 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 70 |
170 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 61 |
171 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 54 |
172 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 41 |
173 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 32 |
174 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 72 |
175 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | Poland | 52 |
176 | Apheresis | Allogeneic | Chronic Myeloid Leukemia | Hematology | 2025 | Standard Therapy | Poland | 50 |
177 | Apheresis | Allogeneic | T-cell Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 17 |
178 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 66 |
179 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2025 | Standard Therapy | Poland | 49 |
180 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2025 | Standard Therapy | Poland | 5 |
181 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 55 |
182 | Apheresis | Allogeneic | Diffuse Large B-cell Lymphoma | Hematology | 2025 | Standard Therapy | Poland | 68 |
183 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 64 |
184 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 51 |
185 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 58 |
186 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
187 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 61 |
188 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
189 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 19 |
190 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
191 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2025 | Standard Therapy | Poland | 47 |
192 | Apheresis | Allogeneic | Polycythemia Vera | Hematology | 2025 | Standard Therapy | Poland | 61 |
193 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 56 |
194 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 53 |
195 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 55 |
196 | Apheresis | Allogeneic | Myelodysplastic Syndrome, Myeloproliferative Neoplasms | Hematology | 2025 | Standard Therapy | Poland | 34 |
197 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 50 |
198 | Apheresis | Allogeneic | Myelodysplastic Disorders | Hematology | 2025 | Standard Therapy | Poland | 71 |
199 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | Poland | 64 |
200 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 54 |
201 | Apheresis | Autologous | Non-Hodgkin lymphoma | Hematology | 2025 | Standard Therapy | Germany | 50 |
202 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 50 |
203 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 35 |
204 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 54 |
205 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 52 |
206 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 61 |
207 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 55 |
208 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 64 |
209 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 68 |
210 | Apheresis | Allogeneic | Primary myelofibrosis | Hematology | 2025 | Standard Therapy | Germany | 71 |
211 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 47 |
212 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 58 |
213 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 68 |
214 | Apheresis | Autologous | No data | Hematology | 2025 | Standard Therapy | Portugal | 44 |
215 | Apheresis | Autologous | No data | Hematology | 2025 | Standard Therapy | Portugal | 59 |
216 | Apheresis | Autologous | Lymphoma | Hematology | 2025 | Standard Therapy | Portugal | 58 |
217 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Sweden | 59 |
218 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 2 |
219 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 41 |
220 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | France | 48 |
221 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Sweden | 64 |
222 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | United Kingdom | 63 |
223 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 64 |
224 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 58 |
225 | Apheresis | Allogeneic | Myelodysplastic Syndrome, Myeloproliferative Neoplasms | Hematology | 2025 | Standard Therapy | Poland | 68 |
226 | Apheresis | Allogeneic | Myelodysplastic Syndrome, Myeloproliferative Neoplasms | Hematology | 2025 | Standard Therapy | Germany | 59 |
227 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 56 |
228 | Apheresis | Allogeneic | Diffuse Large B-cell Lymphoma | Hematology | 2025 | Standard Therapy | Belarus | 53 |
229 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 60 |
230 | Apheresis | Allogeneic | Immunodeficiency – LRBA | Hematology | 2025 | Standard Therapy | Turkey | 14 |
231 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | Poland | 20 |
232 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 65 |
233 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Ukraine | 54 |
234 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 75 |
235 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 58 |
236 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | Poland | 48 |
237 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 37 |
238 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Chile | 40 |
239 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 72 |
240 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Switzerland | 65 |
241 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2025 | Standard Therapy | Portugal | 68 |
242 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Estonia | 9 |
243 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2025 | Standard Therapy | USA | 63 |
244 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Sweden | 67 |
245 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Lithuania | 45 |
246 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 59 |
247 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 69 |
248 | Apheresis | Autologous | T-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
249 | Apheresis | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2025 | Standard Therapy | Germany | 42 |
250 | Apheresis | Autologous | Primary central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
251 | Apheresis | Allogeneic | myelodysplastic syndrome/ Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 62 |
252 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 42 |
253 | Apheresis | Autologous | T-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 55 |
254 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 72 |
255 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 58 |
256 | Apheresis | Autologous | Central nervous system lymphoma | Hematology | 2025 | Standard Therapy | Germany | 65 |
257 | Apheresis | Autologous | Follicular lymphoma | Hematology | 2025 | Standard Therapy | Germany | 67 |
258 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 70 |
259 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 60 |
260 | Apheresis | Autologous | No Data | Hematology | 2025 | Standard Therapy | Portugal | 64 |
261 | Apheresis | Autologous | No Data | Hematology | 2025 | Standard Therapy | Portugal | 63 |
262 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 67 |
263 | Apheresis | Autologous | Acute myeloid leukemia | Hematology | 2025 | Standard Therapy | Germany | 60 |
264 | Apheresis | Autologous | Hodgkin lymphoma rezidiv | Hematology | 2025 | Standard Therapy | Germany | 65 |
265 | Apheresis | Autologous | Non-Hodgkin lymphoma | Hematology | 2025 | Standard Therapy | Germany | 64 |
266 | Apheresis | Autologous | T-cell lymphoma | Hematology | 2025 | Standard Therapy | Germany | 67 |
267 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 70 |
268 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 62 |
269 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 62 |
270 | Apheresis | Autologous | Multiple myeloma | Hematology | 2025 | Standard Therapy | Germany | 66 |
271 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 55 |
272 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Poland | 60 |
273 | Apheresis | Allogeneic | Fanconi's Anemia | Hematology | 2025 | Standard Therapy | Ukraine | 6 |
274 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 69 |
275 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Lithuania | 54 |
276 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Macedonia | 56 |
277 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | CROATIA | 64 |
278 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 75 |
279 | Apheresis | Allogeneic | T-cell Lymphoma | Hematology | 2025 | Standard Therapy | NETHERLANDS | 65 |
280 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 65 |
281 | Apheresis | Allogeneic | Myeloid Sarcoma | Hematology | 2025 | Standard Therapy | Brazil | 48 |
282 | Apheresis | Allogeneic | T-cell Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 17 |
283 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2025 | Standard Therapy | United Kingdom | 13 |
284 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2025 | Standard Therapy | USA | 69 |
285 | Apheresis | Allogeneic | T-cell Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Poland | 13 |
286 | Apheresis | Allogeneic | B-cell precursor Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Slovakia | 67 |
287 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 72 |
288 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Italy | 52 |
289 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Belgium | 64 |
290 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2025 | Standard Therapy | Italy | 68 |
291 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Canada | 56 |
292 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 64 |
293 | Apheresis | Allogeneic | Other Myelofibrosis/Myelosclerosis | Hematology | 2025 | Standard Therapy | USA | 55 |
294 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | USA | 64 |
295 | Apheresis | Allogeneic | Myelodysplastic disorder | Hematology | 2025 | Standard Therapy | France | 63 |
296 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 63 |
297 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | USA | 20 |
298 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | France | 23 |
299 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | USA | 73 |
300 | Apheresis | Allogeneic | Inherited Immune System Disorder | Hematology | 2025 | Standard Therapy | France | 9 |
301 | Apheresis | Allogeneic | Lymphoma - DLBCL | Hematology | 2025 | Standard Therapy | United Kingdom | 55 |
302 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Germany | 61 |
303 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2025 | Standard Therapy | Lithuania | 58 |
304 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2025 | Standard Therapy | Germany | 73 |
305 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2025 | Standard Therapy | Poland | 35 |
306 | Cord Tissue | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 6 |
307 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2024 | Experimental Therapy | Romania | 6 |
308 | Cord Tissue | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 4 |
309 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2024 | Experimental Therapy | Romania | 6 |
310 | Cord Tissue | Allogeneic - Unrelated | Degenerative and Traumatic Cartilage | Orthopedy | 2024 | Experimental Therapy | Poland | 50,3 |
311 | Cord Tissue | Allogeneic - Unrelated | Degenerative and Traumatic Cartilage | Orthopedy | 2024 | Experimental Therapy | Poland | 49,5 |
312 | Cord Tissue | Allogeneic - Unrelated | Degenerative and Traumatic Cartilage | Orthopedy | 2024 | Experimental Therapy | Poland | 58,11 |
313 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2024 | Experimental Therapy | Poland | 7,7 |
314 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2024 | Experimental Therapy | Poland | 15,7 |
315 | Cord Tissue | Allogeneic - Unrelated | Ovarian Dysfunction | Gynecology | 2024 | Experimental Therapy | Poland | 48,1 |
316 | Cord Tissue | Allogeneic - Related | Severe Pulmonary Hypertension +Mitral Regurgitation | Cardiovascular/Pulmonary | 2024 | Experimental Therapy | Romania | 2,6 |
317 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic lateral sclerosis | Neurology | 2024 | Experimental Therapy | Poland | 57,6 |
318 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2024 | Experimental Therapy | Poland | 68,2 |
319 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2024 | Experimental Therapy | Romania | 17 |
320 | Cord Tissue | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 7 |
321 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2024 | Experimental Therapy | Poland | 61,9 |
322 | Cord Tissue | Allogeneic - Unrelated | Degenerative and traumatic cartilage damage | Orthopedy | 2024 | Experimental Therapy | Poland | 45,4 |
323 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic lateral sclerosis | Neurology | 2024 | Experimental Therapy | Poland | 56,9 |
324 | Cord Tissue | Allogeneic - Unrelated | Graft-versus-host disease | Hematology | 2024 | Experimental Therapy | Poland | 0,10 |
325 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic lateral sclerosis | Neurology | 2024 | Experimental Therapy | Poland | 39,0 |
326 | Cord Tissue | Allogeneic - Unrelated | GvHD | Neurology | 2024 | Experimental Therapy | Poland | 9,2 |
327 | Cord Tissue | Allogeneic - Unrelated | Cerebral palsy | Neurology | 2024 | Experimental Therapy | Poland | 5,11 |
328 | Cord Tissue | Allogeneic - Unrelated | Cerebral palsy | Neurology | 2024 | Experimental Therapy | Poland | 13,10 |
329 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2024 | Experimental Therapy | Poland | 1,9 |
330 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2024 | Experimental Therapy | Poland | 7,11 |
331 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2024 | Experimental Therapy | Poland | 1 |
332 | Cord Tissue | Allogeneic - Unrelated | Cerebellar-spinal ataxia | Neurology | 2024 | Experimental Therapy | Poland | 35,5 |
333 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2024 | Experimental Therapy | Poland | 1,9 |
334 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2024 | Experimental Therapy | Poland | 4,5 |
335 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 11 |
336 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 10 |
337 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 6 |
338 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 4 |
339 | Cord Blood | Autologous | Autism | Neurology | 2024 | Experimental Therapy | Romania | 5 |
340 | Cord Blood | Allogeneic | Cerebral Palsy | Neurology | 2024 | Experimental Therapy | Poland | 3,5 |
341 | Cord Blood | Allogeneic | Cerebral Palsy | Neurology | 2024 | Experimental Therapy | Poland | 7,7 |
342 | Cord Blood | Autologous | CP | Neurology | 2024 | Experimental Therapy | Hungary | 4 |
343 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2024 | Experimental Therapy | Poland | 3,7 |
344 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2024 | Experimental Therapy | Poland | 5,9 |
345 | Cord Blood | Autologous | Pervasive developmental disorder | Neurology | 2024 | Experimental Therapy | Poland | 4,8 |
346 | Cord Blood | Allogeneic - Related | fanconi aplastic anemia | Hematology | 2024 | Standard Therapy | Turkey | 12 |
347 | Cord Blood | Autologous | Neuroblastoma | Neurology | 2024 | Standard Therapy | Poland | 4 |
348 | Cord Blood | Autologous | Pervasive developmental disorder | Neurology | 2024 | Experimental Therapy | Poland | 9,9 |
349 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
350 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 70 |
351 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 75 |
352 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 56 |
353 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 23 |
354 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 54 |
355 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
356 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 70 |
357 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 65 |
358 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 48 |
359 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 72 |
360 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia Richter Transformation | Hematology | 2024 | Standard Therapy | Poland | 55 |
361 | Bone Marrow Family | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 63 |
362 | Bone Marrow Family | Allogeneic | Follicular Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 48 |
363 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 65 |
364 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 58 |
365 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 70 |
366 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome - Refractory Cytopenia Of Childhood | Hematology | 2024 | Standard Therapy | Poland | 14 |
367 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome/ Myeloproliferative Neoplasms | Hematology | 2024 | Standard Therapy | Germany | 61 |
368 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome-MPN | Hematology | 2024 | Standard Therapy | Poland | 71 |
369 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 68 |
370 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 64 |
371 | Bone Marrow Family | Allogeneic | Polycythemia Vera/Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 74 |
372 | Bone Marrow Family | Allogeneic | Primary Myelofibrosis | Hematology | 2024 | Standard Therapy | Germany | 62 |
373 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 68 |
374 | Bone Marrow Family | Allogeneic | myelodysplasia | Hematology | 2024 | Standard Therapy | United Kingdom | 57 |
375 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 69 |
376 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 58 |
377 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 60 |
378 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 71 |
379 | Bone Marrow Family | Allogeneic | High risk Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 69 |
380 | Bone Marrow Family | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 74 |
381 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
382 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 8 |
383 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
384 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 8 |
385 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 52 |
386 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 57 |
387 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 66 |
388 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 5 |
389 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 54 |
390 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 56 |
391 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 3 |
392 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2024 | Standard Therapy | Poland | 7 |
393 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2024 | Standard Therapy | Poland | 7 |
394 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2024 | Standard Therapy | Poland | 9 |
395 | Bone Marrow | Allogeneic | B-Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 7 |
396 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2024 | Standard Therapy | Poland | 4 |
397 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2024 | Standard Therapy | Poland | 41 |
398 | Bone Marrow | Allogeneic | Chronic Lymphocytic Leukemia Richter Transformation | Hematology | 2024 | Standard Therapy | Poland | 55 |
399 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 67 |
400 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
401 | Bone Marrow | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 61 |
402 | Bone Marrow | Allogeneic | Genetically Determined Thrombocytopenia | Hematology | 2024 | Standard Therapy | Poland | 4 |
403 | Bone Marrow | Allogeneic | High Risk Acute Myeloid Leukaemia | Hematology | 2024 | Standard Therapy | Poland | 13 |
404 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 32 |
405 | Bone Marrow | Allogeneic | Inherited Metabolic Disease | Hematology | 2024 | Standard Therapy | Poland | 11 |
406 | Bone Marrow | Allogeneic | Mds-Rcc Relapse | Hematology | 2024 | Standard Therapy | Poland | 14 |
407 | Bone Marrow | Allogeneic | Mixed Cellularity Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 43 |
408 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 14 |
409 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 8 |
410 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 14 |
411 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
412 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 9 |
413 | Bone Marrow | Allogeneic | Osteopetrosis type B | Hematology | 2024 | Standard Therapy | Poland | 13 |
414 | Bone Marrow | Allogeneic | Other Leukemia | Hematology | 2024 | Standard Therapy | Poland | 9 |
415 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2024 | Standard Therapy | Poland | 7 |
416 | Bone Marrow | Allogeneic | Primary Immunodeficiency Xlp-1 | Hematology | 2024 | Standard Therapy | Poland | 18 |
417 | Bone Marrow | Allogeneic | Relapse T-Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
418 | Bone Marrow | Allogeneic | Secondary Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 4 |
419 | Bone Marrow | Allogeneic | Secondary Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
420 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 7 |
421 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 3 |
422 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 10 |
423 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 21 |
424 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 18 |
425 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 49 |
426 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 16 |
427 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 24 |
428 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 13 |
429 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 14 |
430 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 21 |
431 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 7 |
432 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2024 | Standard Therapy | Poland | 2 |
433 | Bone Marrow | Allogeneic | Severe Congenital Neutropenia | Hematology | 2024 | Standard Therapy | Poland | 1 |
434 | Bone Marrow | Allogeneic | Shwachman-Diamond Syndrome | Hematology | 2024 | Standard Therapy | Poland | 10 |
435 | Bone Marrow | Allogeneic | Sickle Cell Disease | Hematology | 2024 | Standard Therapy | Poland | 9 |
436 | Bone Marrow | Allogeneic | Biphenotypic Acute Leukemia | Hematology | 2024 | Standard Therapy | Ukraine | 10 |
437 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 58 |
438 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | United Kingdom | 12 |
439 | Bone Marrow | Allogeneic | hemophagocytic lymphohistiocytosis | Hematology | 2024 | Standard Therapy | Sweden | 4 months |
440 | Bone Marrow | Allogeneic | Severe combined immunodeficiency | Hematology | 2024 | Standard Therapy | Germany | 1 |
441 | Bone Marrow | Allogeneic | Beta-Thalassemia Major | Hematology | 2024 | Standard Therapy | India | 11 |
442 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Austria | 4 |
443 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Norway | 33 |
444 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Spain | 16 |
445 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Switzerland | 5 |
446 | Bone Marrow | Allogeneic | T- Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Ireland | 6 |
447 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 12 |
448 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2024 | Standard Therapy | USA | 4 months |
449 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Belgium | 50 |
450 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | France | 31 |
451 | Bone Marrow | Allogeneic | Chronic myelomonocytic leukemia | Hematology | 2024 | Standard Therapy | Italy | 64 |
452 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | France | 10 |
453 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
454 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | USA | 4 |
455 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Canada | 8 |
456 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 17 |
457 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | USA | 8 |
458 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | USA | 67 |
459 | Bone Marrow | Allogeneic | Hodgkins Lymphoma | Hematology | 2024 | Standard Therapy | United Kingdom | 36 |
460 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 72 |
461 | Bone Marrow | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 9 |
462 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2024 | Standard Therapy | USA | 3 |
463 | Apheresis | Allogeneic | A- Thalassemia | Hematology | 2024 | Standard Therapy | Poland | 11 |
464 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 13 |
465 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 21 |
466 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 22 |
467 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
468 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 41 |
469 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 44 |
470 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 44 |
471 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 48 |
472 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 50 |
473 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 50 |
474 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 55 |
475 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
476 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 60 |
477 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 63 |
478 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 44 |
479 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
480 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 51 |
481 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 34 |
482 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 1 |
483 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 10 |
484 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 20 |
485 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 25 |
486 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 26 |
487 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 28 |
488 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 34 |
489 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 35 |
490 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 37 |
491 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
492 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
493 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 40 |
494 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 41 |
495 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 43 |
496 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 51 |
497 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 51 |
498 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 51 |
499 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
500 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
501 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
502 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
503 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
504 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 61 |
505 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 61 |
506 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
507 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
508 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 64 |
509 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 65 |
510 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 66 |
511 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 67 |
512 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 67 |
513 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 68 |
514 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
515 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
516 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
517 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
518 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 69 |
519 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 70 |
520 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 70 |
521 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 72 |
522 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 73 |
523 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 77 |
524 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 59 |
525 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 66 |
526 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 58 |
527 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 54 |
528 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 29 |
529 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 64 |
530 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 27 |
531 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
532 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 63 |
533 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 50 |
534 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
535 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 30 |
536 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 68 |
537 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 77 |
538 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
539 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 47 |
540 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
541 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 65 |
542 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 64 |
543 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 61 |
544 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 64 |
545 | Apheresis | Allogeneic | Acute Myelogenous Leukemia- Core-Binding Factor | Hematology | 2024 | Standard Therapy | Poland | 68 |
546 | Apheresis | Allogeneic | Acute Myelogenous Leukemia, Post Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 63 |
547 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 36 |
548 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 46 |
549 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 48 |
550 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 52 |
551 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 58 |
552 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 61 |
553 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Poland | 67 |
554 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 71 |
555 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 72 |
556 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 63 |
557 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Germany | 32 |
558 | Apheresis | Autologous | Acute Myeloid Leukemia - Relapse | Hematology | 2024 | Standard Therapy | Germany | 68 |
559 | Apheresis | Allogeneic | Acute Myeloid Leukemia Relapse | Hematology | 2024 | Standard Therapy | Germany | 33 |
560 | Apheresis | Allogeneic | Amegakaryocytic/Congenital Thrombocytopenia | Hematology | 2024 | Standard Therapy | Poland | 63 |
561 | Apheresis | Allogeneic | Anaplastic Large Cell Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 52 |
562 | Apheresis | Allogeneic | Angioimmunoblastic T-Cell Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 47 |
563 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 19 |
564 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 62 |
565 | Apheresis | Allogeneic | B-Cell Progenitor Acute Lymphoblastic Leukemia High Risk | Hematology | 2024 | Standard Therapy | Poland | 4 |
566 | Apheresis | Allogeneic | Calr Positive Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 61 |
567 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
568 | Apheresis | Allogeneic | Chronic Myelogenous Leukaemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
569 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 10 |
570 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 35 |
571 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 42 |
572 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 49 |
573 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 72 |
574 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 71 |
575 | Apheresis | Allogeneic | Fanconi Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 20 |
576 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 48 |
577 | Apheresis | Allogeneic | High Risk Acute Myeloid Leukaemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
578 | Apheresis | Allogeneic | High Risk Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 69 |
579 | Apheresis | Allogeneic | High-Risk Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 71 |
580 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 27 |
581 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 27 |
582 | Apheresis | Allogeneic | Hodgkin Disease | Hematology | 2024 | Standard Therapy | Poland | 28 |
583 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 23 |
584 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome/Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 71 |
585 | Apheresis | Allogeneic | Infant Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 41 |
586 | Apheresis | Allogeneic | Kutanes T-Zell-Lymphom, Mycosis Fungoides | Hematology | 2024 | Standard Therapy | Poland | 72 |
587 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 51 |
588 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 64 |
589 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 66 |
590 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 52 |
591 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2024 | Standard Therapy | Germany | 63 |
592 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Poland | 43 |
593 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 52 |
594 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 54 |
595 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 60 |
596 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
597 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
598 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
599 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
600 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
601 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 63 |
602 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 64 |
603 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
604 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
605 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
606 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
607 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 67 |
608 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 68 |
609 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 69 |
610 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 70 |
611 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 71 |
612 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 72 |
613 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
614 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
615 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 58 |
616 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
617 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
618 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 62 |
619 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 70 |
620 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 74 |
621 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 58 |
622 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2024 | Standard Therapy | Germany | 63 |
623 | Apheresis | Allogeneic | Myelodysplastic | Hematology | 2024 | Standard Therapy | Poland | 68 |
624 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 20 |
625 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 22 |
626 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 54 |
627 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 58 |
628 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 60 |
629 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 62 |
630 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 65 |
631 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
632 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
633 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
634 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 69 |
635 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 69 |
636 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 70 |
637 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 71 |
638 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 73 |
639 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 60 |
640 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 53 |
641 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 69 |
642 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 59 |
643 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 60 |
644 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 49 |
645 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 52 |
646 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 63 |
647 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 66 |
648 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 58 |
649 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 67 |
650 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 65 |
651 | Apheresis | Allogeneic | Myelodysplastic Syndrome + Myeloma | Hematology | 2024 | Standard Therapy | Germany | 67 |
652 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 40 |
653 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 58 |
654 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | Poland | 60 |
655 | Apheresis | Allogeneic | Myelofibrosis Post. Polycythemia Vera | Hematology | 2024 | Standard Therapy | Poland | 66 |
656 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | Poland | 67 |
657 | Apheresis | Allogeneic | Myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
658 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2024 | Standard Therapy | Poland | 74 |
659 | Apheresis | Allogeneic | Myeloproliferative Neoplasms/Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 68 |
660 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 23 |
661 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 50 |
662 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 50 |
663 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 67 |
664 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 46 |
665 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Poland | 65 |
666 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 66 |
667 | Apheresis | Autologous | Non-Hodgkin Lymphoma - relapse | Hematology | 2024 | Standard Therapy | Germany | 54 |
668 | Apheresis | Autologous | Nonseminoma | Hematology | 2024 | Standard Therapy | Germany | 38 |
669 | Apheresis | Allogeneic | Osteomyelitis | Hematology | 2024 | Standard Therapy | Poland | 65 |
670 | Apheresis | Allogeneic | Post-Et-Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 59 |
671 | Apheresis | Allogeneic | Post-Pv-Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 64 |
672 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 60 |
673 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 52 |
674 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 67 |
675 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 70 |
676 | Apheresis | Allogeneic | Relapsed B-Cell Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 12 |
677 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
678 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 10 |
679 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
680 | Apheresis | Allogeneic | Severe Aplastic Anemia Progressed To Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 21 |
681 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 63 |
682 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 64 |
683 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 56 |
684 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 56 |
685 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 64 |
686 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 56 |
687 | Apheresis | Autologous | Follicular lymphoma | Hematology | 2024 | Standard Therapy | Germany | 58 |
688 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
689 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 47 |
690 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 69 |
691 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 38 |
692 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
693 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 70 |
694 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 64 |
695 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 53 |
696 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 60 |
697 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 59 |
698 | Apheresis | Autologous | Mantle cell lymphoma | Hematology | 2024 | Standard Therapy | Germany | 45 |
699 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
700 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Germany | 33 |
701 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 64 |
702 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 59 |
703 | Apheresis | Allogeneic | Primary myelofibrosis | Hematology | 2024 | Standard Therapy | Germany | 55 |
704 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 63 |
705 | Apheresis | Allogeneic | Blastic Plasmacytoid Dendritic | Hematology | 2024 | Standard Therapy | USA | 57 |
706 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 32 |
707 | Apheresis | Allogeneic | Macrofocal multiple myeloma | Hematology | 2024 | Standard Therapy | USA | 75 |
708 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | United Kingdom | 62 |
709 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 52 |
710 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 48 |
711 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | United Kingdom | 71 |
712 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Romania | 35 |
713 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Lithuania | 47 |
714 | Apheresis | Allogeneic | Diffuse large B-cell lymphoma | Hematology | 2024 | Standard Therapy | Australia | 46 |
715 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 65 |
716 | Apheresis | Allogeneic | Chronic lymphatic leukemia | Hematology | 2024 | Standard Therapy | Norway | 52 |
717 | Apheresis | Allogeneic | Chronic myelogenous leukemia | Hematology | 2024 | Standard Therapy | Poland | 60 |
718 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Hungary | 32 |
719 | Apheresis | Allogeneic | Malignant histiocytosis | Hematology | 2024 | Standard Therapy | Bulgaria | 41 |
720 | Apheresis | Allogeneic | Myelodysplastic syndrome | Hematology | 2024 | Standard Therapy | USA | 78 |
721 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Hungary | 20 |
722 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 58 |
723 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Portugal | 67 |
724 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 63 |
725 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Lithuania | 19 |
726 | Apheresis | Allogeneic | Hodgkin lymphoma | Hematology | 2024 | Standard Therapy | Russia | 34 |
727 | Apheresis | Allogeneic | chronic lymphocytic leukemia Richters Transformation | Hematology | 2024 | Standard Therapy | United Kingdom | 68 |
728 | Apheresis | Allogeneic | myelodysplasia | Hematology | 2024 | Standard Therapy | Sweden | 66 |
729 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 52 |
730 | Apheresis | Allogeneic | myelodysplasia | Hematology | 2024 | Standard Therapy | Lithuania | 70 |
731 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 72 |
732 | Apheresis | Allogeneic | plasma cell leukemia | Hematology | 2024 | Standard Therapy | USA | 59 |
733 | Apheresis | Allogeneic | Fibrolamellar Carcinoma | Hematology | 2024 | Standard Therapy | Czechia | 41 |
734 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 59 |
735 | Apheresis | Allogeneic | post-ET Myelofibrose | Hematology | 2024 | Standard Therapy | Austria | 61 |
736 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 55 |
737 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2024 | Standard Therapy | Poland | 67 |
738 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Spain | 45 |
739 | Apheresis | Allogeneic | Myelofibrose | Hematology | 2024 | Standard Therapy | Spain | 69 |
740 | Apheresis | Allogeneic | Myelofibrose | Hematology | 2024 | Standard Therapy | Poland | 60 |
741 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | USA | 53 |
742 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 35 |
743 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 69 |
744 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Norway | 18 |
745 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Germany | 51 |
746 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 62 |
747 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Hungary | 56 |
748 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2024 | Standard Therapy | USA | 19 |
749 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Spain | 67 |
750 | Apheresis | Allogeneic | emophagocytic lymphohistiocytosis | Hematology | 2024 | Standard Therapy | United Kingdom | 48 |
751 | Apheresis | Allogeneic | Non-Hodgkin's lymphoma | Hematology | 2024 | Standard Therapy | NETHERLANDS | 61 |
752 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 29 |
753 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
754 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Israel | 63 |
755 | Apheresis | Allogeneic | ETP-Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 35 |
756 | Apheresis | Allogeneic | Hodgkin lymphoma | Hematology | 2024 | Standard Therapy | Poland | 4 |
757 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 23 |
758 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2024 | Standard Therapy | USA | 27 |
759 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 69 |
760 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 44 |
761 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 49 |
762 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 20 |
763 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 50 |
764 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 74 |
765 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Austria | 49 |
766 | Apheresis | Allogeneic | Post-PV Myelofibrose | Hematology | 2024 | Standard Therapy | Germany | 59 |
767 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 66 |
768 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 58 |
769 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 55 |
770 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | France | 70 |
771 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | France | 54 |
772 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 68 |
773 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Poland | 41 |
774 | Apheresis | Allogeneic | Chronic myelogenous leukemia | Hematology | 2024 | Standard Therapy | USA | 31 |
775 | Apheresis | Allogeneic | Other leukemia | Hematology | 2024 | Standard Therapy | Italy | 31 |
776 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Sweden | 42 |
777 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 43 |
778 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 52 |
779 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 64 |
780 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 60 |
781 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 70 |
782 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
783 | Apheresis | Allogeneic | Primary myelofibrosis | Hematology | 2024 | Standard Therapy | Germany | 55 |
784 | Apheresis | Autologous | Amyloid light-chain amyloidosis | Hematology | 2024 | Standard Therapy | Germany | 55 |
785 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
786 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
787 | Apheresis | Autologous | Epstein–Barr virus positive diffuse large B-cell lymphoma | Hematology | 2024 | Standard Therapy | Germany | 63 |
788 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 69 |
789 | Apheresis | Autologous | Angioimmunoblastic T-cell lymphoma | Hematology | 2024 | Standard Therapy | Germany | 58 |
790 | Apheresis | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2024 | Standard Therapy | Germany | 19 |
791 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 66 |
792 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 61 |
793 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Canada | 16 |
794 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 61 |
795 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 75 |
796 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | USA | 62 |
797 | Apheresis | Allogeneic | Myelodysplastic Disorders | Hematology | 2024 | Standard Therapy | France | 66 |
798 | Apheresis | Allogeneic | B-Cell Lymphoma | Hematology | 2024 | Standard Therapy | Canada | 70 |
799 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 60 |
800 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2024 | Standard Therapy | Poland | 57 |
801 | Apheresis | Allogeneic | Diffuse large B-cell lymphoma | Hematology | 2024 | Standard Therapy | Poland | 17 |
802 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 48 |
803 | Apheresis | Allogeneic | Chronic lymphocytic leukemia | Hematology | 2024 | Standard Therapy | Germany | 63 |
804 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 65 |
805 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 64 |
806 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 76 |
807 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 44 |
808 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 62 |
809 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | NETHERLANDS | 25 |
810 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | USA | 42 |
811 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | CROATIA | 66 |
812 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 70 |
813 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Switzerland | 68 |
814 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukaemia | Hematology | 2024 | Standard Therapy | NETHERLANDS | 62 |
815 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 58 |
816 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 62 |
817 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Belarus | 54 |
818 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Spain | 9 |
819 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 66 |
820 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 67 |
821 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 54 |
822 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | South Africa | 54 |
823 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 60 |
824 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Sweden | 60 |
825 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Spain | 67 |
826 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 66 |
827 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 53 |
828 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 65 |
829 | Apheresis | Autologous | Non-Hodgkin lymphoma, rezidiv | Hematology | 2024 | Standard Therapy | Germany | 64 |
830 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 57 |
831 | Apheresis | Allogeneic | Acute myeloid leukemia | Hematology | 2024 | Standard Therapy | Germany | 66 |
832 | Apheresis | Allogeneic | Acute lymphoblastic leukemia | Hematology | 2024 | Standard Therapy | Germany | 50 |
833 | Apheresis | Autologous | Multiple myeloma | Hematology | 2024 | Standard Therapy | Germany | 57 |
834 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 70 |
835 | Apheresis | Allogeneic | Multiple Organ Dysfunction Syndrome | Hematology | 2024 | Standard Therapy | Germany | 42 |
836 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 32 |
837 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 76 |
838 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2024 | Standard Therapy | Italy | 63 |
839 | Apheresis | Allogeneic | Early T-cell precursor Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Australia | 43 |
840 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 72 |
841 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | Germany | 72 |
842 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 52 |
843 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | USA | 73 |
844 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2024 | Standard Therapy | Poland | 68 |
845 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Italy | 63 |
846 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Czechia | 46 |
847 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | France | 64 |
848 | Apheresis | Allogeneic | Primary Immunodeficiencies | Hematology | 2024 | Standard Therapy | Russia | 7 |
849 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 68 |
850 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 62 |
851 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 48 |
852 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2024 | Standard Therapy | USA | 63 |
853 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2024 | Standard Therapy | Spain | 58 |
854 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2024 | Standard Therapy | Poland | 41 |
855 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2024 | Standard Therapy | USA | 73 |
856 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 15 |
857 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Germany | 65 |
858 | Apheresis | Allogeneic | Acute Myelogenous Leukemia | Hematology | 2024 | Standard Therapy | Poland | 38 |
859 | Apheresis | Allogeneic | Plasmacytoma | Hematology | 2024 | Standard Therapy | Poland | 46 |
860 | Apheresis | Autologous | No data | Hematology | 2024 | Standard Therapy | Portugal | 60 |
861 | Apheresis | Autologous | No data | Hematology | 2024 | Standard Therapy | Portugal | 60 |
862 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2023 | Experimental Therapy | Poland | 8 |
863 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2023 | Experimental Therapy | Poland | 16 |
864 | Cord Tissue | Allogeneic - Related | Ags (Autism + Epilepsy) | Neurology | 2023 | Experimental Therapy | Poland/Romania | 15 |
865 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 8,5 |
866 | Cord Tissue | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 10 |
867 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 4 |
868 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
869 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3,2 |
870 | Cord Tissue | Autologous | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 2 |
871 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 3 |
872 | Cord Tissue | Allogeneic - Unrelated | Disorders Of Optic Nerve | Ophthalmology | 2023 | Experimental Therapy | Poland | 39,1 |
873 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2023 | Experimental Therapy | Poland | 65,1 |
874 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2023 | Experimental Therapy | Poland | 50,8 |
875 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2023 | Experimental Therapy | Poland | 8 months |
876 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2023 | Experimental Therapy | Poland | 16,2 |
877 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 20,8 |
878 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 49,8 |
879 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 62,7 |
880 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2023 | Experimental Therapy | Poland | 24,1 |
881 | Cord Tissue | Allogeneic - Unrelated | Mucopolysaccharidosis Type Ii | Hematology | 2023 | Experimental Therapy | Poland | 4,7 |
882 | Cord Tissue | Allogeneic - Unrelated | Non-Inflammatory Diseases Of The Ovary, Fallopian Tube, And Broad Ligament Of The Uterus | Gynecology | 2023 | Experimental Therapy | Poland | 47 |
883 | Cord Tissue | Autologous | Optic Nerve Atrophy, Tetraparesis, Hydrocephalus | Neurology | 2023 | Experimental Therapy | Romania | 5,5 |
884 | Cord Tissue | Allogeneic - Unrelated | Ovarian Dysfunction | Gynecology | 2023 | Experimental Therapy | Poland | 44,8 |
885 | Cord Tissue | Allogeneic - Unrelated | Ovarian Dysfunction | Gynecology | 2023 | Experimental Therapy | Poland | 32,11 |
886 | Cord Tissue | Allogeneic - Unrelated | Polycystic Ovary Syndrome | Gynecology | 2023 | Experimental Therapy | Poland | 39,4 |
887 | Cord Tissue | Allogeneic - Related | Right Parietal Closed Schizencephaly | Neurology | 2023 | Experimental Therapy | Romania | 38 |
888 | Cord Tissue | Allogeneic - Related | Rp+ Usher Syndrome | Neurology | 2023 | Experimental Therapy | Romania | 10 |
889 | Cord Tissue | Allogeneic - Related | Sudden Sensorineural Hearing Loss (Ssnhl) | Neurology | 2023 | Experimental Therapy | Romania | 1 |
890 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 10 |
891 | Cord Blood | Allogeneic | Autism | Neurology | 2023 | Experimental Therapy | Poland | 3,3 |
892 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3 |
893 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3 |
894 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
895 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Portugal | 7 |
896 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Portugal | 5 |
897 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 14 |
898 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Romania | 10 |
899 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 3 |
900 | Cord Blood | Allogeneic - Related | Autism | Neurology | 2023 | Experimental Therapy | Romania | 3,2 |
901 | Cord Blood | Autologous | Autism | Neurology | 2023 | Experimental Therapy | Hungary | 5 |
902 | Cord Blood | Allogeneic - Related | Beta Thalassemia | Hematology | 2023 | Standard Therapy | UK | 8 |
903 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Hungary | 5 |
904 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Standard Therapy | UK | 2,5 |
905 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Standard Therapy | UK | 2,5 |
906 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Poland | 2,1 |
907 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2023 | Experimental Therapy | Romania | 10 |
908 | Cord Blood | Allogeneic - Related | Cerebral Palsy, Psychomotor Retard, Tetraparesis, Microcephaly | Neurology | 2023 | Experimental Therapy | Romania | 9 |
909 | Cord Blood | Autologous | Global Developmental Delay Si Truncal Ataxia | Neurology | 2023 | Experimental Therapy | Romania | 5 |
910 | Cord Blood | Allogeneic | Neuroblastoma | Hematology | 2023 | Standard Therapy | Turkey | 2,1 |
911 | Cord Blood | Allogeneic - Related | Neuroblastoma | Hematology | 2023 | Standard Therapy | Turkey | 2,1 |
912 | Cord Blood | Autologous | Optic Nerve Atrophy, Tetraparesis, Hydrocephalus | Neurology | 2023 | Experimental Therapy | Romania | 5,5 |
913 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2023 | Experimental Therapy | Poland | 3,11 |
914 | Cord Blood | Autologous | Pervasive Developmental Disorder | Neurology | 2023 | Experimental Therapy | Poland | 8,1 |
915 | Cord Blood | Allogeneic - Related | Spasmodic Torticollis | Neurology | 2023 | Experimental Therapy | Romania | 41 |
916 | Cord Blood | Allogeneic | Thalassemia Major | Hematology | 2023 | Standard Therapy | Turkey | 17,4 |
917 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2023 | Standard Therapy | Turkey | 17,4 |
918 | Cord Blood | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 5 months |
919 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
920 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
921 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 35 |
922 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
923 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
924 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
925 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
926 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
927 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 21 |
928 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
929 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
930 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 39 |
931 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
932 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
933 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
934 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
935 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
936 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
937 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
938 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 56 |
939 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
940 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
941 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
942 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
943 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
944 | Bone Marrow Family | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 30 |
945 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
946 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
947 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
948 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 76 |
949 | Bone Marrow Family | Allogeneic | Langerhans Cell Sarcoma | Hematology | 2023 | Standard Therapy | Poland | 66 |
950 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Poland | 63 |
951 | Bone Marrow Family | Allogeneic | Mycosis Fungoides | Hematology | 2023 | Standard Therapy | Poland | 71 |
952 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 71 |
953 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
954 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 70 |
955 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Germany | 70 |
956 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 55 |
957 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
958 | Bone Marrow Family | Allogeneic | Secondary Chronic Myelomonocytic Leukemia To Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
959 | Bone Marrow Family | Allogeneic | Secondary Myelodysplastic Syndrome With Excess Of Blasts | Hematology | 2023 | Standard Therapy | Poland | 15 |
960 | Bone Marrow Family | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
961 | Bone Marrow Family | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
962 | Bone Marrow | Allogeneic | Acute Leukemia Of Ambiguous Lineage | Hematology | 2023 | Standard Therapy | Poland | 1 |
963 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
964 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
965 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
966 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
967 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
968 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
969 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 25 |
970 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 7 |
971 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
972 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 8 months |
973 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
974 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
975 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
976 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
977 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 3 |
978 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
979 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
980 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
981 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
982 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 13 |
983 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
984 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
985 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
986 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
987 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
988 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
989 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 14 |
990 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
991 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 75 |
992 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
993 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 13 |
994 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 6 |
995 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
996 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 34 |
997 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Hematology | 2023 | Standard Therapy | Poland | 7 |
998 | Bone Marrow | Allogeneic | Adrenoleukodystrophy (Ald) - Siemerling-Creutzfeldt Disease | Hematology | 2023 | Standard Therapy | Poland | 4 |
999 | Bone Marrow | Allogeneic | Amegakaryocytic Thrombocytopenia | Hematology | 2023 | Standard Therapy | Poland | 6 months |
1000 | Bone Marrow | Allogeneic | Anemia Fanconi | Hematology | 2023 | Standard Therapy | Poland | 6 |
1001 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 18 |
1002 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
1003 | Bone Marrow | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
1004 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2023 | Standard Therapy | Poland | 12 |
1005 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1006 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
1007 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
1008 | Bone Marrow | Allogeneic | Chronic Myeloid Leukemia Blast Crisis | Hematology | 2023 | Standard Therapy | Poland | 21 |
1009 | Bone Marrow | Allogeneic | Clippers Syndrome | Hematology | 2023 | Standard Therapy | Poland | 49 |
1010 | Bone Marrow | Allogeneic | Congenital Amegakaryocytic Thrombocytopenia (Camt) | Hematology | 2023 | Standard Therapy | Poland | 6 months |
1011 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
1012 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2023 | Standard Therapy | Poland | 2 |
1013 | Bone Marrow | Allogeneic | Hodgkin’s Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 23 |
1014 | Bone Marrow | Allogeneic | Immunodeficiency – Xlp1 | Hematology | 2023 | Standard Therapy | Poland | 10 |
1015 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 5 |
1016 | Bone Marrow | Allogeneic | Mantle Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 68 |
1017 | Bone Marrow | Allogeneic | Metachromatic Leukodystrophy | Hematology | 2023 | Standard Therapy | Poland | 22 |
1018 | Bone Marrow | Allogeneic | Mitochondrial Neurogastrointestinal Encephalopathy | Hematology | 2023 | Standard Therapy | Poland | 33 |
1019 | Bone Marrow | Allogeneic | Mixed Lineage Acute Leukemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
1020 | Bone Marrow | Allogeneic | Monocytopenia And Mycobacterial Infection (Monomac) Syndrome | Hematology | 2023 | Standard Therapy | Poland | 5 |
1021 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Hematology | 2023 | Standard Therapy | Poland | 2 |
1022 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Ih (Hurler) | Hematology | 2023 | Standard Therapy | Poland | 8 months |
1023 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Iv | Hematology | 2023 | Standard Therapy | Poland | 5 |
1024 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 51 |
1025 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 11 |
1026 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 14 |
1027 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 6 |
1028 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 7 |
1029 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 19 |
1030 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 3 |
1031 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 2 |
1032 | Bone Marrow | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 61 |
1033 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 20 |
1034 | Bone Marrow | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 6 |
1035 | Bone Marrow | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 6 months |
1036 | Bone Marrow | Allogeneic | Primary Combined Severe Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 14 |
1037 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 3 |
1038 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 4 |
1039 | Bone Marrow | Allogeneic | Prolymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1040 | Bone Marrow | Allogeneic | Relapsed T Cell Acute Lymphoblastic Leukemia (T-All) | Hematology | 2023 | Standard Therapy | Poland | 5 |
1041 | Bone Marrow | Allogeneic | Secondary Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
1042 | Bone Marrow | Allogeneic | Secondary Myelofibrosis Post Polycythemia Vera | Hematology | 2023 | Standard Therapy | Poland | 60 |
1043 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
1044 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 4 |
1045 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 31 |
1046 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
1047 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
1048 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 15 |
1049 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
1050 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 81 |
1051 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 29 |
1052 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 15 |
1053 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 1 |
1054 | Bone Marrow | Allogeneic | Sickle Cell Disease | Hematology | 2023 | Standard Therapy | Poland | 5 |
1055 | Bone Marrow | Allogeneic | T-Acute Lymphoblastic Leukemia, Ataxia Telangiectasia | Hematology | 2023 | Standard Therapy | Poland | 8 |
1056 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
1057 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2023 | Standard Therapy | Poland | 2 |
1058 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 21 |
1059 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 1 |
1060 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 3 |
1061 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 67 |
1062 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
1063 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
1064 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
1065 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 58 |
1066 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
1067 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
1068 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
1069 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 8 |
1070 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 52 |
1071 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
1072 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 54 |
1073 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
1074 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
1075 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 60 |
1076 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 40 |
1077 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
1078 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 35 |
1079 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
1080 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
1081 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 39 |
1082 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
1083 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
1084 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
1085 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 19 |
1086 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
1087 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
1088 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
1089 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 48 |
1090 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 47 |
1091 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 64 |
1092 | Apheresis | Autologous | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 61 |
1093 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
1094 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
1095 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
1096 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
1097 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 44 |
1098 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
1099 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Germany | 31 |
1100 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 30 |
1101 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1102 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia T-Cell; Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 72 |
1103 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 58 |
1104 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 60 |
1105 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
1106 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
1107 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
1108 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
1109 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
1110 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
1111 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
1112 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
1113 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
1114 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
1115 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
1116 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
1117 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
1118 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
1119 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 87 |
1120 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
1121 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1122 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
1123 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
1124 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 56 |
1125 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
1126 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 33 |
1127 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
1128 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1129 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
1130 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
1131 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
1132 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
1133 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
1134 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1135 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1136 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
1137 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1138 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 31 |
1139 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
1140 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
1141 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 82 |
1142 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
1143 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1144 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
1145 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 72 |
1146 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1147 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
1148 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
1149 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
1150 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 61 |
1151 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 58 |
1152 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
1153 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
1154 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 57 |
1155 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1156 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 75 |
1157 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
1158 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 7 |
1159 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 52 |
1160 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
1161 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
1162 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
1163 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
1164 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
1165 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
1166 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
1167 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
1168 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
1169 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1170 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
1171 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
1172 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1173 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 35 |
1174 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 48 |
1175 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1176 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
1177 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
1178 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 52 |
1179 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 74 |
1180 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
1181 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
1182 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
1183 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 70 |
1184 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 32 |
1185 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
1186 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
1187 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
1188 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1189 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 79 |
1190 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
1191 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
1192 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
1193 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
1194 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
1195 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 16 |
1196 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 44 |
1197 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 68 |
1198 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
1199 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
1200 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
1201 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
1202 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 72 |
1203 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
1204 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
1205 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
1206 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1207 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 36 |
1208 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
1209 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 69 |
1210 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
1211 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 1 |
1212 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
1213 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
1214 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 56 |
1215 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
1216 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
1217 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
1218 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 40 |
1219 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 36 |
1220 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
1221 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
1222 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
1223 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 72 |
1224 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 22 |
1225 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
1226 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
1227 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Germany | 38 |
1228 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 44 |
1229 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 46 |
1230 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1231 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
1232 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
1233 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
1234 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
1235 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
1236 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 68 |
1237 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
1238 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 73 |
1239 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 63 |
1240 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
1241 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 39 |
1242 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1243 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
1244 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 47 |
1245 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 38 |
1246 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 71 |
1247 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 50 |
1248 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 67 |
1249 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
1250 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
1251 | Apheresis | Autologous | Anaplastic Lymphoma Kinase Positive Anaplastic Large-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 37 |
1252 | Apheresis | Allogeneic | Bare Lymphocyte Syndrome Type Ii | Hematology | 2023 | Standard Therapy | Poland | 3 months |
1253 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 66 |
1254 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 49 |
1255 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 66 |
1256 | Apheresis | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 53 |
1257 | Apheresis | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 27 |
1258 | Apheresis | Allogeneic | B-Cell Precursor Acute Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 51 |
1259 | Apheresis | Allogeneic | Beta Thalassemia Major | Hematology | 2023 | Standard Therapy | Poland | 4 |
1260 | Apheresis | Allogeneic | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hematology | 2023 | Standard Therapy | Poland | 66 |
1261 | Apheresis | Allogeneic | Cell Neoplasm | Hematology | 2023 | Standard Therapy | Germany | 47 |
1262 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
1263 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 43 |
1264 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Germany | 36 |
1265 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
1266 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 59 |
1267 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 37 |
1268 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
1269 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
1270 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
1271 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 54 |
1272 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Germany | 28 |
1273 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
1274 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
1275 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
1276 | Apheresis | Autologous | Composite Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 71 |
1277 | Apheresis | Allogeneic | Congenital Pulmonary Lymphangiectasia | Hematology | 2023 | Standard Therapy | Poland | 50 |
1278 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 59 |
1279 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 50 |
1280 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 70 |
1281 | Apheresis | Allogeneic | Ewing Sarcoma | Hematology | 2023 | Standard Therapy | Poland | 62 |
1282 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 62 |
1283 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 53 |
1284 | Apheresis | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2023 | Standard Therapy | Poland | 4 months |
1285 | Apheresis | Autologous | Hodgkin - Relapse | Hematology | 2023 | Standard Therapy | Germany | 43 |
1286 | Apheresis | Allogeneic | Huntington's Disease (Hd) | Hematology | 2023 | Standard Therapy | Germany | 36 |
1287 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 27 |
1288 | Apheresis | Allogeneic | Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 4 |
1289 | Apheresis | Allogeneic | Inherited Immune System Disorder | Hematology | 2023 | Standard Therapy | Poland | 16 |
1290 | Apheresis | Allogeneic | Langerhans Cell Sarcoma | Hematology | 2023 | Standard Therapy | Poland | 66 |
1291 | Apheresis | Autologous | Light-Chain Amyloidosis | Hematology | 2023 | Standard Therapy | Germany | 62 |
1292 | Apheresis | Allogeneic | Macrofocal Multiple Myeloma | Hematology | 2023 | Standard Therapy | Poland | 94 |
1293 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 54 |
1294 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 64 |
1295 | Apheresis | Allogeneic | Mast Cell Sarcoma, Systemic Mastocytosis Nr | Hematology | 2023 | Standard Therapy | Poland | 51 |
1296 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2023 | Standard Therapy | Poland | 64 |
1297 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2023 | Standard Therapy | Germany | 43 |
1298 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2023 | Standard Therapy | Germany | 57 |
1299 | Apheresis | Allogeneic | Mucopolysaccharidosis /Myelodysplastic Syndrome Overlap | Hematology | 2023 | Standard Therapy | Poland | 71 |
1300 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 47 |
1301 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 53 |
1302 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 65 |
1303 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 60 |
1304 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
1305 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
1306 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 72 |
1307 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 61 |
1308 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 68 |
1309 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 54 |
1310 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 67 |
1311 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 69 |
1312 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 61 |
1313 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
1314 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
1315 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 61 |
1316 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 64 |
1317 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 69 |
1318 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 58 |
1319 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 56 |
1320 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 66 |
1321 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
1322 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Poland | 56 |
1323 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 53 |
1324 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 66 |
1325 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 59 |
1326 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 59 |
1327 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 64 |
1328 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 63 |
1329 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 68 |
1330 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 60 |
1331 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 42 |
1332 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 62 |
1333 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 50 |
1334 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 59 |
1335 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 56 |
1336 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 64 |
1337 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2023 | Standard Therapy | Germany | 59 |
1338 | Apheresis | Allogeneic | Mycosis Fungoides | Hematology | 2023 | Standard Therapy | Poland | 62 |
1339 | Apheresis | Allogeneic | Myelodysplastic Disorders | Hematology | 2023 | Standard Therapy | Poland | 57 |
1340 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 71 |
1341 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 64 |
1342 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 67 |
1343 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 56 |
1344 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 41 |
1345 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 70 |
1346 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 57 |
1347 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 70 |
1348 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 47 |
1349 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 29 |
1350 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 66 |
1351 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
1352 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 40 |
1353 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 56 |
1354 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 69 |
1355 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 59 |
1356 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 56 |
1357 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
1358 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 66 |
1359 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 63 |
1360 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 64 |
1361 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 64 |
1362 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 63 |
1363 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 65 |
1364 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 68 |
1365 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 44 |
1366 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 66 |
1367 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 48 |
1368 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 45 |
1369 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 67 |
1370 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 69 |
1371 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 72 |
1372 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 53 |
1373 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 71 |
1374 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 66 |
1375 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 57 |
1376 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 74 |
1377 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 72 |
1378 | Apheresis | Allogeneic | Myelodysplastic Syndrome Lb High Risk | Hematology | 2023 | Standard Therapy | Poland | 58 |
1379 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Multilineage Dysplasia | Hematology | 2023 | Standard Therapy | Poland | 68 |
1380 | Apheresis | Allogeneic | Myelodysplastic Syndrome/Acute Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 42 |
1381 | Apheresis | Allogeneic | Myelodysplastic Syndrome-Eb1 | Hematology | 2023 | Standard Therapy | Poland | 48 |
1382 | Apheresis | Allogeneic | Myelodysplastic Syndromes (Mds) | Hematology | 2023 | Standard Therapy | Poland | 73 |
1383 | Apheresis | Allogeneic | Myelodysplastic Syndromes (Mds) | Hematology | 2023 | Standard Therapy | Poland | 76 |
1384 | Apheresis | Allogeneic | Myelodysplastic Syndromes (Mds) | Hematology | 2023 | Standard Therapy | Poland | 70 |
1385 | Apheresis | Allogeneic | Myelodysplastic Syndromes (Mds) | Hematology | 2023 | Standard Therapy | Poland | 5 |
1386 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 65 |
1387 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 56 |
1388 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 70 |
1389 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 69 |
1390 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 61 |
1391 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 70 |
1392 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 68 |
1393 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2023 | Standard Therapy | Poland | 50 |
1394 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2023 | Standard Therapy | Poland | 54 |
1395 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1396 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2023 | Standard Therapy | Poland | 63 |
1397 | Apheresis | Autologous | No Data | Hematology | 2023 | Standard Therapy | Germany | 69 |
1398 | Apheresis | Autologous | No Data | Hematology | 2023 | Standard Therapy | Germany | 53 |
1399 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 50 |
1400 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 23 |
1401 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 39 |
1402 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 2 |
1403 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 52 |
1404 | Apheresis | Allogeneic | No Data | Hematology | 2023 | Standard Therapy | Poland | 61 |
1405 | Apheresis | Autologous | No Data | Hematology | 2023 | Standard Therapy | Germany | 60 |
1406 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 71 |
1407 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 44 |
1408 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 72 |
1409 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 66 |
1410 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 33 |
1411 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 42 |
1412 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 63 |
1413 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 19 |
1414 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 54 |
1415 | Apheresis | Autologous | Nonseminoma, Relapse | Hematology | 2023 | Standard Therapy | Germany | 48 |
1416 | Apheresis | Allogeneic | Orofacial Myofunctional Disorders (Omds), Primary Myelofibrosis (Pmf) | Hematology | 2023 | Standard Therapy | Poland | 69 |
1417 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 60 |
1418 | Apheresis | Allogeneic | Other Immune System | Hematology | 2023 | Standard Therapy | Poland | 71 |
1419 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2023 | Standard Therapy | Poland | 49 |
1420 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 56 |
1421 | Apheresis | Allogeneic | Other Non-Malignant Disease | Hematology | 2023 | Standard Therapy | Poland | 70 |
1422 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2023 | Standard Therapy | Poland | 36 |
1423 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 47 |
1424 | Apheresis | Autologous | Plasma Cell Leukemia | Hematology | 2023 | Standard Therapy | Germany | 70 |
1425 | Apheresis | Autologous | Plasma Cell Leukemia | Hematology | 2023 | Standard Therapy | Germany | 56 |
1426 | Apheresis | Autologous | Plasmacytoma | Hematology | 2023 | Standard Therapy | Germany | 63 |
1427 | Apheresis | Allogeneic | Post Therapeutic Myelodysplastic Syndrome /Acute Myelogenous Leukemia After Chronic Lymphocytic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 60 |
1428 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 38 |
1429 | Apheresis | Allogeneic | Pra B-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 20 |
1430 | Apheresis | Allogeneic | Pre-B-Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 41 |
1431 | Apheresis | Allogeneic | Pre-B-Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 61 |
1432 | Apheresis | Allogeneic | Pre-B-Acute Myelogenous Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
1433 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 63 |
1434 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2023 | Standard Therapy | Germany | 73 |
1435 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Germany | 70 |
1436 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 68 |
1437 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 68 |
1438 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 31 |
1439 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 63 |
1440 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Germany | 46 |
1441 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2023 | Standard Therapy | Poland | 68 |
1442 | Apheresis | Allogeneic | Relapsed B-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 11 |
1443 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2023 | Standard Therapy | Poland | 55 |
1444 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 58 |
1445 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 36 |
1446 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 62 |
1447 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 9 |
1448 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
1449 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2023 | Standard Therapy | Poland | 17 |
1450 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2023 | Standard Therapy | Poland | 1 |
1451 | Apheresis | Allogeneic | Systemic Mastocytosis | Hematology | 2023 | Standard Therapy | Poland | 63 |
1452 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 15 |
1453 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 28 |
1454 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 12 |
1455 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 65 |
1456 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2023 | Standard Therapy | Poland | 18 |
1457 | Apheresis | Allogeneic | T-Cell Lymphoma | Hematology | 2023 | Standard Therapy | Poland | 65 |
1458 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2023 | Standard Therapy | Poland | 2 |
1459 | Apheresis | Allogeneic | Treatment-Related Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 67 |
1460 | Apheresis | Allogeneic | Treatment-Related Myelodysplastic Syndrome | Hematology | 2023 | Standard Therapy | Poland | 64 |
1461 | Apheresis | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2023 | Standard Therapy | Poland | 2 |
1462 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2022 | Experimental Therapy | Poland | 15 |
1463 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2022 | Experimental Therapy | Poland | 6 |
1464 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2022 | Experimental Therapy | Poland | 12 |
1465 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2022 | Experimental Therapy | Poland | 7 |
1466 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2022 | Experimental Therapy | Poland | 2 |
1467 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease; Acute Lymphoblastic Leukemia | Hematology | 2022 | Experimental Therapy | Poland | 4,6 |
1468 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease; Acute Lymphoblastic Leukemia | Hematology | 2022 | Experimental Therapy | Poland | 5,4 |
1469 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 42,8 |
1470 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 60,5 |
1471 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 69,7 |
1472 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 70,5 |
1473 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 54,2 |
1474 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2022 | Experimental Therapy | Poland | 76,1 |
1475 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,3 |
1476 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 9,1 |
1477 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 3,9 |
1478 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,3 |
1479 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,8 |
1480 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7 |
1481 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 12,8 |
1482 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,1 |
1483 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 5,3 |
1484 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 4,8 |
1485 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7 |
1486 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Romania | 14 |
1487 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 4,9 |
1488 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 2,6 |
1489 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,9 |
1490 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,6 |
1491 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 5,5 |
1492 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,4 |
1493 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,11 |
1494 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 3,5 |
1495 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Poland/Romania | 6,7 |
1496 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,8 |
1497 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,8 |
1498 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Poland/Romania | 8 |
1499 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 13,7 |
1500 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2022 | Experimental Therapy | Poland/Romania | 10,2 |
1501 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,4 |
1502 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,2 |
1503 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 12,4 |
1504 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 10,4 |
1505 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 6,11 |
1506 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 5,3 |
1507 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
1508 | Cord Tissue | Allogeneic - Unrelated | Bone Marrow Transplant Rejection | Hematology | 2022 | Experimental Therapy | Poland | 2,5 |
1509 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 8 |
1510 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 2,3 |
1511 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 12,3 |
1512 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,5 |
1513 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 2,6 |
1514 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 2,4 |
1515 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
1516 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 5,11 |
1517 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,4 |
1518 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,1 |
1519 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Romania | 3 |
1520 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,9 |
1521 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,8 |
1522 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 1,5 |
1523 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 2,4 |
1524 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 3,3 |
1525 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 11,8 |
1526 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 5 |
1527 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 7 |
1528 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
1529 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | Poland | 1,8 |
1530 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2022 | Experimental Therapy | Poland | 21,2 |
1531 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2022 | Experimental Therapy | Poland | 51,4 |
1532 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2022 | Experimental Therapy | Poland | 8,3 |
1533 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2022 | Experimental Therapy | Poland | 18,4 |
1534 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2022 | Experimental Therapy | Poland | 6,5 |
1535 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Global Developmental Delay; Hypoxic Encephalopathy | Neurology | 2022 | Experimental Therapy | Poland | 3,6 |
1536 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy | Neurology | 2022 | Experimental Therapy | Poland | 2,1 |
1537 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2022 | Experimental Therapy | Poland | 10,2 |
1538 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 56,3 |
1539 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 38,7 |
1540 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 49,1 |
1541 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2022 | Experimental Therapy | Poland | 1,1 |
1542 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2022 | Experimental Therapy | Poland | 2,11 |
1543 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2022 | Experimental Therapy | Poland | 16,1 |
1544 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,7 |
1545 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 11,7 |
1546 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 4,2 |
1547 | Cord Tissue | Allogeneic - Related | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Romania | 3 |
1548 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,1 |
1549 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2,3 |
1550 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 4,7 |
1551 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 7,5 |
1552 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 47,1 |
1553 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 22,11 |
1554 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 49,1 |
1555 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 54,6 |
1556 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2022 | Experimental Therapy | Poland | 62,9 |
1557 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2022 | Experimental Therapy | Poland | 2,3 |
1558 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2022 | Experimental Therapy | Poland | 1,4 |
1559 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 25,7 |
1560 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 14,1 |
1561 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 26,1 |
1562 | Cord Tissue | Allogeneic - Unrelated | Ovarian Dysfunction | Gynecology | 2022 | Experimental Therapy | Poland | 37,11 |
1563 | Cord Tissue | Allogeneic - Unrelated | Premature Ovarian Failure; Status After Oncological Treatment Of Breast Cancer | Gynecology | 2022 | Experimental Therapy | Poland | 45,2 |
1564 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2022 | Experimental Therapy | Poland | 41,3 |
1565 | Cord Tissue | Allogeneic - Unrelated | Sequelae Of Spinal Cord Injury; Condition After A Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 23,9 |
1566 | Cord Tissue | Allogeneic - Unrelated | Spasmic Paralysis Of The Limbs | Neurology | 2022 | Experimental Therapy | Poland | 33,9 |
1567 | Cord Tissue | Allogeneic - Unrelated | Spastic Limb Paralysis | Neurology | 2022 | Experimental Therapy | Poland | 30,11 |
1568 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 12,11 |
1569 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 20 |
1570 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 39,11 |
1571 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2022 | Experimental Therapy | Poland | 35,6 |
1572 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 46 |
1573 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
1574 | Cord Blood | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 2,5 |
1575 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7 |
1576 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Hungary | 13 |
1577 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Poland | 8,8 |
1578 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Romania | 5 |
1579 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | UK | 11 |
1580 | Cord Blood | Allogeneic - Related | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Turkey | 19 |
1581 | Cord Blood | Autologous | Hydrocephalus | Neurology | 2022 | Experimental Therapy | Romania | 6 |
1582 | Cord Blood | Allogeneic - Related | Sickle Cell Anemia | Hematology | 2022 | Standard Therapy | Turkey | 7,7 |
1583 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2022 | Standard Therapy | Turkey | 19,2 |
1584 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 3 |
1585 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1586 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
1587 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
1588 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
1589 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 79 |
1590 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 23 |
1591 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
1592 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
1593 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
1594 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
1595 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
1596 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
1597 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
1598 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1599 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
1600 | Bone Marrow Family | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1601 | Bone Marrow Family | Allogeneic | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hematology | 2022 | Standard Therapy | Poland | 55 |
1602 | Bone Marrow Family | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 3 |
1603 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
1604 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia, Type 2 | Hematology | 2022 | Standard Therapy | Poland | 68 |
1605 | Bone Marrow Family | Allogeneic | Leukocyte Adhesion Deficiency | Hematology | 2022 | Standard Therapy | Poland | 33 |
1606 | Bone Marrow Family | Allogeneic | Mycosis Fungoides | Hematology | 2022 | Standard Therapy | Poland | 62 |
1607 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
1608 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 66 |
1609 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 29 |
1610 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 67 |
1611 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
1612 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 69 |
1613 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 64 |
1614 | Bone Marrow Family | Allogeneic | Myelofibrosis Post Essential Thrombocythemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
1615 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2022 | Standard Therapy | Poland | 49 |
1616 | Bone Marrow Family | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 73 |
1617 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 3 |
1618 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 2 |
1619 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 37 |
1620 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
1621 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
1622 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
1623 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
1624 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
1625 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 38 |
1626 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
1627 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
1628 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
1629 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
1630 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
1631 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 8 |
1632 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
1633 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 20 |
1634 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
1635 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
1636 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
1637 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1638 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
1639 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1640 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
1641 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1642 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
1643 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 44 |
1644 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
1645 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 75 |
1646 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
1647 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
1648 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 23 |
1649 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |
1650 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 17 |
1651 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
1652 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
1653 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
1654 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
1655 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
1656 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1657 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
1658 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
1659 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
1660 | Bone Marrow | Allogeneic | Adenosine Deaminase Deficient Severe Combined Immunodeficiency (Ada-Scid) | Hematology | 2022 | Standard Therapy | Poland | 3 months |
1661 | Bone Marrow | Allogeneic | Amyloidosis | Hematology | 2022 | Standard Therapy | Poland | 9 |
1662 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 19 |
1663 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
1664 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
1665 | Bone Marrow | Allogeneic | Bone Marrow Failure Syndrome | Hematology | 2022 | Standard Therapy | Poland | 11 |
1666 | Bone Marrow | Allogeneic | Chediak-Higashi-Syndrome | Hematology | 2022 | Standard Therapy | Poland | 10 |
1667 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 37 |
1668 | Bone Marrow | Allogeneic | Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 7 |
1669 | Bone Marrow | Allogeneic | Common Variable Immunodeficiency With Granulomatous-Lymphocytic Interstitial Lung Disease | Hematology | 2022 | Standard Therapy | Poland | 11 |
1670 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1671 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
1672 | Bone Marrow | Allogeneic | Dock8 Deficiency | Hematology | 2022 | Standard Therapy | Poland | 1 |
1673 | Bone Marrow | Allogeneic | Early Isolated All Bm Relapse | Hematology | 2022 | Standard Therapy | Poland | 6 |
1674 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
1675 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 7 |
1676 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
1677 | Bone Marrow | Allogeneic | Griscelli Syndrome Type 2 | Hematology | 2022 | Standard Therapy | Poland | 2 months |
1678 | Bone Marrow | Allogeneic | Hemophagocytic Lymphocytosis | Hematology | 2022 | Standard Therapy | Poland | 1 |
1679 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2022 | Standard Therapy | Poland | 46 |
1680 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 57 |
1681 | Bone Marrow | Allogeneic | Infant Acute Lymphoblastic Leukemia With Kmt2a Gene Rearrangement | Hematology | 2022 | Standard Therapy | Poland | 7 months |
1682 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
1683 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
1684 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 49 |
1685 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 16 |
1686 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
1687 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
1688 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 14 |
1689 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 15 |
1690 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 51 |
1691 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 8 |
1692 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 12 |
1693 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
1694 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 56 |
1695 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 17 |
1696 | Bone Marrow | Allogeneic | Nhl (Non-Hodgkin's Lymphoma) | Hematology | 2022 | Standard Therapy | Poland | 37 |
1697 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2022 | Standard Therapy | Poland | 9 |
1698 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 13 |
1699 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 11 |
1700 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 3 |
1701 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 53 |
1702 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 37 |
1703 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
1704 | Bone Marrow | Allogeneic | Other Immune System Disorders | Hematology | 2022 | Standard Therapy | Poland | 1 |
1705 | Bone Marrow | Allogeneic | Other Non-Malignant Disease | Hematology | 2022 | Standard Therapy | Poland | 8 |
1706 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2022 | Standard Therapy | Poland | 17 |
1707 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria With Marrow Failure | Hematology | 2022 | Standard Therapy | Poland | 10 |
1708 | Bone Marrow | Allogeneic | Philadelphia-Positive Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
1709 | Bone Marrow | Allogeneic | Pre-B Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 32 |
1710 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 |
1711 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 9 months |
1712 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
1713 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
1714 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
1715 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
1716 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
1717 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1718 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
1719 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
1720 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1721 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 19 |
1722 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
1723 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1724 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 35 |
1725 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1726 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
1727 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
1728 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
1729 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
1730 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 months |
1731 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 2 months |
1732 | Bone Marrow | Allogeneic | Shwachman-Diamond Syndrome – Sds | Hematology | 2022 | Standard Therapy | Poland | 7 |
1733 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
1734 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
1735 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2022 | Standard Therapy | Poland | 1 |
1736 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2022 | Standard Therapy | Poland | 3 |
1737 | Bone Marrow | Allogeneic | X-Linked Congenital Dyskeratosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
1738 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 22 |
1739 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
1740 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
1741 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
1742 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 29 |
1743 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
1744 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
1745 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
1746 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 24 |
1747 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |
1748 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 24 |
1749 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 47 |
1750 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
1751 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 29 |
1752 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 7 |
1753 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
1754 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 7 |
1755 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 8 |
1756 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
1757 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 35 |
1758 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
1759 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 69 |
1760 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
1761 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
1762 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
1763 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 75 |
1764 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
1765 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
1766 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
1767 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1768 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
1769 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 29 |
1770 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 36 |
1771 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 57 |
1772 | Apheresis | Allogeneic | Acute Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 55 |
1773 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 69 |
1774 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 39 |
1775 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
1776 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 69 |
1777 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
1778 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
1779 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 74 |
1780 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 45 |
1781 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 50 |
1782 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1783 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 78 |
1784 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 42 |
1785 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 52 |
1786 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 51 |
1787 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 69 |
1788 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
1789 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
1790 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
1791 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
1792 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 50 |
1793 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 37 |
1794 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 38 |
1795 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
1796 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1797 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
1798 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1799 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
1800 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1801 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
1802 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
1803 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1804 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
1805 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 44 |
1806 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
1807 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
1808 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
1809 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
1810 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 17 |
1811 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
1812 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
1813 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 31 |
1814 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
1815 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
1816 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 74 |
1817 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
1818 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1819 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
1820 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
1821 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 53 |
1822 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 52 |
1823 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1824 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1825 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 77 |
1826 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 34 |
1827 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
1828 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1829 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1830 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 76 |
1831 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 50 |
1832 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
1833 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
1834 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
1835 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
1836 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
1837 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
1838 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
1839 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
1840 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
1841 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
1842 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 73 |
1843 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
1844 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
1845 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 39 |
1846 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
1847 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 45 |
1848 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 52 |
1849 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
1850 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 39 |
1851 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 53 |
1852 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
1853 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
1854 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
1855 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
1856 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
1857 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
1858 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
1859 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1860 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 57 |
1861 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 70 |
1862 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
1863 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
1864 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 28 |
1865 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 88 |
1866 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
1867 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
1868 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
1869 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
1870 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1871 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
1872 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
1873 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
1874 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
1875 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
1876 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
1877 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
1878 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |
1879 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 37 |
1880 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 26 |
1881 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 20 |
1882 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 74 |
1883 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
1884 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
1885 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
1886 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
1887 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
1888 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 48 |
1889 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
1890 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 52 |
1891 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 50 |
1892 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
1893 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 35 |
1894 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
1895 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 47 |
1896 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 34 |
1897 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
1898 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
1899 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
1900 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
1901 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 29 |
1902 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
1903 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
1904 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 39 |
1905 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
1906 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
1907 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 21 |
1908 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 58 |
1909 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 45 |
1910 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 63 |
1911 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 54 |
1912 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 48 |
1913 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 61 |
1914 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 27 |
1915 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 61 |
1916 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 66 |
1917 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2022 | Standard Therapy | Germany | 47 |
1918 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Germany | 55 |
1919 | Apheresis | Allogeneic | Acute Promyelocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
1920 | Apheresis | Allogeneic | Acute Promyelocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 40 |
1921 | Apheresis | Allogeneic | Alk-Positive Anaplastic T-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 15 |
1922 | Apheresis | Autologous | Anaplastic Large Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 22 |
1923 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 22 |
1924 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
1925 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 17 |
1926 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Germany | 67 |
1927 | Apheresis | Allogeneic | Atypical Chronic Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
1928 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
1929 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
1930 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 54 |
1931 | Apheresis | Allogeneic | Beta Thalassemia Major | Hematology | 2022 | Standard Therapy | Poland | 11 |
1932 | Apheresis | Allogeneic | C-All Rez (Acute Lymphoblastic Leukemia) | Hematology | 2022 | Standard Therapy | Poland | 66 |
1933 | Apheresis | Allogeneic | C-All Rez (Acute Lymphoblastic Leukemia) | Hematology | 2022 | Standard Therapy | Poland | 5 |
1934 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 3 |
1935 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 3 |
1936 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 5 |
1937 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
1938 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
1939 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 58 |
1940 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia Richter Transformation 7/22 | Hematology | 2022 | Standard Therapy | Poland | 44 |
1941 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
1942 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
1943 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
1944 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |
1945 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
1946 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
1947 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 70 |
1948 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1949 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
1950 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
1951 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 71 |
1952 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 67 |
1953 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia, Type 0 (Cmml-0) | Hematology | 2022 | Standard Therapy | Poland | 64 |
1954 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 66 |
1955 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 72 |
1956 | Apheresis | Allogeneic | Combined Immunodeficiency Syndrome With Hyper-Igm | Hematology | 2022 | Standard Therapy | Poland | 6 |
1957 | Apheresis | Allogeneic | Congenital Dyserythropoietic Anemia | Hematology | 2022 | Standard Therapy | Poland | 2 |
1958 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 68 |
1959 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 65 |
1960 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 69 |
1961 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 50 |
1962 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 56 |
1963 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 65 |
1964 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 47 |
1965 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2022 | Standard Therapy | Germany | 66 |
1966 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 66 |
1967 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2022 | Standard Therapy | Germany | 39 |
1968 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2022 | Standard Therapy | Germany | 33 |
1969 | Apheresis | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2022 | Standard Therapy | Poland | 12 |
1970 | Apheresis | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2022 | Standard Therapy | Poland | 21 |
1971 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 26 |
1972 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 31 |
1973 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 53 |
1974 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 25 |
1975 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 67 |
1976 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2022 | Standard Therapy | Germany | 69 |
1977 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2022 | Standard Therapy | Germany | 48 |
1978 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 26 |
1979 | Apheresis | Allogeneic | Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 |
1980 | Apheresis | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
1981 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 64 |
1982 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 61 |
1983 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
1984 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 44 |
1985 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 53 |
1986 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 49 |
1987 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 64 |
1988 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
1989 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2022 | Standard Therapy | Germany | 36 |
1990 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2022 | Standard Therapy | Germany | 62 |
1991 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2022 | Standard Therapy | Germany | 63 |
1992 | Apheresis | Allogeneic | Mucopolysaccharidosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
1993 | Apheresis | Allogeneic | Mucopolysaccharidosis Type I | Hematology | 2022 | Standard Therapy | Poland | 3 |
1994 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 58 |
1995 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 53 |
1996 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 57 |
1997 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 64 |
1998 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 50 |
1999 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 67 |
2000 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 55 |
2001 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 73 |
2002 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 63 |
2003 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 65 |
2004 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 58 |
2005 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 37 |
2006 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 47 |
2007 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 68 |
2008 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 53 |
2009 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 60 |
2010 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 60 |
2011 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 47 |
2012 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 59 |
2013 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 64 |
2014 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 59 |
2015 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 52 |
2016 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 73 |
2017 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 68 |
2018 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 63 |
2019 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 66 |
2020 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 50 |
2021 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 69 |
2022 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 57 |
2023 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 55 |
2024 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 61 |
2025 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 64 |
2026 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 71 |
2027 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 61 |
2028 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 62 |
2029 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 60 |
2030 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2022 | Standard Therapy | Germany | 33 |
2031 | Apheresis | Allogeneic | Multiple Myeloma - Relapse | Hematology | 2022 | Standard Therapy | Germany | 43 |
2032 | Apheresis | Autologous | Multiple Myeloma Angioimmunoblastic T-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 62 |
2033 | Apheresis | Allogeneic | Mycosis Fungoides | Hematology | 2022 | Standard Therapy | Poland | 64 |
2034 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
2035 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 69 |
2036 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 76 |
2037 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 45 |
2038 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
2039 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 72 |
2040 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 70 |
2041 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 45 |
2042 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 73 |
2043 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 21 |
2044 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 46 |
2045 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
2046 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
2047 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 49 |
2048 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 62 |
2049 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
2050 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
2051 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 72 |
2052 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 33 |
2053 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 3 |
2054 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
2055 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 16 |
2056 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 66 |
2057 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
2058 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
2059 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 62 |
2060 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 48 |
2061 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 62 |
2062 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 48 |
2063 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 73 |
2064 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 69 |
2065 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 79 |
2066 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 54 |
2067 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 44 |
2068 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
2069 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 56 |
2070 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
2071 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 72 |
2072 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
2073 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
2074 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
2075 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 70 |
2076 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 66 |
2077 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 88 |
2078 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 67 |
2079 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 52 |
2080 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 57 |
2081 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 62 |
2082 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 36 |
2083 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 61 |
2084 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 11 |
2085 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Germany | 61 |
2086 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb2 | Hematology | 2022 | Standard Therapy | Poland | 62 |
2087 | Apheresis | Allogeneic | Myelodysplastic Syndrome Rc | Hematology | 2022 | Standard Therapy | Poland | 3 |
2088 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Excess Blasts 1 | Hematology | 2022 | Standard Therapy | Poland | 59 |
2089 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Excess Blasts 2 | Hematology | 2022 | Standard Therapy | Poland | 67 |
2090 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Fibrosis | Hematology | 2022 | Standard Therapy | Poland | 72 |
2091 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 58 |
2092 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 69 |
2093 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 57 |
2094 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 64 |
2095 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 73 |
2096 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 67 |
2097 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 66 |
2098 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 69 |
2099 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 60 |
2100 | Apheresis | Allogeneic | Myelofibrosis Myeloid Metaplasia | Hematology | 2022 | Standard Therapy | Poland | 69 |
2101 | Apheresis | Allogeneic | Myelofibrosis Post Essential Thrombocythemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
2102 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2022 | Standard Therapy | Poland | 58 |
2103 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2022 | Standard Therapy | Poland | 72 |
2104 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2022 | Standard Therapy | Poland | 73 |
2105 | Apheresis | Autologous | Myeloma | Hematology | 2022 | Standard Therapy | Germany | 54 |
2106 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2022 | Standard Therapy | Poland | 31 |
2107 | Apheresis | Allogeneic | Myeloproliferative Neoplasms With Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 59 |
2108 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 50 |
2109 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 37 |
2110 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 64 |
2111 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 59 |
2112 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 21 |
2113 | Apheresis | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 38 |
2114 | Apheresis | Autologous | Nodular Lymphocyte Predominant Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 31 |
2115 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 73 |
2116 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 61 |
2117 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 53 |
2118 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 18 |
2119 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 28 |
2120 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 55 |
2121 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 59 |
2122 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
2123 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 59 |
2124 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 59 |
2125 | Apheresis | Allogeneic | Other Immune System | Hematology | 2022 | Standard Therapy | Poland | 46 |
2126 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2022 | Standard Therapy | Poland | 72 |
2127 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 32 |
2128 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2022 | Standard Therapy | Poland | 56 |
2129 | Apheresis | Allogeneic | Plasma Cell Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
2130 | Apheresis | Allogeneic | Post-Essential Thrombocythemia-Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 64 |
2131 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis (Post-Pv Mf) | Hematology | 2022 | Standard Therapy | Poland | 48 |
2132 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 65 |
2133 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 65 |
2134 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 58 |
2135 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 39 |
2136 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 67 |
2137 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 37 |
2138 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 69 |
2139 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 62 |
2140 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 66 |
2141 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 70 |
2142 | Apheresis | Allogeneic | Primary Refractory T-Cell Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 55 |
2143 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
2144 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 51 |
2145 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 53 |
2146 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 45 |
2147 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 months |
2148 | Apheresis | Allogeneic | Sezary Syndrome | Hematology | 2022 | Standard Therapy | Poland | 59 |
2149 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
2150 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 37 |
2151 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 30 |
2152 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 46 |
2153 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
2154 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 51 |
2155 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 52 |
2156 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Germany | 60 |
2157 | Apheresis | Autologous | Testicular Cancer | Hematology | 2022 | Standard Therapy | Germany | 48 |
2158 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2022 | Standard Therapy | Poland | 15 |
2159 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2022 | Experimental Therapy | Poland | 60,11 |
2160 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 41,9 |
2161 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 30,1 |
2162 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2022 | Experimental Therapy | Poland | 53 |
2163 | Skeletal Muscle | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Genetic disorder | 2021 | Experimental Therapy | Poland | 7 |
2164 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 7,8 |
2165 | Cord Tissue | Allogeneic - Unrelated | Acute Myeloid Leukemia - Transplantation Failure | Hematology | 2021 | Experimental Therapy | Poland | 13,5 |
2166 | Cord Tissue | Allogeneic - Unrelated | Ags (Autism + Epilepsy) | Neurology | 2021 | Experimental Therapy | Poland | 13,3 |
2167 | Cord Tissue | Allogeneic - Unrelated | Ags (Autism + Epilepsy) | Neurology | 2021 | Experimental Therapy | Romania | 13 |
2168 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 74,4 |
2169 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 64,11 |
2170 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 70,11 |
2171 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 59,2 |
2172 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 47,9 |
2173 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2174 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2175 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 66,8 |
2176 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 28,4 |
2177 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2178 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2179 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2180 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2181 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2182 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2183 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2184 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2185 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2186 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2187 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 54,11 |
2188 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2189 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2190 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2191 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2192 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 55,2 |
2193 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2194 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 70,5 |
2195 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 54,2 |
2196 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 58,11 |
2197 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2198 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2199 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Clinical Trial ALSTEM | Poland | no data |
2200 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 62,4 |
2201 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2021 | Experimental Therapy | Poland | 74,6 |
2202 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4 |
2203 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 9,2 |
2204 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 10 |
2205 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,6 |
2206 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 15,5 |
2207 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | no data |
2208 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7,11 |
2209 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 6,9 |
2210 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,9 |
2211 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 12,5 |
2212 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 12,1 |
2213 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7,5 |
2214 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 8,7 |
2215 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 11,1 |
2216 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 5,3 |
2217 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,5 |
2218 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 8,11 |
2219 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2021 | Experimental Therapy | Poland | 6,4 |
2220 | Cord Tissue | Allogeneic - Unrelated | Bone Marrow Transplant Rejection; Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 6,8 |
2221 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2021 | Experimental Therapy | Poland | 59 |
2222 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 3,1 |
2223 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,1 |
2224 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5 |
2225 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 17 |
2226 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6,6 |
2227 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6,1 |
2228 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,9 |
2229 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11 |
2230 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,11 |
2231 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 12 |
2232 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,9 |
2233 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,9 |
2234 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 7,9 |
2235 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 1,7 |
2236 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
2237 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,11 |
2238 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11,4 |
2239 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,3 |
2240 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
2241 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 2,11 |
2242 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 11,6 |
2243 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,1 |
2244 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 2 |
2245 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 3,4 |
2246 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 9 months |
2247 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 2,1 |
2248 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 23,3 |
2249 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 22,9 |
2250 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 3,11 |
2251 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 5,5 |
2252 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 8 |
2253 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Romania | 11 months |
2254 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 12,2 |
2255 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Devic Syndrome | Neurology | 2021 | Experimental Therapy | Poland | 32,5 |
2256 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 2,6 |
2257 | Cord Tissue | Allogeneic - Unrelated | Condition After Cerebral Infarction | Neurology | 2021 | Experimental Therapy | Poland | 42,7 |
2258 | Cord Tissue | Allogeneic - Unrelated | Condition After Knee Injury | Orthopedy | 2021 | Experimental Therapy | Poland | 54,5 |
2259 | Cord Tissue | Allogeneic - Unrelated | Condition After Knee Injury | Orthopedy | 2021 | Experimental Therapy | Poland | 40,4 |
2260 | Cord Tissue | Allogeneic - Unrelated | Coxarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 69,4 |
2261 | Cord Tissue | Allogeneic - Unrelated | Coxarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 55,2 |
2262 | Cord Tissue | Allogeneic - Unrelated | Coxarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 50,2 |
2263 | Cord Tissue | Allogeneic - Unrelated | Degenerative Disease Of The Spine | Orthopedy | 2021 | Experimental Therapy | Poland | 51,2 |
2264 | Cord Tissue | Allogeneic - Unrelated | Degenerative Disease Of The Spine | Orthopedy | 2021 | Experimental Therapy | Poland | 56,2 |
2265 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2021 | Experimental Therapy | Poland | 6,5 |
2266 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2021 | Experimental Therapy | Poland | 27,2 |
2267 | Cord Tissue | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Hematology | 2021 | Experimental Therapy | Turkey | 25 |
2268 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2021 | Experimental Therapy | Poland | 35,2 |
2269 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 2,4 |
2270 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 6,5 |
2271 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2272 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2273 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2274 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2275 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | 21,11 |
2276 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2277 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2278 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2279 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2280 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2281 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2282 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2283 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2284 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2285 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2286 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2287 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2288 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2289 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2290 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2291 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2292 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 6,7 |
2293 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 9,8 |
2294 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 9,7 |
2295 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 2,11 |
2296 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2021 | Experimental Therapy | Poland | 5,11 |
2297 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy; Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 2,8 |
2298 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 5,7 |
2299 | Cord Tissue | Allogeneic - Related | Global Developmental Delay | Neurology | 2021 | Experimental Therapy | Poland | 2 |
2300 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay; Encephalopathy | Neurology | 2021 | Experimental Therapy | Poland | 2,9 |
2301 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay; Encephalopathy | Neurology | 2021 | Experimental Therapy | Poland | 7,8 |
2302 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 59,11 |
2303 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 48,6 |
2304 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 53,6 |
2305 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 40 |
2306 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 62,11 |
2307 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 63 |
2308 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 72,5 |
2309 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 58,1 |
2310 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 46,3 |
2311 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 50,2 |
2312 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 51,2 |
2313 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 52,5 |
2314 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 4,7 |
2315 | Cord Tissue | Allogeneic - Unrelated | Hemiparesis | Neurology | 2021 | Experimental Therapy | Poland | 37,3 |
2316 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2021 | Experimental Therapy | Poland | 30,5 |
2317 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2021 | Experimental Therapy | Poland | 7 months |
2318 | Cord Tissue | Allogeneic - Unrelated | Internal Damage To The Knee Joint | Orthopedy | 2021 | Experimental Therapy | Poland | 44,8 |
2319 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 5,7 |
2320 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 10,1 |
2321 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 5,5 |
2322 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 4 |
2323 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 2 |
2324 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 9,5 |
2325 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 4,5 |
2326 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 5 |
2327 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 5,6 |
2328 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2021 | Experimental Therapy | Poland | 1,1 |
2329 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2021 | Experimental Therapy | Poland | 1,6 |
2330 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2021 | Experimental Therapy | Poland | 50,7 |
2331 | Cord Tissue | Allogeneic - Unrelated | Nervous System Degeneration | Neurology | 2021 | Experimental Therapy | Poland | 56,9 |
2332 | Cord Tissue | Allogeneic - Unrelated | Non-Hodkin Lymphoma; Chronic Graft Versus Host Disease | Hematology | 2021 | Experimental Therapy | Poland | 14,8 |
2333 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 13,7 |
2334 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 26,4 |
2335 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 45,1 |
2336 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 27,3 |
2337 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2021 | Experimental Therapy | Poland | 22,2 |
2338 | Cord Tissue | Allogeneic - Unrelated | Osteoarthritis | Orthopedy | 2021 | Experimental Therapy | Poland | 57,2 |
2339 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2021 | Experimental Therapy | Poland | 29,7 |
2340 | Cord Tissue | Allogeneic - Unrelated | Soft Tissue Diseases | Orthopedy | 2021 | Experimental Therapy | Poland | 68,4 |
2341 | Cord Tissue | Allogeneic - Unrelated | Soft Tissue Diseases | Orthopedy | 2021 | Experimental Therapy | Poland | 52,7 |
2342 | Cord Tissue | Allogeneic - Unrelated | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2021 | Experimental Therapy | Poland | 24,11 |
2343 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2021 | Experimental Therapy | Poland | 24 |
2344 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
2345 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2021 | Experimental Therapy | Poland | 30,8 |
2346 | Cord Tissue | Allogeneic - Unrelated | Thermal Injury | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2347 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2348 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2349 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2350 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2351 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2352 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2353 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2354 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2355 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2356 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2357 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2358 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2359 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Clinical Trial BIOOPA | Poland | no data |
2360 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2361 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2362 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2363 | Cord Tissue | Allogeneic - Unrelated | Venous Leg Ulcer | Dermatology | 2021 | Experimental Therapy | Poland | no data |
2364 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 5,8 |
2365 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 9,7 |
2366 | Cord Blood | Allogeneic - Related | Autism | Neurology | 2021 | Experimental Therapy | Poland | 7 |
2367 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Poland | 4,1 |
2368 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 3,9 |
2369 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Romania | 5,2 |
2370 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
2371 | Cord Blood | Allogeneic - Related | Autism | Neurology | 2021 | Experimental Therapy | Germany | 8 |
2372 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 9 |
2373 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 7 |
2374 | Cord Blood | Autologous | Autism | Neurology | 2021 | Experimental Therapy | Germany | 6 |
2375 | Cord Blood | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 9 |
2376 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2021 | Experimental Therapy | Poland | 6 |
2377 | Cord Blood | Allogeneic - Related | Diamond Blackfan Anemia | Hematology | 2021 | Standard Therapy | Turkey | 3,12 |
2378 | Cord Blood | Autologous | Fanconi Anemia | Hematology | 2021 | Standard Therapy | Germany | 7 |
2379 | Cord Blood | Allogeneic - Related | Immune Failure-Cd40 L Deficiency | Hematology | 2021 | Standard Therapy | Turkey | 12,4 |
2380 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 5,6 |
2381 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16,6 |
2382 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 7,3 |
2383 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2021 | Standard Therapy | Turkey | 16 |
2384 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2385 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 33 |
2386 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
2387 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
2388 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2389 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2390 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
2391 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
2392 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
2393 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
2394 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2395 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
2396 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2397 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
2398 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
2399 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2400 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
2401 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
2402 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2403 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 36 |
2404 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 39 |
2405 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 71 |
2406 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
2407 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
2408 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
2409 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 52 |
2410 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 48 |
2411 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
2412 | Bone Marrow Family | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 45 |
2413 | Bone Marrow Family | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 2 |
2414 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
2415 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
2416 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
2417 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 8 |
2418 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
2419 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 11 |
2420 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
2421 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
2422 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 1 |
2423 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
2424 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
2425 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
2426 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2427 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
2428 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2429 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 2 |
2430 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2431 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
2432 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
2433 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 15 |
2434 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2435 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2021 | Standard Therapy | Poland | 8 |
2436 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
2437 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 19 |
2438 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
2439 | Bone Marrow | Allogeneic | Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2021 | Standard Therapy | Poland | 32 |
2440 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 16 |
2441 | Bone Marrow | Allogeneic | Bcr-Abl Pos. All | Hematology | 2021 | Standard Therapy | Poland | 51 |
2442 | Bone Marrow | Allogeneic | Beta Thalassemia Major | Hematology | 2021 | Standard Therapy | Poland | 14 |
2443 | Bone Marrow | Allogeneic | Cartilage Hair Hypoplasia | Hematology | 2021 | Standard Therapy | Poland | 7 |
2444 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |
2445 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 1 |
2446 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |
2447 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 44 |
2448 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2449 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
2450 | Bone Marrow | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
2451 | Bone Marrow | Allogeneic | Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
2452 | Bone Marrow | Allogeneic | Combined Immunodeficiency Syndrome With Hyper-Igm | Hematology | 2021 | Standard Therapy | Poland | 5 |
2453 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
2454 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2021 | Standard Therapy | Poland | 3 |
2455 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2021 | Standard Therapy | Poland | 3 |
2456 | Bone Marrow | Allogeneic | Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 2 |
2457 | Bone Marrow | Allogeneic | Inherited Immune System Disorder | Hematology | 2021 | Standard Therapy | Poland | 1 |
2458 | Bone Marrow | Allogeneic | Ipex- Other Immune | Hematology | 2021 | Standard Therapy | Poland | 20 |
2459 | Bone Marrow | Allogeneic | Leukemia Lymphoblastic Acuta | Hematology | 2021 | Standard Therapy | Poland | 6 |
2460 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
2461 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 10 |
2462 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 2 |
2463 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 30 |
2464 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 67 |
2465 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 59 |
2466 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 59 |
2467 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 69 |
2468 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 55 |
2469 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 14 |
2470 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 41 |
2471 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2021 | Standard Therapy | Poland | 7 |
2472 | Bone Marrow | Allogeneic | Other Leukemia Specify | Hematology | 2021 | Standard Therapy | Poland | 35 |
2473 | Bone Marrow | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 72 |
2474 | Bone Marrow | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 7 |
2475 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
2476 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
2477 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 12 |
2478 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 5 |
2479 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 13 |
2480 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 12 |
2481 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
2482 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
2483 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
2484 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2021 | Standard Therapy | Poland | 9 months |
2485 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 28 |
2486 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
2487 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
2488 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
2489 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
2490 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
2491 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 27 |
2492 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 54 |
2493 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 51 |
2494 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
2495 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
2496 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 10 |
2497 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
2498 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 5 |
2499 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 28 |
2500 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2501 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 13 |
2502 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
2503 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
2504 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 20 |
2505 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2506 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
2507 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2508 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
2509 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 19 |
2510 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
2511 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
2512 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 3 |
2513 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 29 |
2514 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 8 |
2515 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 54 |
2516 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 20 |
2517 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
2518 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
2519 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
2520 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2521 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
2522 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia - Relapse | Hematology | 2021 | Standard Therapy | Poland | 38 |
2523 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
2524 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2525 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
2526 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
2527 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2528 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
2529 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
2530 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
2531 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2532 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
2533 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 50 |
2534 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
2535 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2536 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
2537 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
2538 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
2539 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 45 |
2540 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
2541 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2542 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
2543 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2544 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 37 |
2545 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 21 |
2546 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
2547 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 20 |
2548 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 43 |
2549 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 56 |
2550 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2551 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
2552 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
2553 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
2554 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 56 |
2555 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2556 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
2557 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2558 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
2559 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
2560 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
2561 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
2562 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
2563 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2564 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2565 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
2566 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2567 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
2568 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
2569 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
2570 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2571 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2572 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 28 |
2573 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
2574 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
2575 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
2576 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
2577 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2578 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 45 |
2579 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
2580 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 71 |
2581 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2582 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 29 |
2583 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
2584 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 30 |
2585 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
2586 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2587 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2588 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
2589 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2590 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 30 |
2591 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
2592 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 44 |
2593 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2594 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
2595 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
2596 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
2597 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2598 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
2599 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2600 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
2601 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 37 |
2602 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
2603 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2604 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2605 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 12 |
2606 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
2607 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
2608 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2609 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
2610 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 39 |
2611 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2612 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2613 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2614 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
2615 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
2616 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
2617 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
2618 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2619 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2620 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2621 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 57 |
2622 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
2623 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
2624 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2625 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
2626 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
2627 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
2628 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
2629 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
2630 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 56 |
2631 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
2632 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 3 |
2633 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 25 |
2634 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
2635 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
2636 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 51 |
2637 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 50 |
2638 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2639 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
2640 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 35 |
2641 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2642 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 14 |
2643 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 49 |
2644 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 80 |
2645 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2646 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
2647 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
2648 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
2649 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2650 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 10 |
2651 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
2652 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 57 |
2653 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
2654 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2655 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
2656 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
2657 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
2658 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
2659 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 39 |
2660 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
2661 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2662 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 22 |
2663 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 56 |
2664 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
2665 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
2666 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
2667 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 13 |
2668 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 32 |
2669 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 61 |
2670 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 72 |
2671 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 55 |
2672 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 57 |
2673 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 62 |
2674 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 46 |
2675 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 63 |
2676 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 65 |
2677 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 71 |
2678 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 53 |
2679 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 57 |
2680 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 50 |
2681 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 32 |
2682 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 71 |
2683 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2021 | Standard Therapy | Germany | 65 |
2684 | Apheresis | Autologous | Amyloidosis | Hematology | 2021 | Standard Therapy | Germany | 63 |
2685 | Apheresis | Allogeneic | Anaplastic Large Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 56 |
2686 | Apheresis | Autologous | Angioimmunoblastic T-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 62 |
2687 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 54 |
2688 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 7 |
2689 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
2690 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 14 |
2691 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 36 |
2692 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 59 |
2693 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 33 |
2694 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 63 |
2695 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 49 |
2696 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 28 |
2697 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 11 |
2698 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2699 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 60 |
2700 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2701 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
2702 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 45 |
2703 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 37 |
2704 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2705 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2706 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 74 |
2707 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
2708 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2709 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 18 |
2710 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2711 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
2712 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 67 |
2713 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
2714 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 34 |
2715 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
2716 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 71 |
2717 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2021 | Standard Therapy | Germany | 67 |
2718 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 62 |
2719 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
2720 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 68 |
2721 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 63 |
2722 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2021 | Standard Therapy | Germany | 65 |
2723 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2021 | Standard Therapy | Germany | 65 |
2724 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2021 | Standard Therapy | Germany | 71 |
2725 | Apheresis | Allogeneic | Farber Disease | Hematology | 2021 | Standard Therapy | Poland | 9 |
2726 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 54 |
2727 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 55 |
2728 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 64 |
2729 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 50 |
2730 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2021 | Standard Therapy | Germany | 28 |
2731 | Apheresis | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2021 | Standard Therapy | Poland | 23 |
2732 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 41 |
2733 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 40 |
2734 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 27 |
2735 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 19 |
2736 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 26 |
2737 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 32 |
2738 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 21 |
2739 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 37 |
2740 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 30 |
2741 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 47 |
2742 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 36 |
2743 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 30 |
2744 | Apheresis | Allogeneic | Hurler Syndrome | Hematology | 2021 | Standard Therapy | Poland | 2 |
2745 | Apheresis | Allogeneic | Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 12 |
2746 | Apheresis | Allogeneic | Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2747 | Apheresis | Allogeneic | Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 58 |
2748 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
2749 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 57 |
2750 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
2751 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 57 |
2752 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 63 |
2753 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 56 |
2754 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 65 |
2755 | Apheresis | Allogeneic | Metachromatic Leukodystrophy | Hematology | 2021 | Standard Therapy | Poland | 60 |
2756 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2021 | Standard Therapy | Germany | 36 |
2757 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2021 | Standard Therapy | Germany | 50 |
2758 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2021 | Standard Therapy | Germany | 21 |
2759 | Apheresis | Allogeneic | Mucopolysaccharidosis | Hematology | 2021 | Standard Therapy | Poland | 2 |
2760 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Poland | 44 |
2761 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Poland | 60 |
2762 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 70 |
2763 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 71 |
2764 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 53 |
2765 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 51 |
2766 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
2767 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 65 |
2768 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 62 |
2769 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 57 |
2770 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 66 |
2771 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 50 |
2772 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 65 |
2773 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 50 |
2774 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 47 |
2775 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 43 |
2776 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 66 |
2777 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 56 |
2778 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 65 |
2779 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 51 |
2780 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
2781 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 62 |
2782 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 68 |
2783 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 70 |
2784 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 70 |
2785 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 38 |
2786 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
2787 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 63 |
2788 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 71 |
2789 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 52 |
2790 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 63 |
2791 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 57 |
2792 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 68 |
2793 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
2794 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 58 |
2795 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 57 |
2796 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 60 |
2797 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 58 |
2798 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 67 |
2799 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 62 |
2800 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 42 |
2801 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 61 |
2802 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 67 |
2803 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 57 |
2804 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2021 | Standard Therapy | Germany | 68 |
2805 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 68 |
2806 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 41 |
2807 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 60 |
2808 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 8 |
2809 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 61 |
2810 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 62 |
2811 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 68 |
2812 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
2813 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 56 |
2814 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 62 |
2815 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 57 |
2816 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 47 |
2817 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
2818 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 29 |
2819 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 66 |
2820 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
2821 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
2822 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 59 |
2823 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 50 |
2824 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 59 |
2825 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 28 |
2826 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 68 |
2827 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
2828 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 54 |
2829 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 66 |
2830 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 52 |
2831 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
2832 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 75 |
2833 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 72 |
2834 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 62 |
2835 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 40 |
2836 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 65 |
2837 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 67 |
2838 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 72 |
2839 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
2840 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 64 |
2841 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 53 |
2842 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 53 |
2843 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 73 |
2844 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
2845 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 8 |
2846 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 66 |
2847 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 26 |
2848 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 56 |
2849 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 63 |
2850 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 61 |
2851 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
2852 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 66 |
2853 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Germany | 48 |
2854 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Germany | 58 |
2855 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Germany | 59 |
2856 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 62 |
2857 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 63 |
2858 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 64 |
2859 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 66 |
2860 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 65 |
2861 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 56 |
2862 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 75 |
2863 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 65 |
2864 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 51 |
2865 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 63 |
2866 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 75 |
2867 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2868 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 48 |
2869 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2021 | Standard Therapy | Poland | 53 |
2870 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2021 | Standard Therapy | Poland | 67 |
2871 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2021 | Standard Therapy | Poland | 58 |
2872 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2021 | Standard Therapy | Germany | 51 |
2873 | Apheresis | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 64 |
2874 | Apheresis | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 57 |
2875 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 30 |
2876 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 51 |
2877 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 58 |
2878 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 56 |
2879 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 58 |
2880 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 50 |
2881 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 53 |
2882 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 20 |
2883 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 64 |
2884 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 66 |
2885 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 62 |
2886 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 61 |
2887 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 49 |
2888 | Apheresis | Allogeneic | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2021 | Standard Therapy | Germany | 62 |
2889 | Apheresis | Allogeneic | Osteomyelitis | Hematology | 2021 | Standard Therapy | Poland | 47 |
2890 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 69 |
2891 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 43 |
2892 | Apheresis | Autologous | Osteosclerotic Myeloma | Hematology | 2021 | Standard Therapy | Germany | 54 |
2893 | Apheresis | Allogeneic | Other Myelodysplastic Syndromes | Hematology | 2021 | Standard Therapy | Poland | 65 |
2894 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 68 |
2895 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 70 |
2896 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 72 |
2897 | Apheresis | Allogeneic | Other Plasma Cell Disorder | Hematology | 2021 | Standard Therapy | Poland | 67 |
2898 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 45 |
2899 | Apheresis | Allogeneic | Philadelphia-Positive Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
2900 | Apheresis | Allogeneic | Polycythemia Vera | Hematology | 2021 | Standard Therapy | Poland | 65 |
2901 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 71 |
2902 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
2903 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 62 |
2904 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 53 |
2905 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 44 |
2906 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 54 |
2907 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 65 |
2908 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 65 |
2909 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 60 |
2910 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 66 |
2911 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 63 |
2912 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 62 |
2913 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 64 |
2914 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
2915 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
2916 | Apheresis | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 6 |
2917 | Apheresis | Allogeneic | Secondary Acute Lymphoblastic Leukemia From Chronic Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2918 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 70 |
2919 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 64 |
2920 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 39 |
2921 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Germany | 60 |
2922 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 35 |
2923 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
2924 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
2925 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
2926 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
2927 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
2928 | Apheresis | Allogeneic | T-Cell Lymphoblastic Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 26 |
2929 | Apheresis | Allogeneic | T-Cell Lymphoblastic Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 37 |
2930 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 54 |
2931 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
2932 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 66 |
2933 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Germany | 29 |
2934 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 45 |
2935 | Apheresis | Autologous | Testicular Cancer | Hematology | 2021 | Standard Therapy | Germany | 33 |
2936 | Apheresis | Allogeneic | Β - Thalassemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
2937 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 51,1 |
2938 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 44,4 |
2939 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2021 | Experimental Therapy | Poland | 35,8 |
2940 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2021 | Experimental Therapy | Poland | 40.9 |
2941 | Adipose Tissue | Autologous | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2021 | Experimental Therapy | Poland | 27,5 |
2942 | Placenta blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,6 |
2943 | Cord Tissue | Allogeneic - Unrelated | Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 84,5 |
2944 | Cord Tissue | Allogeneic - Unrelated | Acquired Epileptic Aphasia | Neurology | 2020 | Experimental Therapy | Poland | 4,11 |
2945 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Poland | 8,11 |
2946 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Poland | 8 |
2947 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Poland | 2,4 |
2948 | Cord Tissue | Allogeneic - Unrelated | Acute Respiratory Distress Syndrome; Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 53 |
2949 | Cord Tissue | Allogeneic - Unrelated | Acute Respiratory Distress Syndrome; Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 66,11 |
2950 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy | Neurology | 2020 | Experimental Therapy | Poland | 8,1 |
2951 | Cord Tissue | Allogeneic - Unrelated | Alopecia Areata | Dermatology | 2020 | Experimental Therapy | Poland | 36,6 |
2952 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 53,2 |
2953 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 54,4 |
2954 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 48,1 |
2955 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 64,11 |
2956 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 62,9 |
2957 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 69,1 |
2958 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 52,11 |
2959 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 58 |
2960 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 59,7 |
2961 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 52,7 |
2962 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 62,5 |
2963 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 59,6 |
2964 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 59,1 |
2965 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2020 | Experimental Therapy | Poland | 58,1 |
2966 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 4,3 |
2967 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 7,1 |
2968 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 8,7 |
2969 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 7,6 |
2970 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 9,11 |
2971 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 4,9 |
2972 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 6,1 |
2973 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2020 | Experimental Therapy | Poland | 8 |
2974 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 7,1 |
2975 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 7,1 |
2976 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 5,1 |
2977 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 9,4 |
2978 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2020 | Experimental Therapy | Romania | 13 |
2979 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2020 | Experimental Therapy | Poland | 10 |
2980 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2020 | Experimental Therapy | Poland | 6,5 |
2981 | Cord Tissue | Allogeneic - Unrelated | Bone Marrow Transplant Rejection | Hematology | 2020 | Experimental Therapy | Poland | 14,2 |
2982 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2020 | Experimental Therapy | Poland | 57,11 |
2983 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 17,2 |
2984 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,4 |
2985 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,7 |
2986 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 5 |
2987 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,7 |
2988 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 8,7 |
2989 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 15,6 |
2990 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6 |
2991 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 3,1 |
2992 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,7 |
2993 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 13 |
2994 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,9 |
2995 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,1 |
2996 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 8,3 |
2997 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 7,11 |
2998 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 4,4 |
2999 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 4 |
3000 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 6,11 |
3001 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 4,11 |
3002 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 18,2 |
3003 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 5,8 |
3004 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 10,9 |
3005 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Developmental Delay | Neurology | 2020 | Experimental Therapy | Poland | 5,9 |
3006 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 9,8 |
3007 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 1,7 |
3008 | Cord Tissue | Allogeneic - Unrelated | Chondromalacia | Orthopedy | 2020 | Experimental Therapy | Poland | 61,7 |
3009 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Poland | 4,7 |
3010 | Cord Tissue | Allogeneic - Unrelated | Condition After Knee Injury | Orthopedy | 2020 | Experimental Therapy | Poland | 42,1 |
3011 | Cord Tissue | Allogeneic - Unrelated | Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 74,5 |
3012 | Cord Tissue | Allogeneic - Unrelated | Covid-19 | Pulmonology | 2020 | Experimental Therapy | Poland | 76,2 |
3013 | Cord Tissue | Allogeneic - Unrelated | Covid-19; Severe Pneumonia; Acute Respiratory Failure | Pulmonology | 2020 | Experimental Therapy | Poland | 59,5 |
3014 | Cord Tissue | Allogeneic - Unrelated | Coxarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 46,4 |
3015 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2020 | Experimental Therapy | Poland | 5,8 |
3016 | Cord Tissue | Allogeneic - Related | Developmental Delay | Neurology | 2020 | Experimental Therapy | Romania | 13 |
3017 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2020 | Experimental Therapy | Poland | 6 |
3018 | Cord Tissue | Allogeneic - Unrelated | Disorder Of Brain, Unspecified; Adrenoleukodystrophy | Neurology | 2020 | Experimental Therapy | Poland | 11,9 |
3019 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2020 | Experimental Therapy | Poland | 26,6 |
3020 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 35,6 |
3021 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 44 |
3022 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 35,3 |
3023 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 29,3 |
3024 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 30,9 |
3025 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 5,3 |
3026 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 17,11 |
3027 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2020 | Experimental Therapy | Poland | 21,5 |
3028 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 10,9 |
3029 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 2,1 |
3030 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Developmental Delay | Neurology | 2020 | Experimental Therapy | Poland | 15,8 |
3031 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Encephalopathy; Developmental Delay | Neurology | 2020 | Experimental Therapy | Poland | 7,1 |
3032 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2020 | Experimental Therapy | Poland | 40,5 |
3033 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2020 | Experimental Therapy | Poland | 6,4 |
3034 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 61,8 |
3035 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 62,8 |
3036 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 62,11 |
3037 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 60,1 |
3038 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 73,6 |
3039 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 63,8 |
3040 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 60,3 |
3041 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 64,8 |
3042 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 57,5 |
3043 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 53,9 |
3044 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 56,9 |
3045 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 63,7 |
3046 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 49,9 |
3047 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 58 |
3048 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 61,4 |
3049 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 60,2 |
3050 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 50,8 |
3051 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease | Hematology | 2020 | Experimental Therapy | Portugal | 18 |
3052 | Cord Tissue | Allogeneic - Unrelated | Graft Versus Host Disease; Transplantation Failure | Hematology | 2020 | Experimental Therapy | Poland | 2,9 |
3053 | Cord Tissue | Allogeneic - Unrelated | Guillain-Barré Syndrome | Neurology | 2020 | Experimental Therapy | Poland | 43,5 |
3054 | Cord Tissue | Allogeneic - Unrelated | Head Injury | Neurology | 2020 | Experimental Therapy | Poland | 16,3 |
3055 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
3056 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2020 | Experimental Therapy | Poland | 5,4 |
3057 | Cord Tissue | Allogeneic - Unrelated | Hypoxic Encephalopathy; Drug-Resistant Epilepsy | Neurology | 2020 | Experimental Therapy | Poland | 20,9 |
3058 | Cord Tissue | Allogeneic - Unrelated | Limb Ulceration | Dermatology | 2020 | Experimental Therapy | Poland | 82,7 |
3059 | Cord Tissue | Allogeneic - Unrelated | Macular Degeneration | Ophthalmology | 2020 | Experimental Therapy | Poland | 20,8 |
3060 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2020 | Experimental Therapy | Poland | 56,4 |
3061 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2020 | Experimental Therapy | Poland | 8,11 |
3062 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele; Arnold-Chiari Malformation | Neurology | 2020 | Experimental Therapy | Poland | 2,5 |
3063 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele; Hydrocephalus | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
3064 | Cord Tissue | Allogeneic - Unrelated | Myoclonic Epilepsy With Ragged Red Fibers | Neurology | 2020 | Experimental Therapy | Poland | 23,4 |
3065 | Cord Tissue | Allogeneic - Unrelated | No Bone Adhesion | Orthopedy | 2020 | Experimental Therapy | Poland | 69,5 |
3066 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 16,3 |
3067 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 66,3 |
3068 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 23,11 |
3069 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 27,1 |
3070 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 31,9 |
3071 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 58,3 |
3072 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2020 | Experimental Therapy | Poland | 41,2 |
3073 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2020 | Experimental Therapy | Poland | 41,2 |
3074 | Cord Tissue | Allogeneic - Unrelated | Osteoarthritis | Orthopedy | 2020 | Experimental Therapy | Poland | 56,5 |
3075 | Cord Tissue | Allogeneic - Unrelated | Other Specific Cartilage Diseases | Orthopedy | 2020 | Experimental Therapy | Poland | 39,4 |
3076 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2020 | Experimental Therapy | Poland | 4,1 |
3077 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System - Global Development Delay And Microcephaly | Neurology | 2020 | Experimental Therapy | Poland | 2,11 |
3078 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Congenital Genetic Defect | Neurology | 2020 | Experimental Therapy | Poland | 2,6 |
3079 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Congenital Genetic Defect | Neurology | 2020 | Experimental Therapy | Poland | 5,2 |
3080 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Cornelia De Lange Syndrome | Neurology | 2020 | Experimental Therapy | Poland | 4,4 |
3081 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Hypoxia-Ischemic Encephalopathy | Neurology | 2020 | Experimental Therapy | Poland | 4,3 |
3082 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System; Lissencephaly | Neurology | 2020 | Experimental Therapy | Poland | 6,4 |
3083 | Cord Tissue | Allogeneic - Unrelated | Other Sphingolipidoses; Krabbe's Leukodystrophy | Neurology | 2020 | Experimental Therapy | Poland | 4 |
3084 | Cord Tissue | Allogeneic - Unrelated | Other Spinal Muscular Atrophy And Related Syndromes; Bulbar Palsy | Neurology | 2020 | Experimental Therapy | Poland | no data |
3085 | Cord Tissue | Allogeneic - Unrelated | Polyneuropathy | Neurology | 2020 | Experimental Therapy | Poland | 43,11 |
3086 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2020 | Experimental Therapy | Poland | 33,7 |
3087 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2020 | Experimental Therapy | Poland | 61,5 |
3088 | Cord Tissue | Allogeneic - Unrelated | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2020 | Experimental Therapy | Poland | 59,6 |
3089 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2020 | Experimental Therapy | Poland | 11 months |
3090 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2020 | Experimental Therapy | Poland | 1,3 |
3091 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2020 | Experimental Therapy | Poland | 33,2 |
3092 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2020 | Experimental Therapy | Poland | 37,11 |
3093 | Cord Tissue | Allogeneic - Unrelated | State After Encephalitis | Neurology | 2020 | Experimental Therapy | Poland | 3,8 |
3094 | Cord Tissue | Allogeneic - Unrelated | Tendon Injury | Orthopedy | 2020 | Experimental Therapy | Poland | 29 |
3095 | Cord Tissue | Allogeneic - Unrelated | Transplantation Failure; Coexisting Viral Infections | Hematology | 2020 | Experimental Therapy | Poland | 13,1 |
3096 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Poland | no data |
3097 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Germany | 9 |
3098 | Cord Blood | Autologous | Autism | Neurology | 2020 | Experimental Therapy | Germany | 5 |
3099 | Cord Blood | Autologous | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | UK | 5 |
3100 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,2 |
3101 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,9 |
3102 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2020 | Experimental Therapy | Poland | 2,4 |
3103 | Cord Blood | Allogeneic - Related | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | no data |
3104 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 3,4 |
3105 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 3,4 |
3106 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 4,4 |
3107 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2020 | Standard Therapy | Turkey | 4,4 |
3108 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia - Relapse | Hematology | 2020 | Standard Therapy | Germany | 57 |
3109 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 69 |
3110 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 48 |
3111 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
3112 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
3113 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
3114 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 38 |
3115 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3116 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 76 |
3117 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2020 | Standard Therapy | Germany | 61 |
3118 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2020 | Standard Therapy | Germany | 68 |
3119 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3120 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 35 |
3121 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 71 |
3122 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 31 |
3123 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 62 |
3124 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 59 |
3125 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
3126 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3127 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 70 |
3128 | Bone Marrow Family | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 24 |
3129 | Bone Marrow (Apheresismily donor) | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 68 |
3130 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
3131 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
3132 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
3133 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
3134 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 4 |
3135 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 15 |
3136 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 5 |
3137 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 3 |
3138 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 62 |
3139 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 47 |
3140 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
3141 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 16 |
3142 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
3143 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 9 |
3144 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 10 |
3145 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 27 |
3146 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 23 |
3147 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2020 | Standard Therapy | Poland | 6 |
3148 | Bone Marrow | Allogeneic | Congenital Neutropenia | Hematology | 2020 | Standard Therapy | Poland | 2 |
3149 | Bone Marrow | Allogeneic | Familial Hemophagocytic Lymphohistiocytosis Type 2 | Hematology | 2020 | Standard Therapy | Poland | 8 |
3150 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2020 | Standard Therapy | Poland | 11 |
3151 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2020 | Standard Therapy | Poland | 6 |
3152 | Bone Marrow | Allogeneic | Immune Deficiency; Neutropenia | Hematology | 2020 | Standard Therapy | Poland | 4 |
3153 | Bone Marrow | Allogeneic | Metachromatic Leukodystrophy | Hematology | 2020 | Standard Therapy | Poland | 6 |
3154 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Hematology | 2020 | Standard Therapy | Poland | 2 |
3155 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type Ii | Hematology | 2020 | Standard Therapy | Poland | 1 |
3156 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 52 |
3157 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 54 |
3158 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 3 |
3159 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 28 |
3160 | Bone Marrow | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 1 |
3161 | Bone Marrow | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 10 |
3162 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2020 | Standard Therapy | Poland | 1 |
3163 | Bone Marrow | Allogeneic | Primary Immunodeficiency With Severe Mds Associated | Hematology | 2020 | Standard Therapy | Poland | 14 |
3164 | Bone Marrow | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3165 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 5 |
3166 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 57 |
3167 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 27 |
3168 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
3169 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 10 |
3170 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 34 |
3171 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 11 |
3172 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 12 |
3173 | Bone Marrow | Allogeneic | X-Linked Chronic Granulomatous Disease | Hematology | 2020 | Standard Therapy | Poland | 5 |
3174 | Bone Marrow | Allogeneic | Β - Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 13 |
3175 | Bone Marrow | Allogeneic | Β - Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 17 |
3176 | Bone Marrow | Allogeneic | Β - Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 6 |
3177 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 71 |
3178 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
3179 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
3180 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 41 |
3181 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
3182 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
3183 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 60 |
3184 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 9 |
3185 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 23 |
3186 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 40 |
3187 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 51 |
3188 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 71 |
3189 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 34 |
3190 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
3191 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 50 |
3192 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 18 |
3193 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 69 |
3194 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 12 |
3195 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 13 |
3196 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 12 |
3197 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
3198 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 34 |
3199 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 36 |
3200 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
3201 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 56 |
3202 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
3203 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 36 |
3204 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 25 |
3205 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
3206 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 52 |
3207 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 48 |
3208 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
3209 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
3210 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
3211 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3212 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
3213 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
3214 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
3215 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 37 |
3216 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
3217 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 70 |
3218 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 46 |
3219 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 65 |
3220 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
3221 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 73 |
3222 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 27 |
3223 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 29 |
3224 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
3225 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
3226 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
3227 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
3228 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
3229 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3230 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
3231 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 60 |
3232 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 32 |
3233 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
3234 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
3235 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 40 |
3236 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3237 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 65 |
3238 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 38 |
3239 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 49 |
3240 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 65 |
3241 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
3242 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3243 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
3244 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 73 |
3245 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
3246 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
3247 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 70 |
3248 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
3249 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 68 |
3250 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3251 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 60 |
3252 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
3253 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
3254 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 56 |
3255 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 54 |
3256 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
3257 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
3258 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
3259 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
3260 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
3261 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 30 |
3262 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 34 |
3263 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
3264 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
3265 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 35 |
3266 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 5 |
3267 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 65 |
3268 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
3269 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 49 |
3270 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
3271 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
3272 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 39 |
3273 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 45 |
3274 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
3275 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3276 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3277 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 59 |
3278 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
3279 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
3280 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
3281 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 15 |
3282 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
3283 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
3284 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
3285 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
3286 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 51 |
3287 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
3288 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 39 |
3289 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 42 |
3290 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
3291 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
3292 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 69 |
3293 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3294 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 64 |
3295 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
3296 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 37 |
3297 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 72 |
3298 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 64 |
3299 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 45 |
3300 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 67 |
3301 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 67 |
3302 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 61 |
3303 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 36 |
3304 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 34 |
3305 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 48 |
3306 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 60 |
3307 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 48 |
3308 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 35 |
3309 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 42 |
3310 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 59 |
3311 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 20 |
3312 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 58 |
3313 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 44 |
3314 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 30 |
3315 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
3316 | Apheresis | Allogeneic | Acute Undifferentiated Leukemia | Hematology | 2020 | Standard Therapy | Poland | 31 |
3317 | Apheresis | Autologous | Amyloid Light-Chain Amyloidosis | Hematology | 2020 | Standard Therapy | Germany | 62 |
3318 | Apheresis | Autologous | Amyloidosis | Hematology | 2020 | Standard Therapy | Germany | 58 |
3319 | Apheresis | Allogeneic | Anaplastic Large Cell Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 8 |
3320 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 12 |
3321 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 29 |
3322 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 58 |
3323 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 68 |
3324 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 70 |
3325 | Apheresis | Autologous | B-Cell Lymphoma - Second Primary Central Nervous System Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 70 |
3326 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 57 |
3327 | Apheresis | Autologous | Bone Tumor | Hematology | 2020 | Standard Therapy | Germany | 28 |
3328 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 49 |
3329 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 74 |
3330 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 67 |
3331 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 58 |
3332 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 61 |
3333 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 56 |
3334 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 47 |
3335 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 73 |
3336 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 62 |
3337 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 57 |
3338 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 44 |
3339 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2020 | Standard Therapy | Poland | 62 |
3340 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 66 |
3341 | Apheresis | Allogeneic | Chronic Neutrophilic Leukemia | Hematology | 2020 | Standard Therapy | Germany | 31 |
3342 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 63 |
3343 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 68 |
3344 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 51 |
3345 | Apheresis | Allogeneic | Dyskeratosis Congenita | Hematology | 2020 | Standard Therapy | Poland | 19 |
3346 | Apheresis | Allogeneic | Erdheim-Chester Disease | Hematology | 2020 | Standard Therapy | Poland | 4 |
3347 | Apheresis | Autologous | Ewing Sarcoma | Hematology | 2020 | Standard Therapy | Germany | 30 |
3348 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2020 | Standard Therapy | Poland | 1 |
3349 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2020 | Standard Therapy | Poland | 29 |
3350 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2020 | Standard Therapy | Germany | 30 |
3351 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 48 |
3352 | Apheresis | Autologous | Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 22 |
3353 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2020 | Standard Therapy | Germany | 66 |
3354 | Apheresis | Allogeneic | Lymphoblastic Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 24 |
3355 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 56 |
3356 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 56 |
3357 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 48 |
3358 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 53 |
3359 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 59 |
3360 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3361 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 58 |
3362 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 49 |
3363 | Apheresis | Allogeneic | Mast Cell Leukemia | Hematology | 2020 | Standard Therapy | Germany | 55 |
3364 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2020 | Standard Therapy | Germany | 68 |
3365 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2020 | Standard Therapy | Germany | 53 |
3366 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2020 | Standard Therapy | Germany | 18 |
3367 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 54 |
3368 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 66 |
3369 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 56 |
3370 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3371 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 70 |
3372 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 41 |
3373 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 56 |
3374 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 61 |
3375 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 55 |
3376 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 67 |
3377 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 52 |
3378 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 69 |
3379 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 64 |
3380 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 46 |
3381 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 55 |
3382 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 60 |
3383 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3384 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 51 |
3385 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 55 |
3386 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 63 |
3387 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3388 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 55 |
3389 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3390 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
3391 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3392 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 42 |
3393 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 59 |
3394 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 66 |
3395 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3396 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 67 |
3397 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3398 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 60 |
3399 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
3400 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 63 |
3401 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
3402 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 63 |
3403 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 62 |
3404 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 49 |
3405 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 45 |
3406 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 65 |
3407 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 45 |
3408 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 66 |
3409 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 40 |
3410 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 53 |
3411 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 54 |
3412 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 44 |
3413 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
3414 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 48 |
3415 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
3416 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 66 |
3417 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 68 |
3418 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2020 | Standard Therapy | Germany | 54 |
3419 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 67 |
3420 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 59 |
3421 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 60 |
3422 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 62 |
3423 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 55 |
3424 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 70 |
3425 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 66 |
3426 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 51 |
3427 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 56 |
3428 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
3429 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
3430 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 73 |
3431 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
3432 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 37 |
3433 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 59 |
3434 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 70 |
3435 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 74 |
3436 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 66 |
3437 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 22 |
3438 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
3439 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 70 |
3440 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 70 |
3441 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 67 |
3442 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 60 |
3443 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 68 |
3444 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 58 |
3445 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 67 |
3446 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 47 |
3447 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 56 |
3448 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 55 |
3449 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 64 |
3450 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 66 |
3451 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 65 |
3452 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
3453 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 69 |
3454 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Poland | 63 |
3455 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2020 | Standard Therapy | Germany | 73 |
3456 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 63 |
3457 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 69 |
3458 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 70 |
3459 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 63 |
3460 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 62 |
3461 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2020 | Standard Therapy | Poland | 43 |
3462 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2020 | Standard Therapy | Poland | 63 |
3463 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2020 | Standard Therapy | Poland | 52 |
3464 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2020 | Standard Therapy | Poland | 68 |
3465 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2020 | Standard Therapy | Poland | 40 |
3466 | Apheresis | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 71 |
3467 | Apheresis | Allogeneic | No Data | Hematology | 2020 | Standard Therapy | Poland | 64 |
3468 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 65 |
3469 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 58 |
3470 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 63 |
3471 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 58 |
3472 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 62 |
3473 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 53 |
3474 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 57 |
3475 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 69 |
3476 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 62 |
3477 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 34 |
3478 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 42 |
3479 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 62 |
3480 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2020 | Standard Therapy | Germany | 56 |
3481 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2020 | Standard Therapy | Germany | 67 |
3482 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 68 |
3483 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 52 |
3484 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 64 |
3485 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2020 | Standard Therapy | Poland | 57 |
3486 | Apheresis | Allogeneic | Perforin Deficiency | Hematology | 2020 | Standard Therapy | Poland | 2 |
3487 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 59 |
3488 | Apheresis | Autologous | Primary Cerebral Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 66 |
3489 | Apheresis | Autologous | Primary Cerebral Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 59 |
3490 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 63 |
3491 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 61 |
3492 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 51 |
3493 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 66 |
3494 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Poland | 61 |
3495 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Germany | 54 |
3496 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2020 | Standard Therapy | Germany | 58 |
3497 | Apheresis | Allogeneic | Purine Nucleoside Phosphorylase Deficiency | Hematology | 2020 | Standard Therapy | Poland | 1 |
3498 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 43 |
3499 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 76 |
3500 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Poland | 57 |
3501 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 66 |
3502 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2020 | Standard Therapy | Germany | 56 |
3503 | Apheresis | Autologous | Secondary B-Cell Non-Hodgkin-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 73 |
3504 | Apheresis | Autologous | Secondary Diffuse Large B-Cell Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 54 |
3505 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 9 |
3506 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 53 |
3507 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2020 | Standard Therapy | Poland | 52 |
3508 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2020 | Standard Therapy | Poland | 2 |
3509 | Apheresis | Allogeneic | Sezary Syndrome | Hematology | 2020 | Standard Therapy | Poland | 44 |
3510 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 14 |
3511 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 57 |
3512 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 29 |
3513 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 64 |
3514 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 63 |
3515 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Poland | 29 |
3516 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 51 |
3517 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2020 | Standard Therapy | Germany | 60 |
3518 | Apheresis | Allogeneic | T-Cell-Prolymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 55 |
3519 | Apheresis | Allogeneic | T-Cell-Prolymphocytic Leukemia | Hematology | 2020 | Standard Therapy | Poland | 74 |
3520 | Apheresis | Allogeneic | Β - Thalassemia | Hematology | 2020 | Standard Therapy | Poland | 6 |
3521 | Apheresis | Allogeneic | Β - Thalassemia Major | Hematology | 2020 | Standard Therapy | Poland | 17 |
3522 | Adipose Tissue | Autologous | Alopecia | Dermatology | 2020 | Experimental Therapy | Poland | 68,5 |
3523 | Adipose Tissue | Autologous | Chondromalacia | Orthopedy | 2020 | Experimental Therapy | Poland | 45,9 |
3524 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 52,8 |
3525 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 63,4 |
3526 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 41,1 |
3527 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 34,8 |
3528 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 48,1 |
3529 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 57,11 |
3530 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 59,8 |
3531 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 35,1 |
3532 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 61,8 |
3533 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 56,5 |
3534 | Adipose Tissue | Autologous | Gonarthrosis; Shoulder Osteoarthritis | Orthopedy | 2020 | Experimental Therapy | Poland | 42,5 |
3535 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2020 | Experimental Therapy | Poland | 53,6 |
3536 | Adipose Tissue | Autologous | Internal Damage To The Knee Joint | Orthopedy | 2020 | Experimental Therapy | Poland | 49,2 |
3537 | Adipose Tissue | Autologous | Omarthrosis | Orthopedy | 2020 | Experimental Therapy | Poland | 70,1 |
3538 | Adipose Tissue | Autologous | Other Acquired Deformities Of The Ankle And Foot | Orthopedy | 2020 | Experimental Therapy | Poland | 41,6 |
3539 | Adipose Tissue | Autologous | Scar | Dermatology | 2020 | Clinical Trial | Poland | no data |
3540 | Adipose Tissue | Autologous | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2020 | Experimental Therapy | Poland | 61,1 |
3541 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 5,3 |
3542 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 1,9 |
3543 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 6,1 |
3544 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 2,2 |
3545 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 10,1 |
3546 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 18,2 |
3547 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 10,2 |
3548 | Cord Tissue | Allogeneic - Unrelated | Agenesis Of Corpus Callosum; Atrophy Of The Optic Nerves | Neurology | 2019 | Experimental Therapy | Poland | 7,3 |
3549 | Cord Tissue | Allogeneic - Unrelated | Alopecia Areata | Dermatology | 2019 | Experimental Therapy | Poland | 47,11 |
3550 | Cord Tissue | Allogeneic - Unrelated | Alopecia Areata | Dermatology | 2019 | Experimental Therapy | Poland | 57,9 |
3551 | Cord Tissue | Allogeneic - Unrelated | Alopecia Areata | Dermatology | 2019 | Experimental Therapy | Poland | 43,3 |
3552 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 54,9 |
3553 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 58,7 |
3554 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 65,5 |
3555 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 60,11 |
3556 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 38,2 |
3557 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 61,9 |
3558 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 70,11 |
3559 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 73,1 |
3560 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 58,1 |
3561 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 65,1 |
3562 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 39,8 |
3563 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 46,1 |
3564 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 59,1 |
3565 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 61 |
3566 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 66,2 |
3567 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 44,1 |
3568 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 65,1 |
3569 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 65 |
3570 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 41,5 |
3571 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 59,8 |
3572 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 32,2 |
3573 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 56,1 |
3574 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 61,5 |
3575 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 49,7 |
3576 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 67,11 |
3577 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 59,3 |
3578 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | no data |
3579 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 57,7 |
3580 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 62,4 |
3581 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 67,8 |
3582 | Cord Tissue | Allogeneic - Unrelated | Angelman Syndrome; Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 13,5 |
3583 | Cord Tissue | Allogeneic - Unrelated | Arthrogryposis Multiplex Congenita; Myopathy | Neurology | 2019 | Experimental Therapy | Poland | 3,11 |
3584 | Cord Tissue | Allogeneic - Unrelated | Arthrosis Of The Knee Joint - Chondromalacia | Orthopedy | 2019 | Experimental Therapy | Poland | 51,4 |
3585 | Cord Tissue | Allogeneic - Unrelated | Asperger Syndrome | Neurology | 2019 | Experimental Therapy | Poland | 10,8 |
3586 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2019 | Experimental Therapy | Poland | 38,7 |
3587 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,6 |
3588 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 2,6 |
3589 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 11,6 |
3590 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,7 |
3591 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,9 |
3592 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,2 |
3593 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,8 |
3594 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,2 |
3595 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 9 |
3596 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 11,1 |
3597 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 4,8 |
3598 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 13,4 |
3599 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,11 |
3600 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 2,7 |
3601 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
3602 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,2 |
3603 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,9 |
3604 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2019 | Experimental Therapy | Poland | 4 |
3605 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,3 |
3606 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,5 |
3607 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,3 |
3608 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7 |
3609 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 4,2 |
3610 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,3 |
3611 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 4,6 |
3612 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
3613 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 9,5 |
3614 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,11 |
3615 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
3616 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
3617 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | no data |
3618 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,2 |
3619 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,6 |
3620 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
3621 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 7,7 |
3622 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 8,7 |
3623 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 9,11 |
3624 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2019 | Experimental Therapy | Poland | 12,4 |
3625 | Cord Tissue | Allogeneic - Unrelated | Autism; Diabetes Mellitus Type 1 | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
3626 | Cord Tissue | Allogeneic - Unrelated | Autism; Microcephaly | Neurology | 2019 | Experimental Therapy | Poland | 7,8 |
3627 | Cord Tissue | Allogeneic - Unrelated | Best Disease | Ophthalmology | 2019 | Experimental Therapy | Poland | 56,4 |
3628 | Cord Tissue | Allogeneic - Unrelated | Birth Asphyxia | Neurology | 2019 | Experimental Therapy | Poland | 5,4 |
3629 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 50,1 |
3630 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 37,7 |
3631 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome; Multiple System Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 57,2 |
3632 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6 |
3633 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 9,11 |
3634 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 11 months |
3635 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,5 |
3636 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,4 |
3637 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 11,1 |
3638 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4,2 |
3639 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,3 |
3640 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,5 |
3641 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,6 |
3642 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 9,1 |
3643 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4 |
3644 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
3645 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4,3 |
3646 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,9 |
3647 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2 |
3648 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 1,6 |
3649 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 15,5 |
3650 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2,7 |
3651 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 9,9 |
3652 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4,11 |
3653 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,1 |
3654 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 5,6 |
3655 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2,6 |
3656 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 1,1 |
3657 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 5,3 |
3658 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 22,8 |
3659 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 28,2 |
3660 | Cord Tissue | Allogeneic - Unrelated & Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland/Romania | 7,5 |
3661 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 9,7 |
3662 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 10 |
3663 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6,8 |
3664 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,3 |
3665 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 10,8 |
3666 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 7,1 |
3667 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
3668 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 14,9 |
3669 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6,9 |
3670 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 52,7 |
3671 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6,7 |
3672 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 2,9 |
3673 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6,11 |
3674 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 16,1 |
3675 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 5,1 |
3676 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 5,7 |
3677 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3 |
3678 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3 |
3679 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3 |
3680 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 11,6 |
3681 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 3,8 |
3682 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Autism | Neurology | 2019 | Experimental Therapy | Poland | 5,5 |
3683 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Dandy-Walker Malformation | Neurology | 2019 | Experimental Therapy | Poland | 7,3 |
3684 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 18,9 |
3685 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 3,7 |
3686 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 3 |
3687 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 5,5 |
3688 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 5,11 |
3689 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 10,1 |
3690 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 7,11 |
3691 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 5,3 |
3692 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 8,5 |
3693 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 6,3 |
3694 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 5,6 |
3695 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 15,7 |
3696 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 6 |
3697 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy; Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 1,11 |
3698 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy; Microcephalia | Neurology | 2019 | Experimental Therapy | Poland | 9,3 |
3699 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Hydrocephalus | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
3700 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Hydrocephalus | Neurology | 2019 | Experimental Therapy | Poland | 4,2 |
3701 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Hydrocephalus; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 3,7 |
3702 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Wolf-Hirschhorn Syndrome | Neurology | 2019 | Experimental Therapy | Poland | 10,1 |
3703 | Cord Tissue | Allogeneic - Unrelated | Chondrocalcinosis; Moderate Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 79,1 |
3704 | Cord Tissue | Allogeneic - Unrelated | Chondromalacia | Orthopedy | 2019 | Experimental Therapy | Poland | 60,9 |
3705 | Cord Tissue | Allogeneic - Unrelated | Choroideremia | Ophthalmology | 2019 | Experimental Therapy | Poland | 24,5 |
3706 | Cord Tissue | Allogeneic - Unrelated | Choroideremia | Ophthalmology | 2019 | Experimental Therapy | Poland | 30,1 |
3707 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2019 | Experimental Therapy | Poland | 10,5 |
3708 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease; Condition After Bone Marrow Transplantation Due To Severe Aplastic Anemia | Hematology | 2019 | Experimental Therapy | Poland | 9 |
3709 | Cord Tissue | Allogeneic - Unrelated | Condition After Bilateral Optic Nerve Inflammation | Ophthalmology | 2019 | Experimental Therapy | Poland | 46,11 |
3710 | Cord Tissue | Allogeneic - Unrelated | Condition After Sympathetic Inflammation Of The Left Eye | Ophthalmology | 2019 | Experimental Therapy | Poland | 23,1 |
3711 | Cord Tissue | Allogeneic - Related | Coxarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 57 |
3712 | Cord Tissue | Allogeneic - Unrelated | Dandy-Walker Malformation; Trisomy 9 | Neurology | 2019 | Experimental Therapy | Poland | 10,8 |
3713 | Cord Tissue | Allogeneic - Unrelated | Degeneration Of The Cartilage Of The Knee Joint | Orthopedy | 2019 | Experimental Therapy | Poland | 44,7 |
3714 | Cord Tissue | Allogeneic - Unrelated | Degenerative Disease Of The Spine | Orthopedy | 2019 | Experimental Therapy | Poland | 86,11 |
3715 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Chiari Malformation | Neurology | 2019 | Experimental Therapy | Poland | 4,6 |
3716 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Congenital Cytomegalovirus | Neurology | 2019 | Experimental Therapy | Poland | 8,3 |
3717 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 2,1 |
3718 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3719 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3720 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3721 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3722 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3723 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3724 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3725 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3726 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3727 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Clinical Trial | Poland | no data |
3728 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Experimental Therapy | Poland | 2,11 |
3729 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2019 | Experimental Therapy | Poland | 37,5 |
3730 | Cord Tissue | Allogeneic - Unrelated | Dravet's Syndrome | Neurology | 2019 | Experimental Therapy | Poland | 19,7 |
3731 | Cord Tissue | Allogeneic - Related | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2019 | Experimental Therapy | Poland | 15 |
3732 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2019 | Experimental Therapy | Poland | 7,8 |
3733 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2019 | Experimental Therapy | Poland | 7,7 |
3734 | Cord Tissue | Allogeneic - Related | Encephalopathy; Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 6 |
3735 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 17,1 |
3736 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 3,6 |
3737 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy; Delayed Psychomotor Development | Neurology | 2019 | Experimental Therapy | Poland | 13,1 |
3738 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy; Delayed Psychomotor Development | Neurology | 2019 | Experimental Therapy | Poland | 2,5 |
3739 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 4,4 |
3740 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 5,8 |
3741 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 7,4 |
3742 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 7,4 |
3743 | Cord Tissue | Allogeneic - Unrelated | Epidermolysis Bullosa | Dermatology | 2019 | Experimental Therapy | Poland | 51,1 |
3744 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
3745 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 13,9 |
3746 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 9,4 |
3747 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 3,2 |
3748 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Encephalopathy | Neurology | 2019 | Experimental Therapy | Poland | 8,1 |
3749 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 16,2 |
3750 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 2,11 |
3751 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 39,1 |
3752 | Cord Tissue | Allogeneic - Unrelated | Fragile X Syndrome; Pervasive Developmental Disorder | Neurology | 2019 | Experimental Therapy | Poland | 4 |
3753 | Cord Tissue | Allogeneic - Unrelated | Friedreich's Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 59,6 |
3754 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia | Neurology | 2019 | Experimental Therapy | Poland | 2,1 |
3755 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2019 | Experimental Therapy | Poland | 6,7 |
3756 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 70,8 |
3757 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 78,7 |
3758 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 84,1 |
3759 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 48,7 |
3760 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 34,2 |
3761 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 63,7 |
3762 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 64,8 |
3763 | Cord Tissue | Allogeneic - Unrelated | Hyperacute Graft Versus Host Disease; Condition After Bone Marrow Transplantation Due To Severe Congenital Neutropenia | Hematology | 2019 | Experimental Therapy | Poland | 8 months |
3764 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
3765 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2019 | Experimental Therapy | Poland | 2,5 |
3766 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2019 | Experimental Therapy | Poland | 4,8 |
3767 | Cord Tissue | Allogeneic - Unrelated | Ischemic Stroke | Neurology | 2019 | Experimental Therapy | Poland | 40,7 |
3768 | Cord Tissue | Allogeneic - Unrelated | Ischemic Stroke | Neurology | 2019 | Experimental Therapy | Poland | no data |
3769 | Cord Tissue | Allogeneic - Unrelated | Krabbe Disease | Neurology | 2019 | Experimental Therapy | Poland | 3,3 |
3770 | Cord Tissue | Allogeneic - Unrelated | Macular Degeneration | Ophthalmology | 2019 | Experimental Therapy | Poland | 15,2 |
3771 | Cord Tissue | Allogeneic - Unrelated | Microcephalia; Cerebellar Syndrome; Delayed Psychomotor Development | Neurology | 2019 | Experimental Therapy | Poland | 7,7 |
3772 | Cord Tissue | Allogeneic - Unrelated | Multiple System Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 54,1 |
3773 | Cord Tissue | Allogeneic - Unrelated | Multiple System Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 71,11 |
3774 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 46,1 |
3775 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 17,3 |
3776 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2019 | Experimental Therapy | Poland | 13,1 |
3777 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
3778 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 19,11 |
3779 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 2,1 |
3780 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 1,11 |
3781 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2019 | Experimental Therapy | Poland | 4,11 |
3782 | Cord Tissue | Allogeneic - Unrelated | Non-Adhesion Left Tibia Shank Fracture; Neurofibromatosis T. I | Orthopedy | 2019 | Experimental Therapy | Poland | 18,4 |
3783 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 43,9 |
3784 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 68,4 |
3785 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 72,5 |
3786 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 33,3 |
3787 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 26 |
3788 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 23,9 |
3789 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 35,1 |
3790 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 38,3 |
3791 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 24,5 |
3792 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 12,1 |
3793 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 9,8 |
3794 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 41,3 |
3795 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 34,7 |
3796 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 59,4 |
3797 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 53,2 |
3798 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2019 | Experimental Therapy | Poland | 12,3 |
3799 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2019 | Experimental Therapy | Poland | 26,8 |
3800 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2019 | Experimental Therapy | Poland | 71,3 |
3801 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2019 | Experimental Therapy | Poland | 49,8 |
3802 | Cord Tissue | Allogeneic - Unrelated | Other Disorders Of The Central Nervous System; Genetic Defect; Suspected Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,7 |
3803 | Cord Tissue | Allogeneic - Unrelated | Other Disorders Of The Central Nervous System; Genetic Defect; Suspected Autism | Neurology | 2019 | Experimental Therapy | Poland | 6,7 |
3804 | Cord Tissue | Allogeneic - Unrelated | Other Disorders Of The Optic Disc | Neurology | 2019 | Experimental Therapy | Poland | 3 |
3805 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 1,7 |
3806 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 4,1 |
3807 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 11 months |
3808 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 3,1 |
3809 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2019 | Experimental Therapy | Poland | 3,6 |
3810 | Cord Tissue | Allogeneic - Unrelated | Other Vascular And Retinal Disorders | Ophthalmology | 2019 | Experimental Therapy | Poland | 34,2 |
3811 | Cord Tissue | Allogeneic - Unrelated | Parkinson Syndrome | Neurology | 2019 | Experimental Therapy | Poland | 51,2 |
3812 | Cord Tissue | Allogeneic - Unrelated | Paroxysmal Dystonia | Neurology | 2019 | Experimental Therapy | Poland | 3,7 |
3813 | Cord Tissue | Allogeneic - Unrelated | Polyneuropathy | Neurology | 2019 | Experimental Therapy | Poland | 60,8 |
3814 | Cord Tissue | Allogeneic - Unrelated | Progressive Supranuclear Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 62,4 |
3815 | Cord Tissue | Allogeneic - Unrelated | Propionic Aciduria | Neurology | 2019 | Experimental Therapy | Poland | 10,7 |
3816 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 19,1 |
3817 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 35 |
3818 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 21,6 |
3819 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 67,2 |
3820 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 63,4 |
3821 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2019 | Experimental Therapy | Poland | 69 |
3822 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2019 | Experimental Therapy | Poland | 62,7 |
3823 | Cord Tissue | Allogeneic - Related | Sclerosis Multiplex | Neurology | 2019 | Experimental Therapy | Poland | 61 |
3824 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2019 | Experimental Therapy | Poland | 61,6 |
3825 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2019 | Experimental Therapy | Poland | 59,7 |
3826 | Cord Tissue | Allogeneic - Unrelated | Secondary Progressive Multiple Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 22,9 |
3827 | Cord Tissue | Allogeneic - Unrelated | Secondary Progressive Multiple Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 64 |
3828 | Cord Tissue | Allogeneic - Unrelated | Secondary Progressive Multiple Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 54,6 |
3829 | Cord Tissue | Allogeneic - Unrelated | Secondary Progressive Multiple Sclerosis | Neurology | 2019 | Experimental Therapy | Poland | 59,5 |
3830 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2019 | Experimental Therapy | Poland | 5,11 |
3831 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2019 | Experimental Therapy | Poland | 10 months |
3832 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2019 | Experimental Therapy | Poland | 10 months |
3833 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2019 | Experimental Therapy | Poland | 5,11 |
3834 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida; Epilepsy | Neurology | 2019 | Experimental Therapy | Poland | 2,2 |
3835 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2019 | Experimental Therapy | Poland | 33 |
3836 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2019 | Experimental Therapy | Poland | no data |
3837 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2019 | Experimental Therapy | Poland | 27,5 |
3838 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Neurology | 2019 | Experimental Therapy | Poland | 26,9 |
3839 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2019 | Experimental Therapy | Poland | 38,6 |
3840 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2019 | Experimental Therapy | Poland | 27,8 |
3841 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2019 | Experimental Therapy | Poland | 41,1 |
3842 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2019 | Experimental Therapy | Poland | 11 |
3843 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 40 |
3844 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 26,1 |
3845 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 54,11 |
3846 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2019 | Experimental Therapy | Poland | 37 |
3847 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2019 | Experimental Therapy | Poland | 30,5 |
3848 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2019 | Experimental Therapy | Poland | 40 |
3849 | Cord Tissue | Allogeneic - Unrelated | Status After Meningitis And Encephalitis; Encephalopathy | Neurology | 2019 | Experimental Therapy | Poland | 4 |
3850 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Turkey | 2 |
3851 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 6 |
3852 | Cord Blood | Autologous | Autism | Neurology | 2019 | Experimental Therapy | Poland | 3,6 |
3853 | Cord Blood | Autologous | Autism | Neurology | 2019 | Experimental Therapy | Poland | 10,5 |
3854 | Cord Blood | Autologous | Autism | Neurology | 2019 | Experimental Therapy | Germany | 4 |
3855 | Cord Blood | Autologous | Brain Damage | Neurology | 2019 | Experimental Therapy | Germany | 11 months |
3856 | Cord Blood | Autologous | Brain Damage | Neurology | 2019 | Experimental Therapy | Germany | 1,5 |
3857 | Cord Blood | Allogeneic - Related | Brain Damage | Neurology | 2019 | Experimental Therapy | Germany | 7 |
3858 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | UK | 3 |
3859 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 4,5 |
3860 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2019 | Experimental Therapy | Poland | 8,8 |
3861 | Cord Blood | Allogeneic - Related | Fanconi Anemia | Hematology | 2019 | Standard Therapy | Turkey | 12,4 |
3862 | Cord Blood | Autologous | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Portugal | 4 |
3863 | Cord Blood | Allogeneic - Related | Severe Chronic Neutropenia | Hematology | 2019 | Standard Therapy | Germany | 6 |
3864 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2019 | Standard Therapy | Turkey | 5,5 |
3865 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2019 | Standard Therapy | Turkey | 5,11 |
3866 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2019 | Standard Therapy | Turkey | 5,1 |
3867 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2019 | Standard Therapy | Turkey | 3,5 |
3868 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2019 | Standard Therapy | Turkey | 12 |
3869 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2019 | Standard Therapy | Turkey | 16 |
3870 | Bone Marrow Family | Allogeneic | Activated Pi3k Delta Syndrome (Apds) | Hematology | 2019 | Standard Therapy | Poland | 20 |
3871 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
3872 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
3873 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 73 |
3874 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 61 |
3875 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
3876 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
3877 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
3878 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
3879 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
3880 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
3881 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
3882 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
3883 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
3884 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
3885 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
3886 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
3887 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
3888 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
3889 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
3890 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
3891 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2019 | Standard Therapy | Germany | 61 |
3892 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2019 | Standard Therapy | Germany | 22 |
3893 | Bone Marrow Family | Allogeneic | Glanzmann Thrombasthenia | Hematology | 2019 | Standard Therapy | Poland | 11 |
3894 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 58 |
3895 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 78 |
3896 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
3897 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 60 |
3898 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2019 | Standard Therapy | Poland | 48 |
3899 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2019 | Standard Therapy | Poland | 56 |
3900 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 66 |
3901 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 58 |
3902 | Bone Marrow Family | Allogeneic | Refractory Anemia With Blast Excess Relapse | Hematology | 2019 | Standard Therapy | Germany | 53 |
3903 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 27 |
3904 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
3905 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
3906 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 21 |
3907 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 17 |
3908 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
3909 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
3910 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
3911 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 2 |
3912 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 17 |
3913 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
3914 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 51 |
3915 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
3916 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
3917 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
3918 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 10 |
3919 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 13 |
3920 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
3921 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
3922 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
3923 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
3924 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
3925 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
3926 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 10 |
3927 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
3928 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
3929 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
3930 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
3931 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
3932 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
3933 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
3934 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
3935 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 12 |
3936 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
3937 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
3938 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 30 |
3939 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
3940 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 32 |
3941 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
3942 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
3943 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 1 |
3944 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
3945 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 16 |
3946 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
3947 | Bone Marrow | Allogeneic | Adrenoleukodystrophy | Metabolic | 2019 | Standard Therapy | Poland | 3 |
3948 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 18 |
3949 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
3950 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 10 |
3951 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
3952 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 30 |
3953 | Bone Marrow | Allogeneic | C-Hhyp Cartilage-Hair Hypoplasia | Hematology | 2019 | Standard Therapy | Poland | 2 |
3954 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 7 |
3955 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 9 |
3956 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 35 |
3957 | Bone Marrow | Allogeneic | Congenital Amegakaryocytic Thrombocytopenia (Camt) | Hematology | 2019 | Standard Therapy | Poland | 1 |
3958 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2019 | Standard Therapy | Poland | 2 |
3959 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2019 | Standard Therapy | Poland | 6 |
3960 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 62 |
3961 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2019 | Standard Therapy | Poland | 2 |
3962 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2019 | Standard Therapy | Poland | 3 |
3963 | Bone Marrow | Allogeneic | Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 1 |
3964 | Bone Marrow | Allogeneic | Mucopolysaccharidosis Type I | Metabolic | 2019 | Standard Therapy | Poland | 2 |
3965 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
3966 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 57 |
3967 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 63 |
3968 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 8 |
3969 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 14 |
3970 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
3971 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
3972 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 27 |
3973 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 67 |
3974 | Bone Marrow | Allogeneic | Myeloproliferative Syndrome | Hematology | 2019 | Standard Therapy | Poland | 2 |
3975 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2019 | Standard Therapy | Poland | 6 |
3976 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2019 | Standard Therapy | Poland | 16 |
3977 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 59 |
3978 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 3 |
3979 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 1 |
3980 | Bone Marrow | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 64 |
3981 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 43 |
3982 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 55 |
3983 | Bone Marrow | Allogeneic | Ohis - Other Histiocytic Disorders | Hematology | 2019 | Standard Therapy | Poland | 5 |
3984 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2019 | Standard Therapy | Poland | 1 |
3985 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2019 | Standard Therapy | Poland | 5 months |
3986 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2019 | Standard Therapy | Poland | 14 |
3987 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 2 |
3988 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 22 |
3989 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
3990 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 12 |
3991 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 5 |
3992 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 17 |
3993 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
3994 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 22 |
3995 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
3996 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 14 |
3997 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
3998 | Bone Marrow | Allogeneic | Shwachman Diamond Anemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
3999 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 13 |
4000 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 5 |
4001 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 10 |
4002 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 13 |
4003 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 4 |
4004 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 27 |
4005 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 47 |
4006 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
4007 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
4008 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
4009 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 18 |
4010 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 20 |
4011 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
4012 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 43 |
4013 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 51 |
4014 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 7 |
4015 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
4016 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
4017 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
4018 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
4019 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 28 |
4020 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
4021 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
4022 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
4023 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 43 |
4024 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 32 |
4025 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 44 |
4026 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
4027 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
4028 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 39 |
4029 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
4030 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
4031 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
4032 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
4033 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
4034 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 36 |
4035 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
4036 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
4037 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 38 |
4038 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
4039 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
4040 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
4041 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 70 |
4042 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
4043 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
4044 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
4045 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
4046 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
4047 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
4048 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
4049 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
4050 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
4051 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
4052 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 56 |
4053 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
4054 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 45 |
4055 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 45 |
4056 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
4057 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
4058 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
4059 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
4060 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
4061 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 42 |
4062 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
4063 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
4064 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
4065 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
4066 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
4067 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
4068 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 53 |
4069 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 68 |
4070 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
4071 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 61 |
4072 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 70 |
4073 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
4074 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
4075 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 70 |
4076 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
4077 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
4078 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
4079 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
4080 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
4081 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 38 |
4082 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 45 |
4083 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 51 |
4084 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 68 |
4085 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
4086 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
4087 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
4088 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
4089 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
4090 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
4091 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
4092 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 40 |
4093 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
4094 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 63 |
4095 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 44 |
4096 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
4097 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 38 |
4098 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
4099 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 27 |
4100 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
4101 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 61 |
4102 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
4103 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 52 |
4104 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
4105 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 61 |
4106 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 67 |
4107 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
4108 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
4109 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
4110 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
4111 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
4112 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 68 |
4113 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 15 |
4114 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
4115 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
4116 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
4117 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
4118 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
4119 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 39 |
4120 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
4121 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 71 |
4122 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 25 |
4123 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 48 |
4124 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 45 |
4125 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
4126 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 64 |
4127 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 31 |
4128 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 57 |
4129 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 3 |
4130 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 29 |
4131 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 72 |
4132 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
4133 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 57 |
4134 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 58 |
4135 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 31 |
4136 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 47 |
4137 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 64 |
4138 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 46 |
4139 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 40 |
4140 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 60 |
4141 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 65 |
4142 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 68 |
4143 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 65 |
4144 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 26 |
4145 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 52 |
4146 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 38 |
4147 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 56 |
4148 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2019 | Standard Therapy | Germany | 51 |
4149 | Apheresis | Autologous | Amyloidosis | Hematology | 2019 | Standard Therapy | Germany | 60 |
4150 | Apheresis | Allogeneic | Aplasia | Hematology | 2019 | Standard Therapy | Poland | 51 |
4151 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 16 |
4152 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 8 |
4153 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 46 |
4154 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 21 |
4155 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Germany | 28 |
4156 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 66 |
4157 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
4158 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 2 |
4159 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 16 |
4160 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2019 | Standard Therapy | Poland | 3 |
4161 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
4162 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
4163 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
4164 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
4165 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 60 |
4166 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 69 |
4167 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 23 |
4168 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 34 |
4169 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 37 |
4170 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 56 |
4171 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 58 |
4172 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 56 |
4173 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 31 |
4174 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
4175 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2019 | Standard Therapy | Poland | 46 |
4176 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 54 |
4177 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 65 |
4178 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 73 |
4179 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 62 |
4180 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
4181 | Apheresis | Autologous | Embryonal Cell Carcinoma Of The Testicle | Hematology | 2019 | Standard Therapy | Germany | 29 |
4182 | Apheresis | Allogeneic | Extracranial Malignant Germ Cell Tumors | Hematology | 2019 | Standard Therapy | Poland | 53 |
4183 | Apheresis | Allogeneic | Glanzmann Thrombasthenia | Hematology | 2019 | Standard Therapy | Poland | 11 |
4184 | Apheresis | Allogeneic | High-Risk Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
4185 | Apheresis | Allogeneic | Histiocytosis X | Hematology | 2019 | Standard Therapy | Poland | 14 |
4186 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
4187 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 58 |
4188 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 28 |
4189 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 44 |
4190 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 1 |
4191 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 32 |
4192 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 34 |
4193 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 62 |
4194 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 69 |
4195 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
4196 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
4197 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
4198 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
4199 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 68 |
4200 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 65 |
4201 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 54 |
4202 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 64 |
4203 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
4204 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
4205 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 71 |
4206 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
4207 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
4208 | Apheresis | Allogeneic | Mixed Phenotype Acute Leukemia | Hematology | 2019 | Standard Therapy | Poland | 49 |
4209 | Apheresis | Autologous | Monoclonal Gammopathy Of Undetermined Significance-Sporadic Late Onset Nemaline Myopathy | Hematology | 2019 | Standard Therapy | Germany | 36 |
4210 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2019 | Standard Therapy | Germany | 66 |
4211 | Apheresis | Allogeneic | Mucopolysaccharidosis Type I | Metabolic | 2019 | Standard Therapy | Poland | 1 |
4212 | Apheresis | Allogeneic | Mucopolysaccharidosis Type Ii | Metabolic | 2019 | Standard Therapy | Poland | 2 |
4213 | Apheresis | Allogeneic | Mucopolysaccharidosis Type Ii | Metabolic | 2019 | Standard Therapy | Poland | 2 |
4214 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Poland | 52 |
4215 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Poland | 55 |
4216 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
4217 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
4218 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
4219 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 69 |
4220 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
4221 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
4222 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
4223 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 56 |
4224 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 54 |
4225 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 51 |
4226 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
4227 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
4228 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 61 |
4229 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
4230 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 59 |
4231 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
4232 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 39 |
4233 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 52 |
4234 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 59 |
4235 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 63 |
4236 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 40 |
4237 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
4238 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 53 |
4239 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
4240 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 70 |
4241 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
4242 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 56 |
4243 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 63 |
4244 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 35 |
4245 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 70 |
4246 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
4247 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 41 |
4248 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 60 |
4249 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
4250 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
4251 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 63 |
4252 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
4253 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 66 |
4254 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 57 |
4255 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
4256 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 67 |
4257 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
4258 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 70 |
4259 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 64 |
4260 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 66 |
4261 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 68 |
4262 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 58 |
4263 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 59 |
4264 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 72 |
4265 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2019 | Standard Therapy | Germany | 65 |
4266 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
4267 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 55 |
4268 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
4269 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 14 |
4270 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
4271 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
4272 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 75 |
4273 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 45 |
4274 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 70 |
4275 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 72 |
4276 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 69 |
4277 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 45 |
4278 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 40 |
4279 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 65 |
4280 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 72 |
4281 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 50 |
4282 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 59 |
4283 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
4284 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
4285 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 42 |
4286 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 68 |
4287 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 65 |
4288 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 56 |
4289 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 63 |
4290 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
4291 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 64 |
4292 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 42 |
4293 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 68 |
4294 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
4295 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 68 |
4296 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
4297 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
4298 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
4299 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 67 |
4300 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 4 |
4301 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 56 |
4302 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
4303 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 62 |
4304 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
4305 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 61 |
4306 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 63 |
4307 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 44 |
4308 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 45 |
4309 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 33 |
4310 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 66 |
4311 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 65 |
4312 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 49 |
4313 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 69 |
4314 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 71 |
4315 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 25 |
4316 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 42 |
4317 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 46 |
4318 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Poland | 65 |
4319 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 49 |
4320 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 66 |
4321 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 64 |
4322 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 67 |
4323 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2019 | Standard Therapy | Germany | 66 |
4324 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb | Hematology | 2019 | Standard Therapy | Poland | 21 |
4325 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb | Hematology | 2019 | Standard Therapy | Poland | 16 |
4326 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Myeloproliferative Neoplasms Overlap | Hematology | 2019 | Standard Therapy | Germany | 64 |
4327 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 46 |
4328 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 62 |
4329 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 47 |
4330 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 33 |
4331 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 45 |
4332 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 43 |
4333 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 66 |
4334 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 69 |
4335 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 63 |
4336 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 61 |
4337 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2019 | Standard Therapy | Poland | 61 |
4338 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2019 | Standard Therapy | Poland | 45 |
4339 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2019 | Standard Therapy | Poland | 62 |
4340 | Apheresis | Autologous | Myeloma; Amyloidosis | Hematology | 2019 | Standard Therapy | Germany | 47 |
4341 | Apheresis | Autologous | Natural Killer / T-Cell-Non-Hodgkin-Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 32 |
4342 | Apheresis | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 43 |
4343 | Apheresis | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 20 |
4344 | Apheresis | Allogeneic | No Data | Hematology | 2019 | Standard Therapy | Poland | 58 |
4345 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 68 |
4346 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 28 |
4347 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 58 |
4348 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 67 |
4349 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 51 |
4350 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
4351 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 42 |
4352 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 55 |
4353 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 56 |
4354 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
4355 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2019 | Standard Therapy | Germany | 63 |
4356 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2019 | Standard Therapy | Germany | 69 |
4357 | Apheresis | Allogeneic | Osteomyelofibrosis - Other | Hematology | 2019 | Standard Therapy | Poland | 63 |
4358 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 70 |
4359 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 61 |
4360 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 50 |
4361 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2019 | Standard Therapy | Poland | 24 |
4362 | Apheresis | Allogeneic | Plasma Cell Leukemia | Hematology | 2019 | Standard Therapy | Poland | 35 |
4363 | Apheresis | Allogeneic | Polycythemia Vera-Myelofibrosis | Hematology | 2019 | Standard Therapy | Germany | 58 |
4364 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2019 | Standard Therapy | Germany | 70 |
4365 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 65 |
4366 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
4367 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 69 |
4368 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 64 |
4369 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 56 |
4370 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 57 |
4371 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 63 |
4372 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 67 |
4373 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 78 |
4374 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 21 |
4375 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 19 |
4376 | Apheresis | Allogeneic | Primary Mediastinal | Hematology | 2019 | Standard Therapy | Poland | 33 |
4377 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 46 |
4378 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2019 | Standard Therapy | Poland | 45 |
4379 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2019 | Standard Therapy | Germany | 55 |
4380 | Apheresis | Allogeneic | Relapsed Peripheral T Cell Lymphoma | Hematology | 2019 | Standard Therapy | Poland | 65 |
4381 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Poland | 59 |
4382 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 64 |
4383 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2019 | Standard Therapy | Germany | 60 |
4384 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Myeloproliferative Neoplasms | Hematology | 2019 | Standard Therapy | Germany | 56 |
4385 | Apheresis | Autologous | Secondary Primary Central Nervous System Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 66 |
4386 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 12 |
4387 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 11 |
4388 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2019 | Standard Therapy | Poland | 55 |
4389 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2019 | Standard Therapy | Poland | 1 |
4390 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2019 | Standard Therapy | Poland | 44 |
4391 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 55 |
4392 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 59 |
4393 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 67 |
4394 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 45 |
4395 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 72 |
4396 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 61 |
4397 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2019 | Standard Therapy | Germany | 61 |
4398 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2019 | Standard Therapy | Germany | 29 |
4399 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2019 | Standard Therapy | Poland | 20 |
4400 | Apheresis | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2019 | Standard Therapy | Poland | 1 |
4401 | Apheresis | Allogeneic | Β - Thalassemia | Hematology | 2019 | Standard Therapy | Poland | 13 |
4402 | Adipose Tissue | Autologous | Chondromalacia | Orthopedy | 2019 | Experimental Therapy | Poland | 48,8 |
4403 | Adipose Tissue | Autologous | Chondromalacia | Orthopedy | 2019 | Experimental Therapy | Poland | 38,6 |
4404 | Adipose Tissue | Autologous | Coxarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 34 |
4405 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4406 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4407 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4408 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4409 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4410 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4411 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4412 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4413 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4414 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4415 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4416 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4417 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4418 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4419 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4420 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4421 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4422 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4423 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4424 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4425 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4426 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4427 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2019 | Clinical Trial | Poland | no data |
4428 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 44,11 |
4429 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 65,3 |
4430 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 68,6 |
4431 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 36,1 |
4432 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2019 | Experimental Therapy | Poland | 54,3 |
4433 | Adipose Tissue | Autologous | Mild Arthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 21,2 |
4434 | Adipose Tissue | Autologous | Mild Arthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 68,5 |
4435 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 52,8 |
4436 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 44,8 |
4437 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 52,5 |
4438 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 54,5 |
4439 | Adipose Tissue | Autologous | Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 55,11 |
4440 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4441 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4442 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4443 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4444 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4445 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4446 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4447 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4448 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4449 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4450 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4451 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4452 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4453 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4454 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4455 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4456 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4457 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4458 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4459 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4460 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4461 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4462 | Adipose Tissue | Autologous | Scar | Dermatology | 2019 | Clinical Trial | Poland | no data |
4463 | Adipose Tissue | Autologous | Shoulder Osteoarthritis | Orthopedy | 2019 | Experimental Therapy | Poland | 47,1 |
4464 | Adipose Tissue | Autologous | Soft Tissue Diseases Related To Use, Overload And Pressure | Orthopedy | 2019 | Experimental Therapy | Poland | 45,3 |
4465 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2018 | Experimental Therapy | Poland | 7 |
4466 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2018 | Experimental Therapy | Poland | no data |
4467 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2018 | Experimental Therapy | Poland | 4,7 |
4468 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2018 | Experimental Therapy | Poland | 46,7 |
4469 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2018 | Experimental Therapy | Poland | 20,6 |
4470 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2018 | Experimental Therapy | Poland | 82,11 |
4471 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 61,11 |
4472 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 67,1 |
4473 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 41,8 |
4474 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 52,3 |
4475 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 66,3 |
4476 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 46,2 |
4477 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 65,2 |
4478 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 47,3 |
4479 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 52,11 |
4480 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 40 |
4481 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 54,2 |
4482 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 67,11 |
4483 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 41,9 |
4484 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 80,3 |
4485 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 65,7 |
4486 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 65,2 |
4487 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 60,2 |
4488 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 67,9 |
4489 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 49,2 |
4490 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 64,5 |
4491 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 63,7 |
4492 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 62,1 |
4493 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 55,6 |
4494 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 38,8 |
4495 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 69,5 |
4496 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 37,11 |
4497 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 56,8 |
4498 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 71,1 |
4499 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 64,3 |
4500 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 68,5 |
4501 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 78,2 |
4502 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 70,9 |
4503 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 62,4 |
4504 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 61,8 |
4505 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 41,7 |
4506 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 38,1 |
4507 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 62,7 |
4508 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 44,3 |
4509 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2018 | Experimental Therapy | Poland | 55,11 |
4510 | Cord Tissue | Allogeneic - Unrelated | Arthrogryposis Multiplex Congenita; Epilepsia | Neurology | 2018 | Experimental Therapy | Poland | 6,3 |
4511 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2018 | Experimental Therapy | Poland | 18,11 |
4512 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,5 |
4513 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 9 |
4514 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,3 |
4515 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,1 |
4516 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 9,5 |
4517 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5,11 |
4518 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,3 |
4519 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,1 |
4520 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 11,11 |
4521 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,7 |
4522 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5,5 |
4523 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5 |
4524 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,3 |
4525 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5,3 |
4526 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,4 |
4527 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,9 |
4528 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5,1 |
4529 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 11,4 |
4530 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,11 |
4531 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,1 |
4532 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6 |
4533 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 9,2 |
4534 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 9,6 |
4535 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,5 |
4536 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,11 |
4537 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 5 |
4538 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 7,9 |
4539 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,7 |
4540 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 15 |
4541 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 6,3 |
4542 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,3 |
4543 | Cord Tissue | Allogeneic - Related | Autism | Neurology | 2018 | Experimental Therapy | Poland | 4 |
4544 | Cord Tissue | Allogeneic - Unrelated | Autism - Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 6 |
4545 | Cord Tissue | Allogeneic - Related | Autism; Congenital Cytomegalovirus | Neurology | 2018 | Experimental Therapy | Poland | 6 |
4546 | Cord Tissue | Allogeneic - Unrelated | Bilateral Edema Of The Optic Nerves | Ophthalmology | 2018 | Experimental Therapy | Poland | 12,4 |
4547 | Cord Tissue | Allogeneic - Unrelated | Brain Disorder, Unspecified | Neurology | 2018 | Experimental Therapy | Poland | 10,1 |
4548 | Cord Tissue | Allogeneic - Unrelated | Cartilage Damage | Orthopedy | 2018 | Experimental Therapy | Poland | 56 |
4549 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome; Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 3,7 |
4550 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 16,7 |
4551 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,8 |
4552 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,11 |
4553 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,11 |
4554 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 9,4 |
4555 | Cord Tissue | Allogeneic - Unrelated & Related | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 13,1 |
4556 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,4 |
4557 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
4558 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,5 |
4559 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,11 |
4560 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,6 |
4561 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 11,6 |
4562 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,9 |
4563 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,2 |
4564 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,1 |
4565 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,3 |
4566 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,6 |
4567 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,2 |
4568 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 16,5 |
4569 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,1 |
4570 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,6 |
4571 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,9 |
4572 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,5 |
4573 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,4 |
4574 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,3 |
4575 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,11 |
4576 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,1 |
4577 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 7,8 |
4578 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,1 |
4579 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,4 |
4580 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 8,5 |
4581 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 12,4 |
4582 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,7 |
4583 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 10 months |
4584 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 8,9 |
4585 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,2 |
4586 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 15,7 |
4587 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,2 |
4588 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 13,5 |
4589 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
4590 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 7,4 |
4591 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,6 |
4592 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
4593 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 4,2 |
4594 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,9 |
4595 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,1 |
4596 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,9 |
4597 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,5 |
4598 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 7,1 |
4599 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2,3 |
4600 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,11 |
4601 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 13,2 |
4602 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 7,3 |
4603 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,2 |
4604 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 16 |
4605 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,4 |
4606 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 12,2 |
4607 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 3,9 |
4608 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 10 |
4609 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 2 |
4610 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 5,2 |
4611 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 6,6 |
4612 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 9,5 |
4613 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Encephalopathy | Neurology | 2018 | Experimental Therapy | Poland | 1,11 |
4614 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 3,7 |
4615 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 9,2 |
4616 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 2,4 |
4617 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 10,9 |
4618 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 7,4 |
4619 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 3,6 |
4620 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
4621 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 2 |
4622 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 2,4 |
4623 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 8,3 |
4624 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 10,11 |
4625 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 2,3 |
4626 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy; Developmental Delay | Neurology | 2018 | Experimental Therapy | Poland | 8,11 |
4627 | Cord Tissue | Allogeneic - Unrelated | Congenital Myasthenia | Neurology | 2018 | Experimental Therapy | Poland | 6,4 |
4628 | Cord Tissue | Allogeneic - Unrelated | Congenital Myasthenia | Neurology | 2018 | Experimental Therapy | Poland | 3,3 |
4629 | Cord Tissue | Allogeneic - Unrelated | Damage To The Intercondylar Fissure Of The Right Knee | Orthopedy | 2018 | Experimental Therapy | Poland | 40 |
4630 | Cord Tissue | Allogeneic - Unrelated | Degeneration Of The Cartilage Of The Knee Joint | Orthopedy | 2018 | Experimental Therapy | Poland | 34 |
4631 | Cord Tissue | Allogeneic - Unrelated | Degeneration Of The Cartilage Of The Knee Joint | Orthopedy | 2018 | Experimental Therapy | Poland | 57 |
4632 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 6,2 |
4633 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 5,4 |
4634 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 4,8 |
4635 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 7,11 |
4636 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 4,7 |
4637 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2018 | Experimental Therapy | Poland | 4,2 |
4638 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Atrophy Of The Optic Nerves | Neurology | 2018 | Experimental Therapy | Poland | 2 |
4639 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 4,5 |
4640 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2018 | Experimental Therapy | Poland | 14 |
4641 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2018 | Experimental Therapy | Poland | 7,11 |
4642 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2018 | Experimental Therapy | Poland | 5,2 |
4643 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4644 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4645 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4646 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4647 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4648 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4649 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4650 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4651 | Cord Tissue | Allogeneic - Unrelated | Diabetes Mellitus T. 1 | Endocrinology | 2018 | Clinical Trial | Poland | no data |
4652 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2018 | Experimental Therapy | Poland | 8,8 |
4653 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2018 | Experimental Therapy | Poland | 54,8 |
4654 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2018 | Experimental Therapy | Poland | 11,4 |
4655 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2018 | Experimental Therapy | Poland | 24,5 |
4656 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 22,1 |
4657 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 21,2 |
4658 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 20,9 |
4659 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 13,3 |
4660 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 7,6 |
4661 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 4 |
4662 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 3,9 |
4663 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Agenesis Of Corpus Callosum | Neurology | 2018 | Experimental Therapy | Poland | 2 |
4664 | Cord Tissue | Allogeneic - Unrelated | Friedreich's Ataxia | Neurology | 2018 | Experimental Therapy | Poland | 27,6 |
4665 | Cord Tissue | Allogeneic - Unrelated | Friedreich's Ataxia | Neurology | 2018 | Experimental Therapy | Poland | 31,5 |
4666 | Cord Tissue | Allogeneic - Unrelated | Friedreich's Ataxia | Neurology | 2018 | Experimental Therapy | Poland | 22,4 |
4667 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia | Neurology | 2018 | Experimental Therapy | Poland | 2,5 |
4668 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia | Neurology | 2018 | Experimental Therapy | Poland | 9,11 |
4669 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia | Neurology | 2018 | Experimental Therapy | Poland | 7,3 |
4670 | Cord Tissue | Allogeneic - Unrelated | General Hypotonia; Autism | Neurology | 2018 | Experimental Therapy | Poland | 8,4 |
4671 | Cord Tissue | Allogeneic - Unrelated | Genetic Syndrome - Deletion Of Part Of Chromosome 3 | Neurology | 2018 | Experimental Therapy | Poland | 8,1 |
4672 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 44,11 |
4673 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 46,1 |
4674 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 28,11 |
4675 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 66 |
4676 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 48 |
4677 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 43 |
4678 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 48 |
4679 | Cord Tissue | Allogeneic - Unrelated | Holoprosencephaly | Neurology | 2018 | Experimental Therapy | Poland | 12,2 |
4680 | Cord Tissue | Allogeneic - Unrelated | Lack Of Expected Normal Physical Development, Unspecified | Neurology | 2018 | Experimental Therapy | Poland | 10,2 |
4681 | Cord Tissue | Allogeneic - Unrelated | Leber's Hereditary Optic Neuropathy | Ophthalmology | 2018 | Experimental Therapy | Poland | 18,11 |
4682 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2018 | Experimental Therapy | Poland | 5,2 |
4683 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2018 | Experimental Therapy | Poland | 7,5 |
4684 | Cord Tissue | Allogeneic - Unrelated | Microcephalia | Neurology | 2018 | Experimental Therapy | Poland | 12,1 |
4685 | Cord Tissue | Allogeneic - Unrelated | Multiple System Atrophy | Neurology | 2018 | Experimental Therapy | Poland | 47,8 |
4686 | Cord Tissue | Allogeneic - Unrelated | Multiple System Atrophy | Neurology | 2018 | Experimental Therapy | Poland | 61,8 |
4687 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 28,1 |
4688 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 21,7 |
4689 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 22,6 |
4690 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 29,9 |
4691 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 21,8 |
4692 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 66,2 |
4693 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele | Neurology | 2018 | Experimental Therapy | Poland | 1 |
4694 | Cord Tissue | Allogeneic - Unrelated | Myelomeningocele; Hydrocephalus | Neurology | 2018 | Experimental Therapy | Poland | 2,9 |
4695 | Cord Tissue | Allogeneic - Unrelated | Myopathy | Neurology | 2018 | Experimental Therapy | Poland | 57,3 |
4696 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2018 | Experimental Therapy | Poland | 27,4 |
4697 | Cord Tissue | Allogeneic - Unrelated | Neuropathy | Neurology | 2018 | Experimental Therapy | Poland | 47,6 |
4698 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 68,5 |
4699 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 31,11 |
4700 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 55,4 |
4701 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 36,6 |
4702 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 34,11 |
4703 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 27,2 |
4704 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 59,3 |
4705 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 50,8 |
4706 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 38,6 |
4707 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 55,8 |
4708 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 62,5 |
4709 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 35 |
4710 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 57,8 |
4711 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 75,5 |
4712 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 54,4 |
4713 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 80,5 |
4714 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 40,9 |
4715 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 70,11 |
4716 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 47,1 |
4717 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 38,2 |
4718 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 67,1 |
4719 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 64,7 |
4720 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 55,8 |
4721 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 27,5 |
4722 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 38,7 |
4723 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 23,7 |
4724 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 50,1 |
4725 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 70,5 |
4726 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 66,7 |
4727 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 22 |
4728 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 69,8 |
4729 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 78 |
4730 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 30 |
4731 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 73,8 |
4732 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 30,7 |
4733 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 49,7 |
4734 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 34,9 |
4735 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 46,5 |
4736 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 53,7 |
4737 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 56,7 |
4738 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 54,9 |
4739 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 42,4 |
4740 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 44,6 |
4741 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 60,3 |
4742 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 42,2 |
4743 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2018 | Experimental Therapy | Poland | 52 |
4744 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2018 | Experimental Therapy | Poland | 15,8 |
4745 | Cord Tissue | Allogeneic - Unrelated | Other Reduction Deformities Of Brain; Schizencephaly | Neurology | 2018 | Experimental Therapy | Poland | 5,7 |
4746 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 1,11 |
4747 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 1,9 |
4748 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 16,1 |
4749 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 5 |
4750 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 6 |
4751 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 11 months |
4752 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 4,5 |
4753 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 1,2 |
4754 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2018 | Experimental Therapy | Poland | 2,1 |
4755 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System - Syndrome Pierre-Robin | Neurology | 2018 | Experimental Therapy | Poland | 2,7 |
4756 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System- Pitt Hopkins Syndrome | Neurology | 2018 | Experimental Therapy | Poland | 10,1 |
4757 | Cord Tissue | Allogeneic - Unrelated | Paralysis | Neurology | 2018 | Experimental Therapy | Poland | 14,11 |
4758 | Cord Tissue | Allogeneic - Unrelated | Phelan-Mcdermid Syndrome | Neurology | 2018 | Experimental Therapy | Poland | 17,1 |
4759 | Cord Tissue | Allogeneic - Unrelated | Progressive Supranuclear Atrophy | Neurology | 2018 | Experimental Therapy | Poland | 62 |
4760 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 25,5 |
4761 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 36,3 |
4762 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 48,11 |
4763 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 44,3 |
4764 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 52,8 |
4765 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 32,3 |
4766 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 46,7 |
4767 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 47,8 |
4768 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 51,9 |
4769 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 38,1 |
4770 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 30,4 |
4771 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 34,2 |
4772 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 28,6 |
4773 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 83,5 |
4774 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 57,5 |
4775 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 45,11 |
4776 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 28,6 |
4777 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 61,3 |
4778 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 20,8 |
4779 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 76,1 |
4780 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 35,1 |
4781 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 31,2 |
4782 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 64,4 |
4783 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 66,2 |
4784 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 75,7 |
4785 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 62 |
4786 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 44 |
4787 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 48,1 |
4788 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 47,11 |
4789 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 44,2 |
4790 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 42,6 |
4791 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 64,9 |
4792 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 85,1 |
4793 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 61,9 |
4794 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 64,3 |
4795 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 51,6 |
4796 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 40,11 |
4797 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 50,4 |
4798 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 49,2 |
4799 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 33,5 |
4800 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 54,7 |
4801 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2018 | Experimental Therapy | Poland | 36,7 |
4802 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 59,1 |
4803 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 66,8 |
4804 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 39,5 |
4805 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 44,2 |
4806 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 39,1 |
4807 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 47,3 |
4808 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 58,2 |
4809 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2018 | Experimental Therapy | Poland | 42 |
4810 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Neurology | 2018 | Experimental Therapy | Poland | 12 |
4811 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 2,6 |
4812 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 3,1 |
4813 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 4,11 |
4814 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 4,4 |
4815 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1 |
4816 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 2 |
4817 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1,5 |
4818 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1,1 |
4819 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1,4 |
4820 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 2,8 |
4821 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 2,6 |
4822 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 3,2 |
4823 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2018 | Experimental Therapy | Poland | 1,6 |
4824 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 33,11 |
4825 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 30,9 |
4826 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 25,9 |
4827 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 25,9 |
4828 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 34,3 |
4829 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 18,5 |
4830 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 26,6 |
4831 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 18,2 |
4832 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2018 | Experimental Therapy | Poland | 38 |
4833 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2018 | Experimental Therapy | Poland | 64,1 |
4834 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2018 | Experimental Therapy | Poland | 34,1 |
4835 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2018 | Experimental Therapy | Poland | 22,4 |
4836 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2018 | Experimental Therapy | Poland | 34 |
4837 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2018 | Experimental Therapy | Poland | 39,2 |
4838 | Cord Tissue | Allogeneic - Unrelated | State After Encephalitis; Epilepsy | Neurology | 2018 | Experimental Therapy | Poland | 44,11 |
4839 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 70,1 |
4840 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 53,4 |
4841 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 67,3 |
4842 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 42,3 |
4843 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2018 | Experimental Therapy | Poland | 60,9 |
4844 | Cord Tissue | Allogeneic - Unrelated | Tetraparesis | Orthopedy | 2018 | Experimental Therapy | Poland | 32,2 |
4845 | Cord Tissue | Allogeneic - Unrelated | Visual Pathway Dysfunction | Ophthalmology | 2018 | Experimental Therapy | Poland | 48,9 |
4846 | Cord Tissue | Allogeneic - Unrelated | Wolf-Hirschhorn Syndrome | Neurology | 2018 | Experimental Therapy | Poland | 1,8 |
4847 | Cord Blood | Allogeneic - Related | Alpha-Mannosidosis | Neurology | 2018 | Experimental Therapy | Germany | 8 |
4848 | Cord Blood | Autologous | Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 3,5 |
4849 | Cord Blood | Autologous | Autism | Neurology | 2018 | Experimental Therapy | Portugal | 6 |
4850 | Cord Blood | Autologous | Autism | Neurology | 2018 | Experimental Therapy | Portugal | 8 |
4851 | Cord Blood | Allogeneic - Related | Autism | Neurology | 2018 | Experimental Therapy | Poland | 3,9 |
4852 | Cord Blood | Autologous | Autism | Neurology | 2018 | Experimental Therapy | UK | 5,4 |
4853 | Cord Blood | Autologous | Brain Damage | Neurology | 2018 | Experimental Therapy | Germany | 3 |
4854 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | Poland | 1,7 |
4855 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2018 | Experimental Therapy | UK | 3,4 |
4856 | Cord Blood | Allogeneic | Immunodeficiency | Hematology | 2018 | Standard Therapy | Germany | 3 months |
4857 | Cord Blood | Allogeneic - Related | Sickle Cell Anemia | Hematology | 2018 | Standard Therapy | Turkey | 10,1 |
4858 | Cord Blood | Allogeneic - Related | Sickle Cell Anemia | Hematology | 2018 | Standard Therapy | Turkey | 6 |
4859 | Cord Blood | Allogeneic | Sphingolipidosis | Neurology | 2018 | Experimental Therapy | Germany | 4 |
4860 | Cord Blood | Autologous | Stroke | Neurology | 2018 | Experimental Therapy | Germany | 8 months |
4861 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 8,6 |
4862 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 4,3 |
4863 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 3,1 |
4864 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 5 |
4865 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 10,9 |
4866 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Turkey | 3 |
4867 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2018 | Standard Therapy | Germany | 5 |
4868 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
4869 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
4870 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
4871 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 32 |
4872 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 27 |
4873 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
4874 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 28 |
4875 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
4876 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
4877 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
4878 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 64 |
4879 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
4880 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
4881 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 42 |
4882 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
4883 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
4884 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
4885 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
4886 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
4887 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 34 |
4888 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia In First Complete Remission | Hematology | 2018 | Standard Therapy | Poland | 61 |
4889 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 62 |
4890 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 66 |
4891 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 23 |
4892 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 45 |
4893 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 57 |
4894 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 70 |
4895 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 64 |
4896 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 3 |
4897 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 58 |
4898 | Bone Marrow Family | Allogeneic | Relapsed Peripheral T Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 44 |
4899 | Bone Marrow Family | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 9 |
4900 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
4901 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 9 months |
4902 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 12 |
4903 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
4904 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 11 |
4905 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 14 |
4906 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
4907 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 7 |
4908 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
4909 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 14 |
4910 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
4911 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
4912 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 12 |
4913 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
4914 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 18 |
4915 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia - Relapse | Hematology | 2018 | Standard Therapy | Poland | 14 |
4916 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
4917 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
4918 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
4919 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 36 |
4920 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
4921 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 1 |
4922 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
4923 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
4924 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
4925 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
4926 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 32 |
4927 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 17 |
4928 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
4929 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
4930 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 70 |
4931 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
4932 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 72 |
4933 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
4934 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 22 |
4935 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
4936 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 53 |
4937 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 24 |
4938 | Bone Marrow | Allogeneic | Bilineal Leukemia - Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 2 |
4939 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 1 |
4940 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 3 |
4941 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 2 |
4942 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 2 |
4943 | Bone Marrow | Allogeneic | Congenital Hypoplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 2 |
4944 | Bone Marrow | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 68 |
4945 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
4946 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2018 | Standard Therapy | Poland | 3 |
4947 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 31 |
4948 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2018 | Standard Therapy | Poland | 2 |
4949 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 11 |
4950 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 4 |
4951 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 12 |
4952 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 2 |
4953 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 70 |
4954 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 4 |
4955 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 4 |
4956 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 31 |
4957 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 37 |
4958 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 16 |
4959 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 48 |
4960 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 52 |
4961 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 1 |
4962 | Bone Marrow | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 1 |
4963 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 62 |
4964 | Bone Marrow | Allogeneic | Other Non-Malignant Disease | Hematology | 2018 | Standard Therapy | Poland | 29 |
4965 | Bone Marrow | Allogeneic | Primary Myelofibrosis Grade Iii | Hematology | 2018 | Standard Therapy | Germany | 73 |
4966 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 19 |
4967 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 14 |
4968 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 27 |
4969 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 18 |
4970 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 2 |
4971 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
4972 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
4973 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Germany | 54 |
4974 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 2 |
4975 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 1 |
4976 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 7 months |
4977 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 21 |
4978 | Bone Marrow | Allogeneic | T-Cell Leukemia/Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 10 |
4979 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2018 | Standard Therapy | Poland | 14 |
4980 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2018 | Standard Therapy | Poland | 12 |
4981 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 29 |
4982 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
4983 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 65 |
4984 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 48 |
4985 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
4986 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
4987 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
4988 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 42 |
4989 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 47 |
4990 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
4991 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
4992 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
4993 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
4994 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
4995 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
4996 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 27 |
4997 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 1 |
4998 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
4999 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
5000 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
5001 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 21 |
5002 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 39 |
5003 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
5004 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 7 months |
5005 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
5006 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 64 |
5007 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 36 |
5008 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
5009 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 20 |
5010 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 44 |
5011 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
5012 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
5013 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 30 |
5014 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
5015 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 48 |
5016 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
5017 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
5018 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 9 |
5019 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 8 |
5020 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 47 |
5021 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 24 |
5022 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 52 |
5023 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 43 |
5024 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 52 |
5025 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 59 |
5026 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 24 |
5027 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 26 |
5028 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 35 |
5029 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
5030 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 42 |
5031 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
5032 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
5033 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
5034 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
5035 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 72 |
5036 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
5037 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
5038 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
5039 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 30 |
5040 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
5041 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
5042 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
5043 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 51 |
5044 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 64 |
5045 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
5046 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 64 |
5047 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
5048 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
5049 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 76 |
5050 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
5051 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
5052 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
5053 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
5054 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
5055 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 68 |
5056 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 37 |
5057 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 65 |
5058 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
5059 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 33 |
5060 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
5061 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 73 |
5062 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
5063 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
5064 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
5065 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 57 |
5066 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 35 |
5067 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
5068 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 42 |
5069 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 72 |
5070 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
5071 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
5072 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 70 |
5073 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
5074 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
5075 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
5076 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 39 |
5077 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 53 |
5078 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
5079 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
5080 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
5081 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 31 |
5082 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
5083 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
5084 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
5085 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
5086 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 32 |
5087 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
5088 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 69 |
5089 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
5090 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 28 |
5091 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
5092 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
5093 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
5094 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
5095 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 47 |
5096 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 29 |
5097 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 37 |
5098 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 57 |
5099 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
5100 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
5101 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
5102 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 31 |
5103 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
5104 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
5105 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
5106 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 32 |
5107 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
5108 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 68 |
5109 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 54 |
5110 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
5111 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 57 |
5112 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 59 |
5113 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
5114 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 75 |
5115 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 43 |
5116 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 72 |
5117 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 37 |
5118 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
5119 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
5120 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 55 |
5121 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
5122 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
5123 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 61 |
5124 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
5125 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 14 |
5126 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
5127 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 66 |
5128 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
5129 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
5130 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 20 |
5131 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 47 |
5132 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 58 |
5133 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 31 |
5134 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
5135 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 60 |
5136 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 59 |
5137 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 67 |
5138 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 62 |
5139 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 58 |
5140 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 69 |
5141 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 62 |
5142 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 60 |
5143 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 65 |
5144 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 19 |
5145 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
5146 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 62 |
5147 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 67 |
5148 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myeloproliferative Syndrome | Hematology | 2018 | Standard Therapy | Germany | 62 |
5149 | Apheresis | Autologous | Amyloidosis | Hematology | 2018 | Standard Therapy | Germany | 72 |
5150 | Apheresis | Autologous | Amyloidosis | Hematology | 2018 | Standard Therapy | Germany | 75 |
5151 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2018 | Standard Therapy | Germany | 61 |
5152 | Apheresis | Autologous | Apoplexy | Hematology | 2018 | Standard Therapy | Germany | 3 |
5153 | Apheresis | Allogeneic | Atypical Chronic Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
5154 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
5155 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 50 |
5156 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
5157 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
5158 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 52 |
5159 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 46 |
5160 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 65 |
5161 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 69 |
5162 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 43 |
5163 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5164 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 32 |
5165 | Apheresis | Allogeneic | Blastic Nk Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 65 |
5166 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 15 |
5167 | Apheresis | Allogeneic | Chronic Granulomatous Disease | Hematology | 2018 | Standard Therapy | Poland | 2 |
5168 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
5169 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 38 |
5170 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
5171 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 48 |
5172 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 25 |
5173 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 41 |
5174 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Germany | 44 |
5175 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Germany | 54 |
5176 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 39 |
5177 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 63 |
5178 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 56 |
5179 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 71 |
5180 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 51 |
5181 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
5182 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 67 |
5183 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 49 |
5184 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 60 |
5185 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 54 |
5186 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 71 |
5187 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2018 | Standard Therapy | Germany | 71 |
5188 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2018 | Standard Therapy | Poland | 9 |
5189 | Apheresis | Allogeneic | Follicular Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 44 |
5190 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 65 |
5191 | Apheresis | Allogeneic | Follicular Lymphoma (Non-Hodgkin Lymphoma) | Hematology | 2018 | Standard Therapy | Poland | 56 |
5192 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2018 | Standard Therapy | Germany | 23 |
5193 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2018 | Standard Therapy | Germany | 31 |
5194 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 38 |
5195 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 27 |
5196 | Apheresis | Allogeneic | Hypoplastic Mds-Eb2 With Incipient Saml | Hematology | 2018 | Standard Therapy | Poland | 63 |
5197 | Apheresis | Autologous | Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5198 | Apheresis | Allogeneic | Leukemia | Hematology | 2018 | Standard Therapy | Poland | 34 |
5199 | Apheresis | Allogeneic | Lymphomatoid Granulomatosis | Hematology | 2018 | Standard Therapy | Germany | 36 |
5200 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5201 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 64 |
5202 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 44 |
5203 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5204 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2018 | Standard Therapy | Germany | 65 |
5205 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2018 | Standard Therapy | Germany | 31 |
5206 | Apheresis | Allogeneic | Morbus Hodgkin-Relapse | Hematology | 2018 | Standard Therapy | Germany | 35 |
5207 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 67 |
5208 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
5209 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
5210 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5211 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 57 |
5212 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 53 |
5213 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 57 |
5214 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
5215 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 47 |
5216 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 60 |
5217 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5218 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
5219 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 67 |
5220 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
5221 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 54 |
5222 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 58 |
5223 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 51 |
5224 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 69 |
5225 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 52 |
5226 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
5227 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
5228 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
5229 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
5230 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
5231 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 63 |
5232 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 55 |
5233 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 60 |
5234 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
5235 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 62 |
5236 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
5237 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 55 |
5238 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
5239 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
5240 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 52 |
5241 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 61 |
5242 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 69 |
5243 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 73 |
5244 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 42 |
5245 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 60 |
5246 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
5247 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5248 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5249 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 65 |
5250 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 51 |
5251 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 69 |
5252 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 50 |
5253 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 67 |
5254 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 50 |
5255 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 64 |
5256 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2018 | Standard Therapy | Germany | 56 |
5257 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 74 |
5258 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
5259 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 72 |
5260 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 59 |
5261 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 50 |
5262 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 62 |
5263 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 68 |
5264 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 54 |
5265 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
5266 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 22 |
5267 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 64 |
5268 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 77 |
5269 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 66 |
5270 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 60 |
5271 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 68 |
5272 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 39 |
5273 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 62 |
5274 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 56 |
5275 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 63 |
5276 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 63 |
5277 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 27 |
5278 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 70 |
5279 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 39 |
5280 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 71 |
5281 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 32 |
5282 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 59 |
5283 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 59 |
5284 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 63 |
5285 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
5286 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 65 |
5287 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 66 |
5288 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 48 |
5289 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 60 |
5290 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 57 |
5291 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 46 |
5292 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 49 |
5293 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 4 |
5294 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
5295 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 69 |
5296 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 63 |
5297 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 8 |
5298 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 58 |
5299 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 61 |
5300 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Poland | 67 |
5301 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Germany | 61 |
5302 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Germany | 65 |
5303 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Germany | 57 |
5304 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2018 | Standard Therapy | Germany | 27 |
5305 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb | Hematology | 2018 | Standard Therapy | Poland | 61 |
5306 | Apheresis | Allogeneic | Myelodysplastic Syndrome Refractory Anemia With Blast Proliferation Ii | Hematology | 2018 | Standard Therapy | Germany | 57 |
5307 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Germany | 65 |
5308 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Acute Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 74 |
5309 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Myeloproliferative Neoplasms | Hematology | 2018 | Standard Therapy | Germany | 62 |
5310 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 49 |
5311 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 60 |
5312 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 56 |
5313 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 58 |
5314 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 64 |
5315 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 68 |
5316 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 72 |
5317 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 53 |
5318 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 56 |
5319 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 57 |
5320 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 55 |
5321 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2018 | Standard Therapy | Poland | 52 |
5322 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2018 | Standard Therapy | Poland | 61 |
5323 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 69 |
5324 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 70 |
5325 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 38 |
5326 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 22 |
5327 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 60 |
5328 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 19 |
5329 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 65 |
5330 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 22 |
5331 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 67 |
5332 | Apheresis | Allogeneic | No Data | Hematology | 2018 | Standard Therapy | Poland | 46 |
5333 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 23 |
5334 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 69 |
5335 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 70 |
5336 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 17 |
5337 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 31 |
5338 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 66 |
5339 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 17 |
5340 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 58 |
5341 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 11 |
5342 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 64 |
5343 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 30 |
5344 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 54 |
5345 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 72 |
5346 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 54 |
5347 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 58 |
5348 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 63 |
5349 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 48 |
5350 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 62 |
5351 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 62 |
5352 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2018 | Standard Therapy | Germany | 51 |
5353 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2018 | Standard Therapy | Poland | 59 |
5354 | Apheresis | Allogeneic | Other Myelodysplastic Syndromes | Hematology | 2018 | Standard Therapy | Poland | 67 |
5355 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 57 |
5356 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 50 |
5357 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2018 | Standard Therapy | Poland | 64 |
5358 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2018 | Standard Therapy | Poland | 57 |
5359 | Apheresis | Autologous | Plasma Cell Leukemia | Hematology | 2018 | Standard Therapy | Germany | 52 |
5360 | Apheresis | Allogeneic | Post-Essential Thrombocythemia-Myelofibrosis | Hematology | 2018 | Standard Therapy | Germany | 53 |
5361 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
5362 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 69 |
5363 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
5364 | Apheresis | Autologous | Primary Central Nervous System Lymphoma Relapse | Hematology | 2018 | Standard Therapy | Germany | 63 |
5365 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 3 |
5366 | Apheresis | Allogeneic | Primary Myelofibrosis; Secondary Acute Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 53 |
5367 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
5368 | Apheresis | Autologous | Refractory Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 36 |
5369 | Apheresis | Allogeneic | Refractory Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 50 |
5370 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
5371 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
5372 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Primary Myelofibrosis | Hematology | 2018 | Standard Therapy | Germany | 56 |
5373 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 18 |
5374 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 74 |
5375 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 24 |
5376 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 70 |
5377 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
5378 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 13 |
5379 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 2 |
5380 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 7 |
5381 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 13 |
5382 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
5383 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
5384 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
5385 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
5386 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 23 |
5387 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2018 | Standard Therapy | Poland | 5 |
5388 | Apheresis | Allogeneic | Therapy-Related Myelodysplastic Syndromes | Hematology | 2018 | Standard Therapy | Poland | 65 |
5389 | Adipose Tissue | Autologous | Condition After Injury Of The Left Knee Joint | Orthopedy | 2018 | Experimental Therapy | Poland | 33 |
5390 | Adipose Tissue | Autologous | Coxarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 53 |
5391 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
5392 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
5393 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
5394 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
5395 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
5396 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
5397 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
5398 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
5399 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 69 |
5400 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 42 |
5401 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5402 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5403 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5404 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5405 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5406 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5407 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5408 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5409 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5410 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5411 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
5412 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 44,2 |
5413 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 25,8 |
5414 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 38,5 |
5415 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 26,1 |
5416 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 37,11 |
5417 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 62,5 |
5418 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 35,4 |
5419 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 31,3 |
5420 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 13 |
5421 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 11,1 |
5422 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 2,4 |
5423 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 8,1 |
5424 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 7,6 |
5425 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2017 | Experimental Therapy | Poland | 33,4 |
5426 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 67,11 |
5427 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 37,9 |
5428 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 71,7 |
5429 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | no data |
5430 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 47,6 |
5431 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56,7 |
5432 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 48,11 |
5433 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 46,3 |
5434 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 45,9 |
5435 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 75,9 |
5436 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,3 |
5437 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 59,8 |
5438 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 64,9 |
5439 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56,7 |
5440 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 40,11 |
5441 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 69,1 |
5442 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 52 |
5443 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 35,1 |
5444 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 77,2 |
5445 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 35,6 |
5446 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 33,5 |
5447 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,6 |
5448 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 46 |
5449 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 54,1 |
5450 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 63,2 |
5451 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 43,8 |
5452 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 64,7 |
5453 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,6 |
5454 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 70,11 |
5455 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 65,1 |
5456 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,3 |
5457 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 68,1 |
5458 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 59,3 |
5459 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 49,1 |
5460 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 60,1 |
5461 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56,7 |
5462 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 58,7 |
5463 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 63 |
5464 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 62,9 |
5465 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 57,9 |
5466 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 59,11 |
5467 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 46,5 |
5468 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 53,9 |
5469 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 55,2 |
5470 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 54,6 |
5471 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 78,6 |
5472 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 44 |
5473 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 78,7 |
5474 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 60,1 |
5475 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 28,7 |
5476 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 78,5 |
5477 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 54,2 |
5478 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 45,3 |
5479 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 48,2 |
5480 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 71,8 |
5481 | Cord Tissue | Allogeneic - Unrelated | Anterior Ischemic Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 67,7 |
5482 | Cord Tissue | Allogeneic - Unrelated | Arthrogryposis Multiplex Congenita | Neurology | 2017 | Experimental Therapy | Poland | 1,7 |
5483 | Cord Tissue | Allogeneic - Unrelated | Arthrogryposis Multiplex Congenita | Neurology | 2017 | Experimental Therapy | Poland | 3,5 |
5484 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2017 | Experimental Therapy | Poland | 23,9 |
5485 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2017 | Experimental Therapy | Poland | 35,5 |
5486 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7,11 |
5487 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 13,4 |
5488 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 11,11 |
5489 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 9,1 |
5490 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 6,3 |
5491 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7,11 |
5492 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 10,2 |
5493 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,8 |
5494 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 6,8 |
5495 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7 |
5496 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,8 |
5497 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 10,8 |
5498 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 13,1 |
5499 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,11 |
5500 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,8 |
5501 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 12,2 |
5502 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 5,1 |
5503 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 6,5 |
5504 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7,8 |
5505 | Cord Tissue | Allogeneic - Unrelated | Autism; Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 7,11 |
5506 | Cord Tissue | Allogeneic - Unrelated | Cartilage Damage | Orthopedy | 2017 | Experimental Therapy | Poland | 61 |
5507 | Cord Tissue | Allogeneic - Unrelated | Cartilage Damage | Orthopedy | 2017 | Experimental Therapy | Poland | 46 |
5508 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 33 |
5509 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 11,5 |
5510 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 60,5 |
5511 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 52,6 |
5512 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 60,11 |
5513 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 46,5 |
5514 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 18,7 |
5515 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 15,4 |
5516 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,11 |
5517 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 31,9 |
5518 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,7 |
5519 | Cord Tissue | Allogeneic - Related | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 12 |
5520 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,9 |
5521 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,3 |
5522 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,1 |
5523 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 13,6 |
5524 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 8,2 |
5525 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,7 |
5526 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 8,4 |
5527 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 15,1 |
5528 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 18,4 |
5529 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 7,9 |
5530 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,5 |
5531 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,7 |
5532 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,5 |
5533 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,1 |
5534 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,4 |
5535 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,3 |
5536 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,7 |
5537 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,2 |
5538 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,7 |
5539 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,11 |
5540 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 15,3 |
5541 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 13,6 |
5542 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,4 |
5543 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3,3 |
5544 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,3 |
5545 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,2 |
5546 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 3 |
5547 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,9 |
5548 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 7,8 |
5549 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,2 |
5550 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 10 |
5551 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,6 |
5552 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 1,11 |
5553 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,2 |
5554 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 24,8 |
5555 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 8,1 |
5556 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 1,6 |
5557 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,8 |
5558 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 10,9 |
5559 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 17 |
5560 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,6 |
5561 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,9 |
5562 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,8 |
5563 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 8,6 |
5564 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,2 |
5565 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 1,6 |
5566 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,5 |
5567 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,2 |
5568 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 5,8 |
5569 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 3,6 |
5570 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 2,1 |
5571 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy; Neonatal Cerebral Leukomalacia | Neurology | 2017 | Experimental Therapy | Poland | 1,9 |
5572 | Cord Tissue | Allogeneic - Unrelated | Chronic Myelogenous Leukemia | Hematology | 2017 | Experimental Therapy | Poland | 5,11 |
5573 | Cord Tissue | Allogeneic - Unrelated | Condition After Encephalitis | Neurology | 2017 | Experimental Therapy | Poland | 19,7 |
5574 | Cord Tissue | Allogeneic - Unrelated | Condition After Myelitis | Neurology | 2017 | Experimental Therapy | Poland | 34,11 |
5575 | Cord Tissue | Allogeneic - Unrelated | Congenital Fiber-Type Disproportion Myopathy | Neurology | 2017 | Experimental Therapy | Poland | 1,1 |
5576 | Cord Tissue | Allogeneic - Unrelated | Congenital Malformations Of The Nervous System, Unspecified | Neurology | 2017 | Experimental Therapy | Poland | 8,2 |
5577 | Cord Tissue | Allogeneic - Unrelated | Cranium Bifidum | Neurology | 2017 | Experimental Therapy | Poland | 5,2 |
5578 | Cord Tissue | Allogeneic - Unrelated | Cri Du Chat Syndrome | Neurology | 2017 | Experimental Therapy | Poland | 8,6 |
5579 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 3,5 |
5580 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 6,3 |
5581 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 5 |
5582 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 7,9 |
5583 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2017 | Experimental Therapy | Poland | 8,3 |
5584 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 11,8 |
5585 | Cord Tissue | Allogeneic - Unrelated | Devic’s Disease | Neurology | 2017 | Experimental Therapy | Poland | 45,2 |
5586 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 28,6 |
5587 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 28,11 |
5588 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 23,9 |
5589 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 9,1 |
5590 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2017 | Experimental Therapy | Poland | 14,5 |
5591 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 21,1 |
5592 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 5 |
5593 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 5,5 |
5594 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2017 | Experimental Therapy | Poland | 1,6 |
5595 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 4,4 |
5596 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy; Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 1,5 |
5597 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 3,1 |
5598 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 16,4 |
5599 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 9,11 |
5600 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 12,11 |
5601 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 15,9 |
5602 | Cord Tissue | Allogeneic - Unrelated | Epilepsy; Autism | Neurology | 2017 | Experimental Therapy | Poland | 6 |
5603 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 22,1 |
5604 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 31,6 |
5605 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 32,3 |
5606 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 33,4 |
5607 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 42,1 |
5608 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 22,4 |
5609 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2017 | Experimental Therapy | Poland | 4,7 |
5610 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2017 | Experimental Therapy | Poland | 7,11 |
5611 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2017 | Experimental Therapy | Poland | 58 |
5612 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2017 | Experimental Therapy | Poland | 65,6 |
5613 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2017 | Experimental Therapy | Poland | 66 |
5614 | Cord Tissue | Allogeneic - Unrelated | Hydrocephalus; Neonatal Cerebral Leukomalacia | Neurology | 2017 | Experimental Therapy | Poland | 2,3 |
5615 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2017 | Experimental Therapy | Poland | 1,9 |
5616 | Cord Tissue | Allogeneic - Unrelated | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2017 | Experimental Therapy | Poland | 1,1 |
5617 | Cord Tissue | Allogeneic - Unrelated | Ischemia Within The Optic Nerve | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,11 |
5618 | Cord Tissue | Allogeneic - Unrelated | Krabbe Disease | Neurology | 2017 | Experimental Therapy | Poland | 6,3 |
5619 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2017 | Experimental Therapy | Poland | 7,1 |
5620 | Cord Tissue | Allogeneic - Unrelated | Moyamoya Disease | Neurology | 2017 | Experimental Therapy | Poland | 17,7 |
5621 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 26,11 |
5622 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 34,1 |
5623 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 6,7 |
5624 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 12,1 |
5625 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 10,8 |
5626 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 8 |
5627 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 29,8 |
5628 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 7,4 |
5629 | Cord Tissue | Allogeneic - Unrelated | Myopathy Of Congenital Fiber Type Disproportion; Damage To The Central Nervous System | Neurology | 2017 | Experimental Therapy | Poland | 2,2 |
5630 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 37,7 |
5631 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 41,11 |
5632 | Cord Tissue | Allogeneic - Unrelated | Myotonic Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 3,2 |
5633 | Cord Tissue | Allogeneic - Unrelated | No Bone Adhesion | Orthopedy | 2017 | Experimental Therapy | Poland | 14,1 |
5634 | Cord Tissue | Allogeneic - Unrelated | No Bone Adhesion | Orthopedy | 2017 | Experimental Therapy | Poland | 17,11 |
5635 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 39 |
5636 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 30,9 |
5637 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,7 |
5638 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 66,11 |
5639 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 31,5 |
5640 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 39,7 |
5641 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 76,1 |
5642 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 77,5 |
5643 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 30,6 |
5644 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 85,7 |
5645 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 52,8 |
5646 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,1 |
5647 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 59 |
5648 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2017 | Experimental Therapy | Poland | 66,1 |
5649 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 56,4 |
5650 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 30,11 |
5651 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 74,5 |
5652 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2017 | Experimental Therapy | Poland | 7,11 |
5653 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2017 | Experimental Therapy | Poland | 2,1 |
5654 | Cord Tissue | Allogeneic - Unrelated | Other Specific Disorders Of The Central Nervous System | Neurology | 2017 | Experimental Therapy | Poland | 2,4 |
5655 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 58,1 |
5656 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 49 |
5657 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 56,8 |
5658 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 65,2 |
5659 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 43,4 |
5660 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 42,11 |
5661 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 41 |
5662 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 52,1 |
5663 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 61,5 |
5664 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 48,1 |
5665 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 31,1 |
5666 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 52,11 |
5667 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 36,11 |
5668 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 63,11 |
5669 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 31,9 |
5670 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 45,5 |
5671 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 49,1 |
5672 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 26,9 |
5673 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 65,4 |
5674 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 43,11 |
5675 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 22,1 |
5676 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 61,3 |
5677 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 61,7 |
5678 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 65,1 |
5679 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 43,1 |
5680 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 36,9 |
5681 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2017 | Experimental Therapy | Poland | 48,8 |
5682 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 52,9 |
5683 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 47,2 |
5684 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 46,9 |
5685 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 38 |
5686 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 25,2 |
5687 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 53,1 |
5688 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 47,6 |
5689 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 32,9 |
5690 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 69,2 |
5691 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2017 | Experimental Therapy | Poland | 64,3 |
5692 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Neurology | 2017 | Experimental Therapy | Poland | 29,4 |
5693 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis; Epilepsy | Neurology | 2017 | Experimental Therapy | Poland | 2,8 |
5694 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 1,11 |
5695 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 6,4 |
5696 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 6,3 |
5697 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 1,1 |
5698 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 4,1 |
5699 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 3,6 |
5700 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 3,4 |
5701 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 2,11 |
5702 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 5,8 |
5703 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 6,1 |
5704 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 2,8 |
5705 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 2,3 |
5706 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 18,5 |
5707 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 5,1 |
5708 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 11,1 |
5709 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 10,3 |
5710 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2017 | Experimental Therapy | Poland | 9 months |
5711 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 34,11 |
5712 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 34,1 |
5713 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 24,9 |
5714 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 39 |
5715 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 6,4 |
5716 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | no data |
5717 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | no data |
5718 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 27,3 |
5719 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 33,8 |
5720 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 3,4 |
5721 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 38,4 |
5722 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 14,4 |
5723 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2017 | Experimental Therapy | Poland | 57,1 |
5724 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury; Tetraparesis | Orthopedy | 2017 | Experimental Therapy | Poland | 42,9 |
5725 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 10,6 |
5726 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 41,4 |
5727 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 12,11 |
5728 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 8,5 |
5729 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2017 | Experimental Therapy | Poland | 24,9 |
5730 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 44,1 |
5731 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 24,6 |
5732 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 35,9 |
5733 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2017 | Experimental Therapy | Poland | 24,6 |
5734 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,4 |
5735 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 31,6 |
5736 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 30 |
5737 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 23,7 |
5738 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 27,11 |
5739 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 45,4 |
5740 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 48,1 |
5741 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2017 | Experimental Therapy | Poland | 37,8 |
5742 | Cord Tissue | Allogeneic - Unrelated | Syndrome Ifap | Hematology | 2017 | Experimental Therapy | Poland | 3,5 |
5743 | Cord Tissue | Allogeneic - Unrelated | Syringomyelia | Neurology | 2017 | Experimental Therapy | Poland | 42,6 |
5744 | Cord Tissue | Allogeneic - Unrelated | Tetraparesis | Orthopedy | 2017 | Experimental Therapy | Poland | 27,11 |
5745 | Cord Tissue | Allogeneic - Unrelated | Transverse Myelitis | Neurology | 2017 | Experimental Therapy | Poland | 8,3 |
5746 | Cord Tissue | Allogeneic - Unrelated | Traumatic Brain Injury | Neurology | 2017 | Experimental Therapy | Poland | 9,4 |
5747 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Poland | 4,11 |
5748 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Poland | 6,2 |
5749 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Poland | 7,3 |
5750 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Romania | 5,4 |
5751 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Romania | 4,1 |
5752 | Cord Blood | Autologous | Autism | Neurology | 2017 | Experimental Therapy | Romania | 4,1 |
5753 | Cord Blood | Allogeneic - Related | Cd40 Ligand Deficiency | Hematology | 2017 | Standard Therapy | Turkey | 9,7 |
5754 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Spain | 7 |
5755 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 2,2 |
5756 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 5,4 |
5757 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 10,3 |
5758 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | Poland | 6,8 |
5759 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | UK | 7 |
5760 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2017 | Experimental Therapy | UK | 3,4 |
5761 | Cord Blood | Allogeneic - Related | Chronic Granulomatous Disease | Hematology | 2017 | Standard Therapy | Turkey | 3,9 |
5762 | Cord Blood | no data | Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | UK | 3 |
5763 | Cord Blood | Allogeneic - Related | Relapse Of Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7,3 |
5764 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2017 | Standard Therapy | Turkey | 4,1 |
5765 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2017 | Standard Therapy | Turkey | 4,1 |
5766 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
5767 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 47 |
5768 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 46 |
5769 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
5770 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 52 |
5771 | Bone Marrow Family | Allogeneic | Chronic Granulomatous Disease | Hematology | 2017 | Standard Therapy | Poland | 4 |
5772 | Bone Marrow Family | Allogeneic | Hurler Syndrome | Hematology | 2017 | Standard Therapy | Poland | 2 |
5773 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 68 |
5774 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 69 |
5775 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 50 |
5776 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 29 |
5777 | Bone Marrow Family | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2017 | Standard Therapy | Poland | 7 |
5778 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 68 |
5779 | Bone Marrow Family | Allogeneic | No Data | no data | 2017 | Standard Therapy | Poland | 39 |
5780 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 39 |
5781 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 65 |
5782 | Bone Marrow Family | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 32 |
5783 | Bone Marrow Family | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 56 |
5784 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
5785 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 6 |
5786 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 30 |
5787 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
5788 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 14 |
5789 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 16 |
5790 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
5791 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 9 |
5792 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 21 |
5793 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 3 |
5794 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 8 |
5795 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 14 |
5796 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 4 |
5797 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
5798 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 2 |
5799 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
5800 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 18 |
5801 | Bone Marrow | Allogeneic | Acute Megakaryocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 2 |
5802 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
5803 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 19 |
5804 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 76 |
5805 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 22 |
5806 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
5807 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
5808 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
5809 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 13 |
5810 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
5811 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 1 |
5812 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
5813 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
5814 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
5815 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 68 |
5816 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
5817 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
5818 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 17 |
5819 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
5820 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 56 |
5821 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
5822 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 9 |
5823 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 12 |
5824 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 2 |
5825 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 70 |
5826 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia (High Risk) | Hematology | 2017 | Standard Therapy | Germany | 31 |
5827 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2017 | Standard Therapy | Poland | 2 |
5828 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2017 | Standard Therapy | Poland | 4 |
5829 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
5830 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
5831 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
5832 | Bone Marrow | Allogeneic | Hyper-Igm Syndrome | Hematology | 2017 | Standard Therapy | Poland | 2 |
5833 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 1 |
5834 | Bone Marrow | Allogeneic | Leukemia | Hematology | 2017 | Standard Therapy | Poland | 40 |
5835 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 60 |
5836 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 61 |
5837 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 2 |
5838 | Bone Marrow | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 50 |
5839 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2017 | Standard Therapy | Poland | 8 |
5840 | Bone Marrow | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 32 |
5841 | Bone Marrow | Allogeneic | Other Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 11 |
5842 | Bone Marrow | Allogeneic | Primary Immunodeficiency; Nijmegen Breakage Syndrome | Hematology | 2017 | Standard Therapy | Poland | 6 |
5843 | Bone Marrow | Allogeneic | Pure Red Cell Aplasia | Hematology | 2017 | Standard Therapy | Poland | 5 |
5844 | Bone Marrow | Allogeneic | Secondary Acute Myelogenous Leukemia After Ewing Sarcoma | Hematology | 2017 | Standard Therapy | Poland | 16 |
5845 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 6 |
5846 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 1 |
5847 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 1 |
5848 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 2 |
5849 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 1 |
5850 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 8 |
5851 | Bone Marrow | Allogeneic | T-Cell Leukemia/Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 18 |
5852 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2017 | Standard Therapy | Poland | 11 |
5853 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2017 | Standard Therapy | Poland | 2 |
5854 | Apheresis | Allogeneic | Accrued Hemophagocytic Lymphohistiocytosis | Hematology | 2017 | Standard Therapy | Germany | 43 |
5855 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
5856 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 43 |
5857 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 17 |
5858 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
5859 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 43 |
5860 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 3 |
5861 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 12 |
5862 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 19 |
5863 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
5864 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 33 |
5865 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 56 |
5866 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
5867 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 35 |
5868 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
5869 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 12 |
5870 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
5871 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
5872 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
5873 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 19 |
5874 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 11 |
5875 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 4 |
5876 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 41 |
5877 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
5878 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 30 |
5879 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
5880 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 56 |
5881 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 17 |
5882 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 36 |
5883 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 43 |
5884 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 21 |
5885 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
5886 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
5887 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 6 |
5888 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
5889 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
5890 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 10 |
5891 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 26 |
5892 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 8 |
5893 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 13 |
5894 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 26 |
5895 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 39 |
5896 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
5897 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
5898 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 48 |
5899 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
5900 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
5901 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 47 |
5902 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 48 |
5903 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 20 |
5904 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 44 |
5905 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 66 |
5906 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 75 |
5907 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 61 |
5908 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
5909 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
5910 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
5911 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 45 |
5912 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
5913 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 46 |
5914 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
5915 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
5916 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
5917 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 75 |
5918 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
5919 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
5920 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
5921 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 56 |
5922 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
5923 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 75 |
5924 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 69 |
5925 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
5926 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 70 |
5927 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 34 |
5928 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 52 |
5929 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
5930 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
5931 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
5932 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 48 |
5933 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
5934 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
5935 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
5936 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
5937 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 39 |
5938 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
5939 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 35 |
5940 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 29 |
5941 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
5942 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
5943 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
5944 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
5945 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
5946 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
5947 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
5948 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
5949 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 43 |
5950 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 42 |
5951 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
5952 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 68 |
5953 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 52 |
5954 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 49 |
5955 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
5956 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
5957 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
5958 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 35 |
5959 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
5960 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 31 |
5961 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
5962 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
5963 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 49 |
5964 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
5965 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 22 |
5966 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
5967 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 61 |
5968 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 40 |
5969 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
5970 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 68 |
5971 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
5972 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 46 |
5973 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
5974 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
5975 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
5976 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 16 |
5977 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
5978 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 71 |
5979 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
5980 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 62 |
5981 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 66 |
5982 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 69 |
5983 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 55 |
5984 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 59 |
5985 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
5986 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 37 |
5987 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
5988 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 26 |
5989 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 46 |
5990 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 68 |
5991 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 71 |
5992 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 53 |
5993 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
5994 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 27 |
5995 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 72 |
5996 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 72 |
5997 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 37 |
5998 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 71 |
5999 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 58 |
6000 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 38 |
6001 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 64 |
6002 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 57 |
6003 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 56 |
6004 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 52 |
6005 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 63 |
6006 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 44 |
6007 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 62 |
6008 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 54 |
6009 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 25 |
6010 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 71 |
6011 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 34 |
6012 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 49 |
6013 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 68 |
6014 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 39 |
6015 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 30 |
6016 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Germany | 57 |
6017 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 64 |
6018 | Apheresis | Autologous | Angioimmunoblastic Lymphadenopathy With Dysproteinemia | Hematology | 2017 | Standard Therapy | Germany | 36 |
6019 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
6020 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 44 |
6021 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 28 |
6022 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 64 |
6023 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 48 |
6024 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 65 |
6025 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 57 |
6026 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 50 |
6027 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2017 | Standard Therapy | Germany | 68 |
6028 | Apheresis | Allogeneic | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hematology | 2017 | Standard Therapy | Poland | 56 |
6029 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
6030 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 45 |
6031 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 47 |
6032 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 67 |
6033 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 65 |
6034 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
6035 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
6036 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 31 |
6037 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2017 | Standard Therapy | Poland | 29 |
6038 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2017 | Standard Therapy | Poland | 74 |
6039 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2017 | Standard Therapy | Poland | 57 |
6040 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 54 |
6041 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 58 |
6042 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 51 |
6043 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 61 |
6044 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 72 |
6045 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 60 |
6046 | Apheresis | Allogeneic | Chronic Myeloproliferative Neoplasm Blast Crisis | Hematology | 2017 | Standard Therapy | Poland | 29 |
6047 | Apheresis | Allogeneic | Common Variable Immunodeficiency, Relapsed Hemophagocytic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 44 |
6048 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 61 |
6049 | Apheresis | Allogeneic | Diffuse Large B-Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 41 |
6050 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2017 | Standard Therapy | Germany | 67 |
6051 | Apheresis | Autologous | Follicular B-Cell Non-Hodgkin-Lymphoma Grade I-Ii Relapse | Hematology | 2017 | Standard Therapy | Germany | 59 |
6052 | Apheresis | Allogeneic | Follicular Ca | Hematology | 2017 | Standard Therapy | Poland | 42 |
6053 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 47 |
6054 | Apheresis | Allogeneic | Hemophagocytosis | Hematology | 2017 | Standard Therapy | Poland | 52 |
6055 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 25 |
6056 | Apheresis | Allogeneic | Langerhans Lymphohistiocytosis | Hematology | 2017 | Standard Therapy | Poland | 2 |
6057 | Apheresis | Autologous | Light-Chain Myeloma | Hematology | 2017 | Standard Therapy | Germany | 62 |
6058 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 58 |
6059 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 63 |
6060 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 61 |
6061 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 64 |
6062 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 59 |
6063 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 68 |
6064 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 50 |
6065 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 56 |
6066 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 62 |
6067 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 53 |
6068 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2017 | Standard Therapy | Germany | 38 |
6069 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2017 | Standard Therapy | Germany | 60 |
6070 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 61 |
6071 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 65 |
6072 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
6073 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 61 |
6074 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 60 |
6075 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 58 |
6076 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 61 |
6077 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 63 |
6078 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 58 |
6079 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 72 |
6080 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 63 |
6081 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 50 |
6082 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 52 |
6083 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 72 |
6084 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 57 |
6085 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 56 |
6086 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 59 |
6087 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
6088 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 72 |
6089 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 69 |
6090 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 52 |
6091 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 67 |
6092 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
6093 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
6094 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 50 |
6095 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 67 |
6096 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 53 |
6097 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 62 |
6098 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 44 |
6099 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 62 |
6100 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 56 |
6101 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 60 |
6102 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
6103 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2017 | Standard Therapy | Germany | 64 |
6104 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 60 |
6105 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 3 |
6106 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 56 |
6107 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 54 |
6108 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 75 |
6109 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 64 |
6110 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 64 |
6111 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 46 |
6112 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 53 |
6113 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 71 |
6114 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 50 |
6115 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
6116 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 67 |
6117 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 65 |
6118 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 68 |
6119 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 59 |
6120 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
6121 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 69 |
6122 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 54 |
6123 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 65 |
6124 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
6125 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 54 |
6126 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 49 |
6127 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 39 |
6128 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 67 |
6129 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 69 |
6130 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 76 |
6131 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 70 |
6132 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 53 |
6133 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 69 |
6134 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
6135 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 66 |
6136 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 68 |
6137 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
6138 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 61 |
6139 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 61 |
6140 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 22 |
6141 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 40 |
6142 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 57 |
6143 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 63 |
6144 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Poland | 70 |
6145 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 51 |
6146 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 53 |
6147 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 68 |
6148 | Apheresis | Allogeneic | Myelodysplastic Syndrome In Fanconi Anemia | Hematology | 2017 | Standard Therapy | Poland | 23 |
6149 | Apheresis | Allogeneic | Myelodysplastic Syndrome With Excess Of Blasts | Hematology | 2017 | Standard Therapy | Germany | 62 |
6150 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 63 |
6151 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 63 |
6152 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 66 |
6153 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
6154 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 55 |
6155 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
6156 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 62 |
6157 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 72 |
6158 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2017 | Standard Therapy | Germany | 70 |
6159 | Apheresis | Allogeneic | Myelofibrosis With Myeloid Metaplasia | Hematology | 2017 | Standard Therapy | Poland | 47 |
6160 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 44 |
6161 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 56 |
6162 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 57 |
6163 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2017 | Standard Therapy | Poland | 38 |
6164 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2017 | Standard Therapy | Poland | 7 |
6165 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2017 | Standard Therapy | Germany | 37 |
6166 | Apheresis | Allogeneic | Niemann–Pick Disease | Hematology | 2017 | Standard Therapy | Poland | 2 |
6167 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 36 |
6168 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 58 |
6169 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 53 |
6170 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 1 |
6171 | Apheresis | Allogeneic | No Data | Hematology | 2017 | Standard Therapy | Poland | 55 |
6172 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 63 |
6173 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 56 |
6174 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 47 |
6175 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 57 |
6176 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 65 |
6177 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 58 |
6178 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 42 |
6179 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 36 |
6180 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 63 |
6181 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 68 |
6182 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 52 |
6183 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 53 |
6184 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 56 |
6185 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 65 |
6186 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 55 |
6187 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 69 |
6188 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Poland | 69 |
6189 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 72 |
6190 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 51 |
6191 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 57 |
6192 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2017 | Standard Therapy | Germany | 52 |
6193 | Apheresis | Allogeneic | Osteopetrosis | Metabolic | 2017 | Standard Therapy | Poland | 3 |
6194 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2017 | Standard Therapy | Poland | 59 |
6195 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 71 |
6196 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2017 | Standard Therapy | Germany | 61 |
6197 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 51 |
6198 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 66 |
6199 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 50 |
6200 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 4 |
6201 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2017 | Standard Therapy | Poland | 2 |
6202 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 29 |
6203 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2017 | Standard Therapy | Poland | 32 |
6204 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 38 |
6205 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 63 |
6206 | Apheresis | Allogeneic | Richter's Transformation At Chronic Lymphocytic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 60 |
6207 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2017 | Standard Therapy | Poland | 24 |
6208 | Apheresis | Allogeneic | Secondary Myelodysplastic Syndrome | Hematology | 2017 | Standard Therapy | Germany | 61 |
6209 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 14 |
6210 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 27 |
6211 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 32 |
6212 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2017 | Standard Therapy | Poland | 16 |
6213 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 30 |
6214 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 7 |
6215 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 25 |
6216 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Poland | 28 |
6217 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2017 | Standard Therapy | Germany | 24 |
6218 | Apheresis | Allogeneic | T-Cell Lymphoblastic Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 19 |
6219 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 56 |
6220 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2017 | Standard Therapy | Germany | 63 |
6221 | Apheresis | Allogeneic | Β - Thalassemia Major | Hematology | 2017 | Standard Therapy | Poland | 4 |
6222 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 22 |
6223 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 32,3 |
6224 | Cord Tissue | Allogeneic - Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 44,7 |
6225 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 14 |
6226 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 6 |
6227 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 60,5 |
6228 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 3,11 |
6229 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 11,11 |
6230 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 6,11 |
6231 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 9,7 |
6232 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy; Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 8,4 |
6233 | Cord Tissue | Allogeneic - Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2016 | Experimental Therapy | Poland | 86,5 |
6234 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 44,5 |
6235 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,8 |
6236 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 32,2 |
6237 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,7 |
6238 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59,4 |
6239 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 33,4 |
6240 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 37,4 |
6241 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 39,3 |
6242 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 63,2 |
6243 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 54,11 |
6244 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,9 |
6245 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 46,9 |
6246 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 58 |
6247 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55 |
6248 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 58,1 |
6249 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,7 |
6250 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 52,6 |
6251 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59,11 |
6252 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,9 |
6253 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59 |
6254 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,9 |
6255 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 42,7 |
6256 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 45,1 |
6257 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,4 |
6258 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 36,1 |
6259 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 59,1 |
6260 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,2 |
6261 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 49,7 |
6262 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,1 |
6263 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 46,1 |
6264 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 72,4 |
6265 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 54,3 |
6266 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 56,1 |
6267 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,8 |
6268 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 64,7 |
6269 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 64,2 |
6270 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 62,8 |
6271 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 56,5 |
6272 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 51,3 |
6273 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 33,1 |
6274 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,4 |
6275 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 73,7 |
6276 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,6 |
6277 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,4 |
6278 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 79,2 |
6279 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 72,6 |
6280 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 48,4 |
6281 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 54,2 |
6282 | Cord Tissue | Allogeneic - Unrelated & Related | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 50,9 |
6283 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,9 |
6284 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 62,6 |
6285 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,2 |
6286 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,9 |
6287 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 49,4 |
6288 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,7 |
6289 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 58,1 |
6290 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,8 |
6291 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 39,6 |
6292 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 47,11 |
6293 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 49,3 |
6294 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,2 |
6295 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 31,9 |
6296 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 53,4 |
6297 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 65,9 |
6298 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 52,7 |
6299 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 71,5 |
6300 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 68,5 |
6301 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 44,5 |
6302 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,7 |
6303 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 51,9 |
6304 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 49,3 |
6305 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 68,2 |
6306 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,4 |
6307 | Cord Tissue | Allogeneic - Unrelated & Related | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 41,2 |
6308 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 72,1 |
6309 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 56,8 |
6310 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 48,1 |
6311 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 56,3 |
6312 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 66,1 |
6313 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | no data |
6314 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 61,2 |
6315 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 60,8 |
6316 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2016 | Experimental Therapy | Poland | 55,5 |
6317 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2016 | Experimental Therapy | Poland | 20,3 |
6318 | Cord Tissue | Allogeneic - Unrelated | Atrophy Of The Optic Nerves | Ophthalmology | 2016 | Experimental Therapy | Poland | 20,11 |
6319 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 18,4 |
6320 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6 |
6321 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 12,11 |
6322 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 8,5 |
6323 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 7,11 |
6324 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 8,5 |
6325 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6,9 |
6326 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 10,1 |
6327 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6,2 |
6328 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 11,3 |
6329 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6,1 |
6330 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 13,2 |
6331 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 8,4 |
6332 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 5 |
6333 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 12,3 |
6334 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 24,5 |
6335 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 10,3 |
6336 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6 |
6337 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2016 | Experimental Therapy | Poland | 20,9 |
6338 | Cord Tissue | Allogeneic - Unrelated | Cartilage Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 57 |
6339 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Syndrome | Neurology | 2016 | Experimental Therapy | Poland | 28,6 |
6340 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 7,1 |
6341 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 5,1 |
6342 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 10,11 |
6343 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 10,3 |
6344 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 12,2 |
6345 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
6346 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 9,7 |
6347 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 10,3 |
6348 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 2,9 |
6349 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 9,11 |
6350 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 2,1 |
6351 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 4,2 |
6352 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 12,6 |
6353 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 3 |
6354 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 9,9 |
6355 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 3 |
6356 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 13,7 |
6357 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 2,2 |
6358 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 12,11 |
6359 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 10,8 |
6360 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 1,1 |
6361 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 7,6 |
6362 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 6,8 |
6363 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 16,4 |
6364 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 13,1 |
6365 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 4,1 |
6366 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 3,7 |
6367 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | Poland | 4,4 |
6368 | Cord Tissue | Allogeneic - Unrelated | Chondronecrosis Femoral Condyle | Orthopedy | 2016 | Experimental Therapy | Poland | 54 |
6369 | Cord Tissue | Allogeneic - Unrelated | Choroideremia | Ophthalmology | 2016 | Experimental Therapy | Poland | 50,8 |
6370 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 19,2 |
6371 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2016 | Experimental Therapy | Poland | 8 months |
6372 | Cord Tissue | Allogeneic - Unrelated | Degeneration Of The Cartilage Of The Knee Joint | Orthopedy | 2016 | Experimental Therapy | Poland | 54 |
6373 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2016 | Experimental Therapy | Poland | 3,1 |
6374 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2016 | Experimental Therapy | Poland | 7,4 |
6375 | Cord Tissue | Allogeneic - Unrelated | Developmental Delay | Neurology | 2016 | Experimental Therapy | Poland | 2,7 |
6376 | Cord Tissue | Allogeneic - Unrelated | Diffuse Cartilage Damage Left Medial Compartment Of The Knee | Orthopedy | 2016 | Experimental Therapy | Poland | 50 |
6377 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 48,8 |
6378 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 14,4 |
6379 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 34,7 |
6380 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 9,2 |
6381 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 4,8 |
6382 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 10 |
6383 | Cord Tissue | Allogeneic - Unrelated | Duchenne Muscular Dystrophy (Dmd) | Neurology | 2016 | Experimental Therapy | Poland | 19,2 |
6384 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
6385 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 3 |
6386 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 4,3 |
6387 | Cord Tissue | Allogeneic - Unrelated | Endometrial Atrophy | Gynecology | 2016 | Experimental Therapy | Poland | 37,3 |
6388 | Cord Tissue | Allogeneic - Unrelated | Endometrial Atrophy | Gynecology | 2016 | Experimental Therapy | Poland | 39,1 |
6389 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 19,5 |
6390 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 14,9 |
6391 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 13,11 |
6392 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 14,7 |
6393 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 14,9 |
6394 | Cord Tissue | Allogeneic - Unrelated | Epilepsy | Neurology | 2016 | Experimental Therapy | Poland | 16,2 |
6395 | Cord Tissue | Allogeneic - Unrelated | Epileptic Encephalopathy | Neurology | 2016 | Experimental Therapy | Poland | 3,6 |
6396 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 35,3 |
6397 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 39,1 |
6398 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 25,4 |
6399 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 59,6 |
6400 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 30,3 |
6401 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 15 |
6402 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 31,11 |
6403 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 33,4 |
6404 | Cord Tissue | Allogeneic - Unrelated | Fetal Alcohol Spectrum Disorders | Neurology | 2016 | Experimental Therapy | Poland | 5,2 |
6405 | Cord Tissue | Allogeneic - Unrelated | Gangliosidosis T. 1 | Neurology | 2016 | Experimental Therapy | Poland | 1,4 |
6406 | Cord Tissue | Allogeneic - Unrelated | Global Developmental Delay | Neurology | 2016 | Experimental Therapy | Poland | 6,9 |
6407 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2016 | Experimental Therapy | Poland | 65,8 |
6408 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2016 | Experimental Therapy | Poland | 69,6 |
6409 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2016 | Experimental Therapy | Poland | 69,3 |
6410 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2016 | Experimental Therapy | Poland | 49 |
6411 | Cord Tissue | Allogeneic - Unrelated | Hereditary Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 69 |
6412 | Cord Tissue | Allogeneic - Unrelated | Injuries To The Spinal Nerves | Neurology | 2016 | Experimental Therapy | Poland | 5 months |
6413 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 2,9 |
6414 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
6415 | Cord Tissue | Allogeneic - Unrelated | Malformation Syndrome | Neurology | 2016 | Experimental Therapy | Poland | 3,5 |
6416 | Cord Tissue | Allogeneic - Unrelated | Meniscus Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 35,5 |
6417 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2016 | Experimental Therapy | Poland | 31,9 |
6418 | Cord Tissue | Allogeneic - Unrelated | Myopia; Hyperopia; Astigmatism; Abnormal Refraction And Accommodation; Optic Atrophy | Ophthalmology | 2016 | Experimental Therapy | Poland | 37,1 |
6419 | Cord Tissue | Allogeneic - Unrelated | Neurodevelopmental Disorders | Neurology | 2016 | Experimental Therapy | Poland | 4,5 |
6420 | Cord Tissue | Allogeneic - Unrelated | No Data | Ophthalmology | 2016 | Experimental Therapy | Poland | 66,1 |
6421 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2016 | Experimental Therapy | Poland | 69,9 |
6422 | Cord Tissue | Allogeneic - Unrelated | Optic Atrophy | Ophthalmology | 2016 | Experimental Therapy | Poland | 69,1 |
6423 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2016 | Experimental Therapy | Poland | 66 |
6424 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2016 | Experimental Therapy | Poland | 79,8 |
6425 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2016 | Experimental Therapy | Poland | 33,5 |
6426 | Cord Tissue | Allogeneic - Unrelated | Patella Cartilage Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 60 |
6427 | Cord Tissue | Allogeneic - Unrelated | Patella Cartilage Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 60 |
6428 | Cord Tissue | Allogeneic - Unrelated | Patella Cartilage Damage | Orthopedy | 2016 | Experimental Therapy | Poland | 53 |
6429 | Cord Tissue | Allogeneic - Unrelated | Polyneuropathy | Neurology | 2016 | Experimental Therapy | Poland | 70,8 |
6430 | Cord Tissue | Allogeneic - Unrelated | Premature Ovarian Failure | Gynecology | 2016 | Experimental Therapy | Poland | 23,4 |
6431 | Cord Tissue | Allogeneic - Unrelated | Premature Ovarian Failure | Gynecology | 2016 | Experimental Therapy | Poland | 34,9 |
6432 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 38 |
6433 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 63,1 |
6434 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 32,7 |
6435 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 23,6 |
6436 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 54,6 |
6437 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | no data |
6438 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 59,4 |
6439 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 60,7 |
6440 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2016 | Experimental Therapy | Poland | 44,8 |
6441 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 29,11 |
6442 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 44,8 |
6443 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 55,4 |
6444 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 54,8 |
6445 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 41,4 |
6446 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 49,3 |
6447 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 61,11 |
6448 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 45,8 |
6449 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 38,1 |
6450 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 68,5 |
6451 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2016 | Experimental Therapy | Poland | 38,4 |
6452 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 28,8 |
6453 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 47,9 |
6454 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 58,4 |
6455 | Cord Tissue | Allogeneic - Unrelated | Spastic Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 18 |
6456 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 2,4 |
6457 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 4,8 |
6458 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 1,5 |
6459 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 7,4 |
6460 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 1,3 |
6461 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
6462 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 15,9 |
6463 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 2,11 |
6464 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2016 | Experimental Therapy | Poland | 4,9 |
6465 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 33,5 |
6466 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 22,2 |
6467 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 28 |
6468 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 33,11 |
6469 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 20,7 |
6470 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 24,5 |
6471 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 25,6 |
6472 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 18,8 |
6473 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 7,4 |
6474 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 48,3 |
6475 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 58,1 |
6476 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 37,11 |
6477 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 29,7 |
6478 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 17,9 |
6479 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2016 | Experimental Therapy | Poland | 44,5 |
6480 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 34,9 |
6481 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 3,3 |
6482 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 34,2 |
6483 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 17,1 |
6484 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2016 | Experimental Therapy | Poland | 1,1 |
6485 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 64 |
6486 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 62,5 |
6487 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 54,3 |
6488 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2016 | Experimental Therapy | Poland | 41,8 |
6489 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2016 | Experimental Therapy | Poland | 53 |
6490 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2016 | Experimental Therapy | Poland | 24,5 |
6491 | Cord Tissue | Allogeneic - Unrelated | Stargardt's Disease | Ophthalmology | 2016 | Experimental Therapy | Poland | 37,7 |
6492 | Cord Tissue | Allogeneic - Unrelated | Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 27,9 |
6493 | Cord Tissue | Allogeneic - Unrelated | Tetraparesis | Orthopedy | 2016 | Experimental Therapy | Poland | 27,2 |
6494 | Cord Tissue | Allogeneic - Unrelated | Traumatic Brain Injury | Neurology | 2016 | Experimental Therapy | Poland | 54,9 |
6495 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Hungary | 7 |
6496 | Cord Blood | Allogeneic - Unrelated | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 6 |
6497 | Cord Blood | Autologous | Autism | Neurology | 2016 | Experimental Therapy | Poland | 6 |
6498 | Cord Blood | Autologous | Brain Damage | Neurology | 2016 | Experimental Therapy | Germany | 1 |
6499 | Cord Blood | Allogeneic - Related | Cerebral Palsy | Neurology | 2016 | Experimental Therapy | UK | 6 |
6500 | Cord Blood | Allogeneic - Related | Hermansky-Pudlak Syndrome Type 2 | Hematology | 2016 | Standard Therapy | Turkey | 6 |
6501 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2016 | Standard Therapy | Germany | 4,3 |
6502 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 38 |
6503 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 38 |
6504 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
6505 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 32 |
6506 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
6507 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 72 |
6508 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia, Minimal Residual Disease | Hematology | 2016 | Standard Therapy | Poland | 50 |
6509 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 18 |
6510 | Bone Marrow Family | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 32 |
6511 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 59 |
6512 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 67 |
6513 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 62 |
6514 | Bone Marrow Family | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 59 |
6515 | Bone Marrow Family | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 4 |
6516 | Bone Marrow Family | Allogeneic | Plasma Cell Disorder | Hematology | 2016 | Standard Therapy | Poland | 54 |
6517 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
6518 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 6 |
6519 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 14 |
6520 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 7 |
6521 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 11 |
6522 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
6523 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
6524 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 25 |
6525 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 1 |
6526 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
6527 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 15 |
6528 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 6 |
6529 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
6530 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 55 |
6531 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
6532 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 12 |
6533 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 67 |
6534 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 29 |
6535 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 33 |
6536 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 39 |
6537 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
6538 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 45 |
6539 | Bone Marrow | Allogeneic | Anemia | Hematology | 2016 | Standard Therapy | Poland | 16 |
6540 | Bone Marrow | Allogeneic | Anemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
6541 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 20 |
6542 | Bone Marrow | Allogeneic | Bilineal Leukemia - Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 27 |
6543 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2016 | Standard Therapy | Poland | 2 |
6544 | Bone Marrow | Allogeneic | Digeorge Syndrome | Hematology | 2016 | Standard Therapy | Poland | 24 |
6545 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 7 |
6546 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 41 |
6547 | Bone Marrow | Allogeneic | High-Risk Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
6548 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 17 |
6549 | Bone Marrow | Allogeneic | Hurler Syndrome | Metabolic | 2016 | Standard Therapy | Poland | 2 |
6550 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 3 |
6551 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 1 |
6552 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 56 |
6553 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 31 |
6554 | Bone Marrow | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Poland | 22 |
6555 | Bone Marrow | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 3 |
6556 | Bone Marrow | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 7 |
6557 | Bone Marrow | Allogeneic | No Data | Hematology | 2016 | Standard Therapy | Poland | 33 |
6558 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 46 |
6559 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2016 | Standard Therapy | Poland | 6 |
6560 | Bone Marrow | Allogeneic | Osteopetrosis | Metabolic | 2016 | Standard Therapy | Poland | 1 |
6561 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
6562 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
6563 | Bone Marrow | Allogeneic | Severe Aplastic Anemia; Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2016 | Standard Therapy | Poland | 17 |
6564 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 2 |
6565 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 4 |
6566 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 7 months |
6567 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 12 |
6568 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 4 |
6569 | Bone Marrow | Allogeneic | Thalassemia Major | Hematology | 2016 | Standard Therapy | Germany | 18 |
6570 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
6571 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 43 |
6572 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
6573 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 24 |
6574 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 13 |
6575 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 58 |
6576 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 20 |
6577 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 23 |
6578 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 27 |
6579 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
6580 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
6581 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 38 |
6582 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 28 |
6583 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
6584 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 39 |
6585 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
6586 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 20 |
6587 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
6588 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 |
6589 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 33 |
6590 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 21 |
6591 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
6592 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 57 |
6593 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 29 |
6594 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 1 |
6595 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 42 |
6596 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia - Relapse | Hematology | 2016 | Standard Therapy | Germany | 27 |
6597 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 58 |
6598 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
6599 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
6600 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
6601 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
6602 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
6603 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
6604 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
6605 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
6606 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 31 |
6607 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
6608 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
6609 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 29 |
6610 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 32 |
6611 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 49 |
6612 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 64 |
6613 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 42 |
6614 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 13 |
6615 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 8 |
6616 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
6617 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
6618 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 32 |
6619 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
6620 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 43 |
6621 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
6622 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
6623 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 15 |
6624 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
6625 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 57 |
6626 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 56 |
6627 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 52 |
6628 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 35 |
6629 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 72 |
6630 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
6631 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
6632 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
6633 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 69 |
6634 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
6635 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 55 |
6636 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
6637 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
6638 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
6639 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
6640 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 48 |
6641 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 67 |
6642 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 59 |
6643 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 9 months |
6644 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 36 |
6645 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 66 |
6646 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 68 |
6647 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
6648 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 60 |
6649 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 37 |
6650 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
6651 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 51 |
6652 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
6653 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
6654 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 59 |
6655 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 65 |
6656 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 41 |
6657 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 50 |
6658 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 68 |
6659 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 54 |
6660 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 24 |
6661 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 44 |
6662 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 55 |
6663 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 30 |
6664 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 50 |
6665 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
6666 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 47 |
6667 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 63 |
6668 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Poland | 19 |
6669 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 62 |
6670 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 29 |
6671 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 39 |
6672 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 48 |
6673 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 69 |
6674 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 38 |
6675 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 66 |
6676 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 50 |
6677 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 74 |
6678 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 18 |
6679 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 54 |
6680 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 62 |
6681 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 55 |
6682 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 54 |
6683 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 41 |
6684 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 53 |
6685 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 68 |
6686 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 71 |
6687 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2016 | Standard Therapy | Germany | 68 |
6688 | Apheresis | Allogeneic | Acute Myeloid Leukemia M2/M4 | Hematology | 2016 | Standard Therapy | Poland | 59 |
6689 | Apheresis | Allogeneic | Adrenoleukodystrophy | Metabolic | 2016 | Standard Therapy | Poland | 1 |
6690 | Apheresis | Autologous | Amyloid Light-Chain Amyloidosis | Hematology | 2016 | Standard Therapy | Germany | 45 |
6691 | Apheresis | Autologous | Amyloidosis | Hematology | 2016 | Standard Therapy | Germany | 71 |
6692 | Apheresis | Autologous | Anaplastic Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 57 |
6693 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 23 |
6694 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 44 |
6695 | Apheresis | Autologous | B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 55 |
6696 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 57 |
6697 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 42 |
6698 | Apheresis | Autologous | Burkitt Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 40 |
6699 | Apheresis | Allogeneic | C-Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Germany | 60 |
6700 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 52 |
6701 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
6702 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
6703 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 62 |
6704 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 46 |
6705 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2016 | Standard Therapy | Poland | 40 |
6706 | Apheresis | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
6707 | Apheresis | Allogeneic | Composite Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 51 |
6708 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 39 |
6709 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 51 |
6710 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 64 |
6711 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma - Relapse | Hematology | 2016 | Standard Therapy | Germany | 69 |
6712 | Apheresis | Allogeneic | Fanconi Anemia | Hematology | 2016 | Standard Therapy | Poland | 7 |
6713 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 38 |
6714 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
6715 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
6716 | Apheresis | Allogeneic | High-Risk Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 5 |
6717 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 31 |
6718 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 32 |
6719 | Apheresis | Allogeneic | Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 38 |
6720 | Apheresis | Autologous | Hodgkin Lymphoma-Relapse | Hematology | 2016 | Standard Therapy | Germany | 44 |
6721 | Apheresis | Allogeneic | Leukemia | Hematology | 2016 | Standard Therapy | Poland | 53 |
6722 | Apheresis | Allogeneic | Lymphoblastic Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 33 |
6723 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 56 |
6724 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 63 |
6725 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 53 |
6726 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 60 |
6727 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2016 | Standard Therapy | Germany | 32 |
6728 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
6729 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
6730 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 44 |
6731 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
6732 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 70 |
6733 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
6734 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 62 |
6735 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 63 |
6736 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
6737 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 73 |
6738 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 65 |
6739 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
6740 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
6741 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 59 |
6742 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 66 |
6743 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
6744 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 68 |
6745 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 63 |
6746 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 57 |
6747 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 68 |
6748 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 56 |
6749 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 61 |
6750 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
6751 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 64 |
6752 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 64 |
6753 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 52 |
6754 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 55 |
6755 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 67 |
6756 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 49 |
6757 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 56 |
6758 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 47 |
6759 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 53 |
6760 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 58 |
6761 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 49 |
6762 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 69 |
6763 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 61 |
6764 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 54 |
6765 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 65 |
6766 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2016 | Standard Therapy | Germany | 48 |
6767 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 60 |
6768 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 56 |
6769 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 50 |
6770 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 73 |
6771 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 47 |
6772 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 67 |
6773 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 62 |
6774 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 61 |
6775 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 68 |
6776 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 65 |
6777 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 15 |
6778 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 52 |
6779 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 20 |
6780 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 60 |
6781 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 9 |
6782 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 61 |
6783 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 63 |
6784 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 15 |
6785 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 37 |
6786 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 59 |
6787 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 62 |
6788 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 58 |
6789 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 69 |
6790 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Poland | 66 |
6791 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Germany | 67 |
6792 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2016 | Standard Therapy | Germany | 57 |
6793 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Rcmd | Hematology | 2016 | Standard Therapy | Poland | 32 |
6794 | Apheresis | Allogeneic | Myelodysplastic Syndrome - Raeb | Hematology | 2016 | Standard Therapy | Poland | 56 |
6795 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 72 |
6796 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 66 |
6797 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
6798 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 63 |
6799 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 51 |
6800 | Apheresis | Allogeneic | Myeloma Multiplex | Hematology | 2016 | Standard Therapy | Poland | 38 |
6801 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Poland | 52 |
6802 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Germany | 63 |
6803 | Apheresis | Autologous | Neuroblastoma | Hematology | 2016 | Standard Therapy | Germany | 5 |
6804 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 45 |
6805 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 70 |
6806 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 43 |
6807 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 69 |
6808 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 28 |
6809 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 1 |
6810 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 30 |
6811 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 71 |
6812 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 58 |
6813 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 17 |
6814 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 59 |
6815 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 58 |
6816 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 55 |
6817 | Apheresis | Allogeneic | No Data | no data | 2016 | Standard Therapy | Poland | 44 |
6818 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 38 |
6819 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 58 |
6820 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 32 |
6821 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 39 |
6822 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 61 |
6823 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 73 |
6824 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 27 |
6825 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 65 |
6826 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 61 |
6827 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2016 | Standard Therapy | Poland | 47 |
6828 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 58 |
6829 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 68 |
6830 | Apheresis | Autologous | Plasmacytoma | Hematology | 2016 | Standard Therapy | Germany | 48 |
6831 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 62 |
6832 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 51 |
6833 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 62 |
6834 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2016 | Standard Therapy | Poland | 5 |
6835 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 50 |
6836 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
6837 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Poland | 67 |
6838 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Germany | 56 |
6839 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2016 | Standard Therapy | Germany | 58 |
6840 | Apheresis | Allogeneic | Refractory Anemia With Excess Blasts | Hematology | 2016 | Standard Therapy | Poland | 62 |
6841 | Apheresis | Allogeneic | Severe Aplastic Anemia / Amyloidosis | Hematology | 2016 | Standard Therapy | Poland | 45 |
6842 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Myeloproliferative Syndrome | Hematology | 2016 | Standard Therapy | Germany | 28 |
6843 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2016 | Standard Therapy | Poland | 18 |
6844 | Apheresis | Autologous | Small Cell Ovarian Carcinoma | Hematology | 2016 | Standard Therapy | Germany | 18 |
6845 | Apheresis | Allogeneic | T Cell Lymphoma/ Nos - Not Otherwise Specified | Hematology | 2016 | Standard Therapy | Poland | 55 |
6846 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 19 |
6847 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 21 |
6848 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 41 |
6849 | Apheresis | Allogeneic | T-Cell Leukemia/Lymphoma | Hematology | 2016 | Standard Therapy | Poland | 31 |
6850 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 48 |
6851 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 24 |
6852 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 55 |
6853 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2016 | Standard Therapy | Germany | 33 |
6854 | Apheresis | Allogeneic | T-Cell-Prolymphocytic Leukemia | Hematology | 2016 | Standard Therapy | Poland | 61 |
6855 | Apheresis | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2016 | Standard Therapy | Poland | 1 |
6856 | Apheresis | Allogeneic | X-Linked Lymphoproliferative Disease | Hematology | 2016 | Standard Therapy | Poland | 12 |
6857 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 1,4 |
6858 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 11 months |
6859 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 51,5 |
6860 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 6,6 |
6861 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 13,4 |
6862 | Cord Tissue | Allogeneic - Unrelated | Adrenoleukodystrophy; Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 23 |
6863 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61,6 |
6864 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61 |
6865 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 56 |
6866 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 51 |
6867 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 65 |
6868 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 60 |
6869 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 52 |
6870 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 59,4 |
6871 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61,5 |
6872 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 58 |
6873 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61,6 |
6874 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 62 |
6875 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 26,5 |
6876 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 27 |
6877 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 63,11 |
6878 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 67,6 |
6879 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 37,6 |
6880 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 58,1 |
6881 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 46,2 |
6882 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 48,7 |
6883 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 61,3 |
6884 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2015 | Experimental Therapy | Poland | 54 |
6885 | Cord Tissue | Allogeneic - Unrelated | Anterior Ischemic Optic Neuropathy | Ophthalmology | 2015 | Experimental Therapy | Poland | 54,1 |
6886 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 5,4 |
6887 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 3 |
6888 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 12,5 |
6889 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 6,1 |
6890 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 4,6 |
6891 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 5,6 |
6892 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2015 | Experimental Therapy | Poland | 8,7 |
6893 | Cord Tissue | Allogeneic - Unrelated | Bilateral Blindness | Ophthalmology | 2015 | Experimental Therapy | Poland | 36,1 |
6894 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 18,7 |
6895 | Cord Tissue | Allogeneic - Unrelated | Cerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 26,1 |
6896 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 3,8 |
6897 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 15,8 |
6898 | Cord Tissue | Allogeneic - Unrelated & Related | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 7,1 |
6899 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 13,1 |
6900 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 8,11 |
6901 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 2,7 |
6902 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 12,1 |
6903 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 4,1 |
6904 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 22 |
6905 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 9,9 |
6906 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 1,6 |
6907 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 14,1 |
6908 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2015 | Experimental Therapy | Poland | 16,9 |
6909 | Cord Tissue | Allogeneic - Unrelated | Ceroid Lipofuscinosis | Neurology | 2015 | Experimental Therapy | Poland | 5,1 |
6910 | Cord Tissue | Allogeneic - Unrelated | Ceroid Lipofuscinosis | Neurology | 2015 | Experimental Therapy | Poland | 7,1 |
6911 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2015 | Experimental Therapy | Poland | 10 |
6912 | Cord Tissue | Allogeneic - Unrelated | Decerebration Rigidity | Neurology | 2015 | Experimental Therapy | Poland | 9,6 |
6913 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development | Neurology | 2015 | Experimental Therapy | Poland | 3,6 |
6914 | Cord Tissue | Allogeneic - Unrelated | Delayed Psychomotor Development, Deafness | Neurology | 2015 | Experimental Therapy | Poland | 3,3 |
6915 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 14,5 |
6916 | Cord Tissue | Allogeneic - Unrelated | Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 8 months |
6917 | Cord Tissue | Allogeneic - Unrelated & Related | Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 11,2 |
6918 | Cord Tissue | Allogeneic - Unrelated | Facioscapulohumeral Muscular Dystrophy | Neurology | 2015 | Experimental Therapy | Poland | 30,1 |
6919 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2015 | Experimental Therapy | Poland | 66 |
6920 | Cord Tissue | Allogeneic - Unrelated | Gonarthrosis | Orthopedy | 2015 | Experimental Therapy | Poland | 65 |
6921 | Cord Tissue | Allogeneic - Unrelated | Iatrogenic Spinal Cord Injury | Neurology | 2015 | Experimental Therapy | Poland | 17,2 |
6922 | Cord Tissue | Allogeneic - Unrelated | Intracranial Injury | Neurology | 2015 | Experimental Therapy | Poland | 24,3 |
6923 | Cord Tissue | Allogeneic - Unrelated | Leukodystrophy | Neurology | 2015 | Experimental Therapy | Poland | 18,8 |
6924 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2015 | Experimental Therapy | Poland | 15,8 |
6925 | Cord Tissue | Allogeneic - Unrelated | Optic Neuropathy | Ophthalmology | 2015 | Experimental Therapy | Poland | 45,1 |
6926 | Cord Tissue | Allogeneic - Unrelated | Polyneuropathy | Neurology | 2015 | Experimental Therapy | Poland | 74,2 |
6927 | Cord Tissue | Allogeneic - Unrelated | Retinitis Pigmentosa | Ophthalmology | 2015 | Experimental Therapy | Poland | 34,5 |
6928 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2015 | Experimental Therapy | Poland | 23,2 |
6929 | Cord Tissue | Allogeneic - Unrelated | Sclerosis Multiplex | Neurology | 2015 | Experimental Therapy | Poland | 33,3 |
6930 | Cord Tissue | Allogeneic - Unrelated | Severe Developmental Delay | Neurology | 2015 | Experimental Therapy | Poland | 1,1 |
6931 | Cord Tissue | Allogeneic - Unrelated | Spina Bifida | Neurology | 2015 | Experimental Therapy | Poland | 2 |
6932 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 31,2 |
6933 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 18,8 |
6934 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 40 |
6935 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 26,1 |
6936 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 37,1 |
6937 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 32,1 |
6938 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 21,4 |
6939 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 24,7 |
6940 | Cord Tissue | Allogeneic - Unrelated | Spinal Cord Injury | Orthopedy | 2015 | Experimental Therapy | Poland | 34,4 |
6941 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2015 | Experimental Therapy | Poland | 11 months |
6942 | Cord Tissue | Allogeneic - Unrelated | Spinal Muscular Atrophy | Neurology | 2015 | Experimental Therapy | Poland | 26,2 |
6943 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 35,6 |
6944 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 44,6 |
6945 | Cord Tissue | Allogeneic - Unrelated | Spinocerebellar Ataxia | Neurology | 2015 | Experimental Therapy | Poland | 24,3 |
6946 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2015 | Experimental Therapy | Poland | 62,8 |
6947 | Cord Tissue | Allogeneic - Unrelated | Stroke | Neurology | 2015 | Experimental Therapy | Poland | 54,9 |
6948 | Cord Tissue | Allogeneic - Unrelated | Traumatic Encephalopathy | Neurology | 2015 | Experimental Therapy | Poland | 20,11 |
6949 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2015 | Standard Therapy | Poland | 4 |
6950 | Cord Blood | Autologous | Brain Damage | Neurology | 2015 | Experimental Therapy | Germany | 5 |
6951 | Cord Blood | Autologous | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2015 | Experimental Therapy | UK | 6 months |
6952 | Cord Blood | Autologous | Neuroblastoma | Hematology | 2015 | Standard Therapy | Germany | 5 |
6953 | Cord Blood | Allogeneic - Related | Scid (Severe Combined Immunodeficiency) | Hematology | 2015 | Standard Therapy | UK | 3 months |
6954 | Cord Blood | Allogeneic - Related | Sickle Cell Anemia | Hematology | 2015 | Standard Therapy | UK | 2,6 |
6955 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2015 | Standard Therapy | UK | 12 |
6956 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2015 | Standard Therapy | Turkey | 3 |
6957 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2015 | Standard Therapy | Turkey | 2 |
6958 | Bone Marrow Family | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 74 |
6959 | Bone Marrow Family | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 64 |
6960 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 23 |
6961 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 72 |
6962 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 43 |
6963 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 63 |
6964 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 73 |
6965 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 61 |
6966 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 33 |
6967 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 42 |
6968 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 57 |
6969 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 37 |
6970 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 72 |
6971 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 63 |
6972 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 66 |
6973 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 45 |
6974 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 48 |
6975 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 59 |
6976 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 58 |
6977 | Apheresis | Autologous | Anaplastic Large Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 57 |
6978 | Apheresis | Autologous | Anaplastic T-Cell Lymphoma - Relapse | Hematology | 2015 | Standard Therapy | Germany | 26 |
6979 | Apheresis | Allogeneic | Aplastic Anemia - Relapse | Hematology | 2015 | Standard Therapy | Germany | 53 |
6980 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 59 |
6981 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 48 |
6982 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 23 |
6983 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 62 |
6984 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2015 | Standard Therapy | Germany | 51 |
6985 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2015 | Standard Therapy | Germany | 50 |
6986 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 31 |
6987 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 57 |
6988 | Apheresis | Autologous | Ewing Sarcoma | Hematology | 2015 | Standard Therapy | Germany | 24 |
6989 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2015 | Standard Therapy | Germany | 17 |
6990 | Apheresis | Autologous | Gray Zone Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 26 |
6991 | Apheresis | Autologous | Hodgkin Relapse | Hematology | 2015 | Standard Therapy | Germany | 29 |
6992 | Apheresis | Autologous | Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 53 |
6993 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 56 |
6994 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 66 |
6995 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 53 |
6996 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 63 |
6997 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 58 |
6998 | Apheresis | Autologous | Mantle Cell Lymphoma-Relapse | Hematology | 2015 | Standard Therapy | Germany | 66 |
6999 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2015 | Standard Therapy | Germany | 25 |
7000 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2015 | Standard Therapy | Germany | 22 |
7001 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 58 |
7002 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 54 |
7003 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 62 |
7004 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
7005 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 69 |
7006 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
7007 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 75 |
7008 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
7009 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
7010 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
7011 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
7012 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 65 |
7013 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 37 |
7014 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 54 |
7015 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 29 |
7016 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 68 |
7017 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 50 |
7018 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
7019 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 69 |
7020 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
7021 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
7022 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 43 |
7023 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 53 |
7024 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 73 |
7025 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 66 |
7026 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
7027 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 70 |
7028 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 71 |
7029 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 62 |
7030 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 56 |
7031 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 74 |
7032 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 50 |
7033 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 51 |
7034 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 63 |
7035 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 53 |
7036 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 72 |
7037 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 48 |
7038 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 63 |
7039 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 60 |
7040 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 65 |
7041 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 71 |
7042 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
7043 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
7044 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 61 |
7045 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 64 |
7046 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 48 |
7047 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2015 | Standard Therapy | Germany | 49 |
7048 | Apheresis | Allogeneic | Multiple Myeloma, Second Acute Myeloid Leukemia | Hematology | 2015 | Standard Therapy | Germany | 64 |
7049 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 57 |
7050 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 60 |
7051 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 29 |
7052 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2015 | Standard Therapy | Germany | 73 |
7053 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 62 |
7054 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 22 |
7055 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 61 |
7056 | Apheresis | Allogeneic | Post–Polycythemia Vera Myelofibrosis | Hematology | 2015 | Standard Therapy | Germany | 54 |
7057 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 61 |
7058 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 41 |
7059 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 70 |
7060 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2015 | Standard Therapy | Germany | 70 |
7061 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2015 | Standard Therapy | Germany | 44 |
7062 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2014 | Experimental Therapy | Poland | 6 |
7063 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2014 | Experimental Therapy | Poland | 60,1 |
7064 | Cord Tissue | Allogeneic - Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2014 | Experimental Therapy | Poland | 24,1 |
7065 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2014 | Experimental Therapy | Poland | 12,6 |
7066 | Cord Tissue | Allogeneic - Unrelated | Autism | Neurology | 2014 | Experimental Therapy | Poland | 8,3 |
7067 | Cord Tissue | Allogeneic - Unrelated | Birth Asphyxia; Retinopathy | Neurology | 2014 | Experimental Therapy | Poland | 11 months |
7068 | Cord Tissue | Allogeneic - Unrelated | Central Motor Coordination Impairment After Hypoxic Ischemic Lesion At Birth | Neurology | 2014 | Experimental Therapy | Poland | 2,1 |
7069 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Poland | 4,1 |
7070 | Cord Tissue | Allogeneic - Unrelated | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Poland | 15,1 |
7071 | Cord Tissue | Allogeneic - Unrelated | Muscular Dystrophy | Neurology | 2014 | Experimental Therapy | Poland | 6 |
7072 | Cord Tissue | Allogeneic - Unrelated | Neuropathy | Neurology | 2014 | Experimental Therapy | Poland | 23,6 |
7073 | Cord Blood | Allogeneic - Unrelated | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Spain | 15 |
7074 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Turkey | 8,8 |
7075 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2014 | Standard Therapy | Germany | 45 |
7076 | Cord Blood | Autologous | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Portugal | 6 |
7077 | Cord Blood | Allogeneic - Related | Beta Thalassemia | Hematology | 2014 | Standard Therapy | Germany | 6 |
7078 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | Portugal | 4 |
7079 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2014 | Experimental Therapy | UK | 1 |
7080 | Cord Blood | Autologous | Hsv Encephalitis And Nmda Receptor Antibody Encephalitis | Neurology | 2014 | Experimental Therapy | UK | 2 |
7081 | Cord Blood | Autologous | Hypoxia-Ischemic Encephalopathy (Hie) | Neurology | 2014 | Experimental Therapy | UK | 3 months |
7082 | Cord Blood | Allogeneic - Related | Leukemia | Hematology | 2014 | Standard Therapy | UK | 4 |
7083 | Cord Blood | Autologous | Severe Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 11 |
7084 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 35 |
7085 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 73 |
7086 | Bone Marrow | Allogeneic | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2014 | Standard Therapy | Germany | 44 |
7087 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 60 |
7088 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 52 |
7089 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 69 |
7090 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 51 |
7091 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 69 |
7092 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 52 |
7093 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 29 |
7094 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 76 |
7095 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 48 |
7096 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 53 |
7097 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2014 | Standard Therapy | Germany | 45 |
7098 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 27 |
7099 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2014 | Standard Therapy | Germany | 44 |
7100 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 46 |
7101 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2014 | Standard Therapy | Germany | 67 |
7102 | Apheresis | Autologous | Bing–Neel Syndrome; Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 64 |
7103 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2014 | Standard Therapy | Germany | 42 |
7104 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2014 | Standard Therapy | Germany | 57 |
7105 | Apheresis | Allogeneic | Composite Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
7106 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 53 |
7107 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 50 |
7108 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 63 |
7109 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2014 | Standard Therapy | Germany | 24 |
7110 | Apheresis | Autologous | Lymphoma-Relapse | Hematology | 2014 | Standard Therapy | Germany | 56 |
7111 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 51 |
7112 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 62 |
7113 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 58 |
7114 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 62 |
7115 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 51 |
7116 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
7117 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 68 |
7118 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 60 |
7119 | Apheresis | Autologous | Marginal Zone Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 52 |
7120 | Apheresis | Allogeneic | Morbus Hodgkin | Hematology | 2014 | Standard Therapy | Germany | 31 |
7121 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 44 |
7122 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 37 |
7123 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2014 | Standard Therapy | Germany | 19 |
7124 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 70 |
7125 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 71 |
7126 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
7127 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 71 |
7128 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 66 |
7129 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
7130 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 53 |
7131 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 59 |
7132 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
7133 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 30 |
7134 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 64 |
7135 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 70 |
7136 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 77 |
7137 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 52 |
7138 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 60 |
7139 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 69 |
7140 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 63 |
7141 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2014 | Standard Therapy | Germany | 63 |
7142 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 68 |
7143 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 49 |
7144 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 55 |
7145 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2014 | Standard Therapy | Germany | 57 |
7146 | Apheresis | Allogeneic | Myeloproliferative Neoplasms | Hematology | 2014 | Standard Therapy | Germany | 56 |
7147 | Apheresis | Allogeneic | Myeloproliferative Syndrome | Hematology | 2014 | Standard Therapy | Germany | 60 |
7148 | Apheresis | Autologous | Neuroblastoma | Hematology | 2014 | Standard Therapy | Germany | 7 |
7149 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 60 |
7150 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 43 |
7151 | Apheresis | Autologous | Post-Transplant Lymphoproliferative Disorder | Hematology | 2014 | Standard Therapy | Germany | 60 |
7152 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 69 |
7153 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 64 |
7154 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 42 |
7155 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 51 |
7156 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 56 |
7157 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2014 | Standard Therapy | Germany | 75 |
7158 | Apheresis | Autologous | Secondary Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 59 |
7159 | Apheresis | Autologous | T-Cell Lymphoblastic Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 54 |
7160 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 46 |
7161 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 48 |
7162 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2014 | Standard Therapy | Germany | 43 |
7163 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2014 | Standard Therapy | Germany | 56 |
7164 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 18,9 |
7165 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 2,11 |
7166 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 3,5 |
7167 | Cord Tissue | Allogeneic - Unrelated | Acute Myeloid Leukemia | Hematology | 2013 | Experimental Therapy | Poland | 3,5 |
7168 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 18,8 |
7169 | Cord Tissue | Allogeneic - Unrelated | Chronic Graft Versus Host Disease | Hematology | 2013 | Experimental Therapy | Poland | 17,5 |
7170 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 8 |
7171 | Cord Blood | Allogeneic - Related | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Poland | 3 |
7172 | Cord Blood | Allogeneic - Related | Aplastic Anemia | Hematology | 2013 | Standard Therapy | Poland | 3 |
7173 | Cord Blood | Allogeneic - Related | Leukemia | Hematology | 2013 | Standard Therapy | Turkey | 7 |
7174 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2013 | Standard Therapy | UK | 5 |
7175 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | 7,12 |
7176 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | 3 |
7177 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2013 | Standard Therapy | Turkey | ? |
7178 | Cord Blood | Allogeneic - Related | Wiskott-Aldrich Syndrome | Hematology | 2013 | Standard Therapy | Germany | 3 |
7179 | Cord Blood | Allogeneic - Related | X-Linked Lymphoproliferative Syndrome | Hematology | 2013 | Standard Therapy | Poland | 10 months |
7180 | Bone Marrow Family | Allogeneic | Follicular Lymphoma + Non-Hodgkin-Hodgkin | Hematology | 2013 | Standard Therapy | Germany | 38 |
7181 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 58 |
7182 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 73 |
7183 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2013 | Standard Therapy | Germany | 71 |
7184 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 44 |
7185 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 17 |
7186 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
7187 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 51 |
7188 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 21 |
7189 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 18 |
7190 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 59 |
7191 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
7192 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2013 | Standard Therapy | Germany | 62 |
7193 | Apheresis | Autologous | Angioimmunoblastic Lymphadenopathy With Dysproteinemia - Relapse | Hematology | 2013 | Standard Therapy | Germany | 51 |
7194 | Apheresis | Autologous | Angioimmunoblastic Lymphadenopathy With Dysproteinemia - Relapse | Hematology | 2013 | Standard Therapy | Germany | 54 |
7195 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 55 |
7196 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 62 |
7197 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2013 | Standard Therapy | Germany | 52 |
7198 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2013 | Standard Therapy | Germany | 32 |
7199 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2013 | Standard Therapy | Germany | 51 |
7200 | Apheresis | Autologous | Burkitt Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 49 |
7201 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 48 |
7202 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 48 |
7203 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 64 |
7204 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 61 |
7205 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2013 | Standard Therapy | Germany | 54 |
7206 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2013 | Standard Therapy | Germany | 62 |
7207 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2013 | Standard Therapy | Germany | 54 |
7208 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 39 |
7209 | Apheresis | Autologous | Diffuse Large B-Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 43 |
7210 | Apheresis | Allogeneic | Hypoplastic Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 32 |
7211 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 47 |
7212 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2013 | Standard Therapy | Germany | 50 |
7213 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2013 | Standard Therapy | Germany | 62 |
7214 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 70 |
7215 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 52 |
7216 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 48 |
7217 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
7218 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 62 |
7219 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 73 |
7220 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 55 |
7221 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 53 |
7222 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 56 |
7223 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 61 |
7224 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 54 |
7225 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 60 |
7226 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 64 |
7227 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 66 |
7228 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 59 |
7229 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
7230 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 59 |
7231 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
7232 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 45 |
7233 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 50 |
7234 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 78 |
7235 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 46 |
7236 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 53 |
7237 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 65 |
7238 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 61 |
7239 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 40 |
7240 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2013 | Standard Therapy | Germany | 58 |
7241 | Apheresis | Allogeneic | Mycosis Fungoides | Hematology | 2013 | Standard Therapy | Germany | 62 |
7242 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2013 | Standard Therapy | Germany | 62 |
7243 | Apheresis | Autologous | Neuroblastoma | Hematology | 2013 | Standard Therapy | Germany | 3 |
7244 | Apheresis | Autologous | Neuroblastoma | Hematology | 2013 | Standard Therapy | Germany | 1 |
7245 | Apheresis | Allogeneic | No Data | Hematology | 2013 | Standard Therapy | Germany | 51 |
7246 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
7247 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
7248 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 60 |
7249 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2013 | Standard Therapy | Germany | 68 |
7250 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2013 | Standard Therapy | Germany | 73 |
7251 | Apheresis | Autologous | Plasmacytoma | Hematology | 2013 | Standard Therapy | Germany | 62 |
7252 | Apheresis | Allogeneic | Primary Central Nervous System Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 52 |
7253 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2013 | Standard Therapy | Germany | 43 |
7254 | Apheresis | Allogeneic | Primary Myelofibrosis, Second Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 60 |
7255 | Apheresis | Allogeneic | Primary Osteomyelofibrosis | Hematology | 2013 | Standard Therapy | Germany | 59 |
7256 | Apheresis | Allogeneic | T-Cell Acute Myeloid Leukemia | Hematology | 2013 | Standard Therapy | Germany | 61 |
7257 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2013 | Standard Therapy | Germany | 45 |
7258 | Apheresis | Autologous | Teratocarcinoma | Hematology | 2013 | Standard Therapy | Germany | 49 |
7259 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2013 | Standard Therapy | Germany | 27 |
7260 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 19,7 |
7261 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 7,1 |
7262 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2012 | Experimental Therapy | Poland | 4,3 |
7263 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 2 |
7264 | Cord Blood | Allogeneic - Related | Beta Thalassemia | Hematology | 2012 | Standard Therapy | Germany | 14 |
7265 | Cord Blood | Autologous | Brain Damage | Neurology | 2012 | Experimental Therapy | Germany | 3 |
7266 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2012 | Experimental Therapy | Portugal | 3 |
7267 | Cord Blood | Allogeneic - Related | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Hungary | 3 |
7268 | Cord Blood | Allogeneic - Related | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Turkey | 4,1 |
7269 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2012 | Standard Therapy | Turkey | 6,7 |
7270 | Cord Blood | Allogeneic - Related | Thalassemia Major, Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Turkey | 3,6 |
7271 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2012 | Experimental Therapy | Germany | 5 |
7272 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 64 |
7273 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 75 |
7274 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 55 |
7275 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2012 | Standard Therapy | Germany | 56 |
7276 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome Refractory Anemia With Blast Excess | Hematology | 2012 | Standard Therapy | Germany | 70 |
7277 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 18 |
7278 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 42 |
7279 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 43 |
7280 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 60 |
7281 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 39 |
7282 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 62 |
7283 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 55 |
7284 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2012 | Standard Therapy | Germany | 17 |
7285 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2012 | Standard Therapy | Germany | 48 |
7286 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2012 | Standard Therapy | Germany | 46 |
7287 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2012 | Standard Therapy | Germany | 68 |
7288 | Apheresis | Allogeneic | Acute Myeloid Leukemia (High Risk) | Hematology | 2012 | Standard Therapy | Germany | 57 |
7289 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 47 |
7290 | Apheresis | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2012 | Standard Therapy | Germany | 43 |
7291 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2012 | Standard Therapy | Germany | 70 |
7292 | Apheresis | Autologous | Central Nervous System Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
7293 | Apheresis | Autologous | Cerebral Diffuse Large B-Cell Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 55 |
7294 | Apheresis | Autologous | Diffuse Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
7295 | Apheresis | Autologous | Extragonadal Germ Cell Tumor | Hematology | 2012 | Standard Therapy | Germany | 59 |
7296 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
7297 | Apheresis | Autologous | Follicular Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
7298 | Apheresis | Autologous | Follicular Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 59 |
7299 | Apheresis | Autologous | Lymphoblastic B-Cell Non-Hodgkin-Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 52 |
7300 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 61 |
7301 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 52 |
7302 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
7303 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 55 |
7304 | Apheresis | Autologous | Medulloblastoma | Hematology | 2012 | Standard Therapy | Germany | 42 |
7305 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2012 | Standard Therapy | Germany | 27 |
7306 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 51 |
7307 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 60 |
7308 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 52 |
7309 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 71 |
7310 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 61 |
7311 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 53 |
7312 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 55 |
7313 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 70 |
7314 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 46 |
7315 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 64 |
7316 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 56 |
7317 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 68 |
7318 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 48 |
7319 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 59 |
7320 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 62 |
7321 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 72 |
7322 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 50 |
7323 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 60 |
7324 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 65 |
7325 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2012 | Standard Therapy | Germany | 67 |
7326 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Germany | 49 |
7327 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2012 | Standard Therapy | Germany | 69 |
7328 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 62 |
7329 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 57 |
7330 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 62 |
7331 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 57 |
7332 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 44 |
7333 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2012 | Standard Therapy | Germany | 43 |
7334 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2012 | Standard Therapy | Germany | 61 |
7335 | Apheresis | Autologous | Plasmablastic Lymphoma | Hematology | 2012 | Standard Therapy | Germany | 54 |
7336 | Apheresis | Autologous | Plasmacytoma | Hematology | 2012 | Standard Therapy | Germany | 69 |
7337 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2012 | Standard Therapy | Germany | 36 |
7338 | Cord Tissue | Allogeneic - Unrelated | Acute Graft Versus Host Disease | Hematology | 2011 | Experimental Therapy | Poland | 17,2 |
7339 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Poland | 5 |
7340 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | UK | 8 |
7341 | Cord Blood | Allogeneic - Related | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Hungary | 2 |
7342 | Cord Blood | Autologous | Brain Damage | Neurology | 2011 | Experimental Therapy | Germany | 3 |
7343 | Cord Blood | Autologous | Brain Damage | Neurology | 2011 | Experimental Therapy | Germany | 7 |
7344 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2011 | Experimental Therapy | Portugal | 6 |
7345 | Cord Blood | Allogeneic - Related | Chronic Granulomatous Disease | Hematology | 2011 | Standard Therapy | Poland | 7,5 |
7346 | Cord Blood | Allogeneic - Related | Fanconi Anemia | Hematology | 2011 | Standard Therapy | Poland | 12 |
7347 | Cord Blood | Allogeneic - Related | Histiocytosis | Hematology | 2011 | Standard Therapy | Poland | 2,5 |
7348 | Cord Blood | Allogeneic | Scid (Severe Combined Immunodeficiency) | Hematology | 2011 | Standard Therapy | Germany | 1 |
7349 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2011 | Standard Therapy | Turkey | 15 |
7350 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2011 | Standard Therapy | Turkey | 15 |
7351 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2011 | Experimental Therapy | Germany | 2 |
7352 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 65 |
7353 | Bone Marrow Family | Allogeneic | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 50 |
7354 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 64 |
7355 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 45 |
7356 | Bone Marrow | Autologous | Coronary Artery Disease | Hematology | 2011 | Standard Therapy | Germany | 68 |
7357 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 70 |
7358 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 55 |
7359 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 64 |
7360 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 71 |
7361 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2011 | Standard Therapy | Germany | 62 |
7362 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2011 | Standard Therapy | Germany | 62 |
7363 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2011 | Standard Therapy | Germany | 69 |
7364 | Bone Marrow | Autologous | Ischemic Myopathy | Hematology | 2011 | Standard Therapy | Germany | 40 |
7365 | Bone Marrow | Autologous | Peripheral Artery Disease | Hematology | 2011 | Standard Therapy | Germany | 74 |
7366 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2011 | Standard Therapy | Germany | 31 |
7367 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Germany | 41 |
7368 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Germany | 42 |
7369 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2011 | Standard Therapy | Germany | 31 |
7370 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 64 |
7371 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 42 |
7372 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 73 |
7373 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 54 |
7374 | Apheresis | Autologous | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 70 |
7375 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 65 |
7376 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 69 |
7377 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 25 |
7378 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 48 |
7379 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 59 |
7380 | Apheresis | Allogeneic | Acute Myeloid Leukemia - Relapse | Hematology | 2011 | Standard Therapy | Germany | 53 |
7381 | Apheresis | Autologous | Anaplastic Lymphoma Kinase Positive Anaplastic Large-Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 60 |
7382 | Apheresis | Autologous | Angioimmunoblastic T-Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 63 |
7383 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2011 | Standard Therapy | Germany | 62 |
7384 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 41 |
7385 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 61 |
7386 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 51 |
7387 | Apheresis | Autologous | Central Nervous System Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 41 |
7388 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2011 | Standard Therapy | Germany | 62 |
7389 | Apheresis | Autologous | Follicular Lymphoma-Relapse | Hematology | 2011 | Standard Therapy | Germany | 68 |
7390 | Apheresis | Autologous | Germ Cell Tumor | Hematology | 2011 | Standard Therapy | Germany | 28 |
7391 | Apheresis | Autologous | Lymphoblastic Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 49 |
7392 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 62 |
7393 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 51 |
7394 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 67 |
7395 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2011 | Standard Therapy | Germany | 70 |
7396 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2011 | Standard Therapy | Germany | 24 |
7397 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 58 |
7398 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 70 |
7399 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 59 |
7400 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 44 |
7401 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 52 |
7402 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 70 |
7403 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 55 |
7404 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 69 |
7405 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 58 |
7406 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 58 |
7407 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 60 |
7408 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 56 |
7409 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 66 |
7410 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 57 |
7411 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 47 |
7412 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 66 |
7413 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 60 |
7414 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 61 |
7415 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 69 |
7416 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2011 | Standard Therapy | Germany | 54 |
7417 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2011 | Standard Therapy | Germany | 68 |
7418 | Apheresis | Allogeneic | Myelofibrosis | Hematology | 2011 | Standard Therapy | Germany | 40 |
7419 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 47 |
7420 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2011 | Standard Therapy | Germany | 61 |
7421 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2011 | Standard Therapy | Germany | 43 |
7422 | Apheresis | Autologous | Plasmacytoma | Hematology | 2011 | Standard Therapy | Germany | 68 |
7423 | Apheresis | Autologous | Plasmacytoma | Hematology | 2011 | Standard Therapy | Germany | 51 |
7424 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 43 |
7425 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2011 | Standard Therapy | Germany | 36 |
7426 | Apheresis | Allogeneic | Refractory Acute Myeloid Leukemia | Hematology | 2011 | Standard Therapy | Germany | 27 |
7427 | Apheresis | Autologous | Richter's Transformation | Hematology | 2011 | Standard Therapy | Germany | 71 |
7428 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 50 |
7429 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2011 | Standard Therapy | Germany | 48 |
7430 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2011 | Standard Therapy | Germany | 56 |
7431 | Apheresis | Autologous | Testicular Cancer Relapse | Hematology | 2011 | Standard Therapy | Germany | 43 |
7432 | Cord Blood | Autologous | Brain Damage | Neurology | 2010 | Experimental Therapy | Germany | 5 |
7433 | Cord Blood | Autologous | Brain Damage | Neurology | 2010 | Experimental Therapy | Germany | 4 |
7434 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2010 | Experimental Therapy | Portugal | 1 |
7435 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2010 | Experimental Therapy | Portugal | 1 |
7436 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2010 | Experimental Therapy | Portugal | 6 |
7437 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2010 | Experimental Therapy | UK | 3 |
7438 | Cord Blood | Allogeneic - Related | Pre-B Acute Lymphoblastic Leukemia | Hematology | 2010 | Standard Therapy | Hungary | 1,5 |
7439 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2010 | Experimental Therapy | Germany | 3 |
7440 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2010 | Experimental Therapy | Germany | 2 |
7441 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 57 |
7442 | Bone Marrow | Autologous | Chronic Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 71 |
7443 | Bone Marrow | Autologous | Coronary Artery Disease | Hematology | 2010 | Standard Therapy | Germany | 75 |
7444 | Bone Marrow | Autologous | Coronary Artery Disease; Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 52 |
7445 | Bone Marrow | Autologous | Dilated Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 67 |
7446 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 70 |
7447 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 49 |
7448 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 48 |
7449 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 50 |
7450 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 54 |
7451 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 73 |
7452 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2010 | Standard Therapy | Germany | 47 |
7453 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2010 | Standard Therapy | Germany | 51 |
7454 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2010 | Standard Therapy | Germany | 54 |
7455 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2010 | Standard Therapy | Germany | 51 |
7456 | Bone Marrow | Autologous | Peripheral Artery Disease | Hematology | 2010 | Standard Therapy | Germany | 56 |
7457 | Bone Marrow | Autologous | Peripheral Artery Disease With Ulcer | Hematology | 2010 | Standard Therapy | Germany | 79 |
7458 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2010 | Standard Therapy | Germany | 26 |
7459 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2010 | Standard Therapy | Germany | 64 |
7460 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 47 |
7461 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 44 |
7462 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 48 |
7463 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 59 |
7464 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 50 |
7465 | Apheresis | Allogeneic | Acute Myeloid Leukemia; Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 66 |
7466 | Apheresis | Allogeneic | Atypical Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 25 |
7467 | Apheresis | Allogeneic | B-Cell Chronic Lymphoblastic Leukemia | Hematology | 2010 | Standard Therapy | Germany | 56 |
7468 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 54 |
7469 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2010 | Standard Therapy | Germany | 52 |
7470 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2010 | Standard Therapy | Germany | 45 |
7471 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2010 | Standard Therapy | Germany | 57 |
7472 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2010 | Standard Therapy | Germany | 43 |
7473 | Apheresis | Autologous | Diffuse Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 57 |
7474 | Apheresis | Autologous | Extramedullary Plasmacytoma | Hematology | 2010 | Standard Therapy | Germany | 48 |
7475 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 61 |
7476 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 72 |
7477 | Apheresis | Allogeneic | Mantle Cell Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 53 |
7478 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2010 | Standard Therapy | Germany | 29 |
7479 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2010 | Standard Therapy | Germany | 21 |
7480 | Apheresis | Autologous | Morbus Hodgkin-Relapse | Hematology | 2010 | Standard Therapy | Germany | 23 |
7481 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 43 |
7482 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 57 |
7483 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 62 |
7484 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 45 |
7485 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 47 |
7486 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 52 |
7487 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 52 |
7488 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 67 |
7489 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 55 |
7490 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 57 |
7491 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 51 |
7492 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 53 |
7493 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 69 |
7494 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 58 |
7495 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 70 |
7496 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 64 |
7497 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 69 |
7498 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 68 |
7499 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 63 |
7500 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 61 |
7501 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 56 |
7502 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 68 |
7503 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 52 |
7504 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 60 |
7505 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2010 | Standard Therapy | Germany | 64 |
7506 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 70 |
7507 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 57 |
7508 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 60 |
7509 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2010 | Standard Therapy | Germany | 33 |
7510 | Apheresis | Allogeneic | Myelodysplastic Syndrome; Acute Myelogenous Leukemia | Hematology | 2010 | Standard Therapy | Germany | 54 |
7511 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2010 | Standard Therapy | Germany | 48 |
7512 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2010 | Standard Therapy | Germany | 44 |
7513 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 66 |
7514 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2010 | Standard Therapy | Germany | 60 |
7515 | Apheresis | Allogeneic | Primary Myelofibrosis | Hematology | 2010 | Standard Therapy | Germany | 59 |
7516 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2010 | Standard Therapy | Germany | 48 |
7517 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 61 |
7518 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 41 |
7519 | Apheresis | Allogeneic | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2010 | Standard Therapy | Germany | 43 |
7520 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2010 | Standard Therapy | Germany | 49 |
7521 | Apheresis | Autologous | Testicular Carcinoma | Hematology | 2010 | Standard Therapy | Germany | 39 |
7522 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2009 | Standard Therapy | Germany | 10 |
7523 | Cord Blood | Allogeneic - Related | Beta Thalassemia | Hematology | 2009 | Standard Therapy | Germany | 10 |
7524 | Cord Blood | Autologous | Brain Damage | Neurology | 2009 | Experimental Therapy | Germany | 2 |
7525 | Cord Blood | Autologous | Brain Damage | Neurology | 2009 | Experimental Therapy | Germany | 4 months |
7526 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2009 | Experimental Therapy | Portugal | 2 |
7527 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2009 | Experimental Therapy | Portugal | 2 |
7528 | Cord Blood | Autologous | Cerebral Palsy | Neurology | 2009 | Experimental Therapy | UK | 3 |
7529 | Cord Blood | Allogeneic - Related | Myelodysplastic Syndrome | Hematology | 2009 | Standard Therapy | Poland | 5 |
7530 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2009 | Standard Therapy | Turkey | 12 |
7531 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2009 | Experimental Therapy | Germany | 3 |
7532 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2009 | Experimental Therapy | Germany | 3 |
7533 | Cord Blood | Autologous | Typ-1-Diabetes | Endocrinology | 2009 | Experimental Therapy | Germany | 3 |
7534 | Bone Marrow | Autologous | Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 67 |
7535 | Bone Marrow | Autologous | Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 50 |
7536 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 49 |
7537 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 64 |
7538 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 55 |
7539 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 56 |
7540 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 46 |
7541 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 46 |
7542 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2009 | Standard Therapy | Germany | 63 |
7543 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 57 |
7544 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 47 |
7545 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 57 |
7546 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 61 |
7547 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 44 |
7548 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 32 |
7549 | Bone Marrow | Autologous | Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 57 |
7550 | Bone Marrow | Autologous | Non St-Elevated Myocardial Infarction | Hematology | 2009 | Standard Therapy | Germany | 56 |
7551 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2009 | Standard Therapy | Germany | 24 |
7552 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2009 | Standard Therapy | Germany | 43 |
7553 | Apheresis | Autologous | Acute Lymphoblastic Leukemia; Lymphoma - Relapse | Hematology | 2009 | Standard Therapy | Germany | 47 |
7554 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 42 |
7555 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 49 |
7556 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 56 |
7557 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 57 |
7558 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 56 |
7559 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 61 |
7560 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2009 | Standard Therapy | Germany | 57 |
7561 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 60 |
7562 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2009 | Standard Therapy | Germany | 43 |
7563 | Apheresis | Autologous | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2009 | Standard Therapy | Germany | 61 |
7564 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2009 | Standard Therapy | Germany | 47 |
7565 | Apheresis | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2009 | Standard Therapy | Germany | 49 |
7566 | Apheresis | Autologous | Hodgkin Relapse | Hematology | 2009 | Standard Therapy | Germany | 46 |
7567 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 69 |
7568 | Apheresis | Autologous | Mantle Cell Non-Hodgkin-Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 56 |
7569 | Apheresis | Autologous | Mucosa Associated Lymphoid Tissue/ Diffuse Large Cell Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 55 |
7570 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 68 |
7571 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 55 |
7572 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 51 |
7573 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 58 |
7574 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 63 |
7575 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2009 | Standard Therapy | Germany | 63 |
7576 | Apheresis | Allogeneic | Multiple Myeloma; Myelodysplastic Syndrome | Hematology | 2009 | Standard Therapy | Germany | 44 |
7577 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 70 |
7578 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 57 |
7579 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 67 |
7580 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2009 | Standard Therapy | Germany | 68 |
7581 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2009 | Standard Therapy | Germany | 46 |
7582 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2009 | Standard Therapy | Germany | 74 |
7583 | Apheresis | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2009 | Standard Therapy | Germany | 39 |
7584 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 63 |
7585 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 50 |
7586 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 60 |
7587 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 49 |
7588 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 68 |
7589 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 57 |
7590 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 53 |
7591 | Apheresis | Autologous | Plasmacytoma | Hematology | 2009 | Standard Therapy | Germany | 64 |
7592 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2009 | Standard Therapy | Germany | 55 |
7593 | Apheresis | Allogeneic | Severe Aplastic Anemia And Paroxysmal Nocturnal Hemoglobinuria | Hematology | 2009 | Standard Therapy | Germany | 47 |
7594 | Cord Blood | Allogeneic - Related | Acute Lymphoblastic Leukemia | Hematology | 2008 | Standard Therapy | Poland | 5 |
7595 | Cord Blood | Autologous | Brain Damage | Neurology | 2008 | Experimental Therapy | Germany | 1 |
7596 | Cord Blood | Autologous | Cerebral Ischemia | Neurology | 2008 | Experimental Therapy | Poland | 1,5 |
7597 | Cord Blood | Allogeneic - Related | Thalassemia Major | Hematology | 2008 | Standard Therapy | Turkey | 7 |
7598 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2008 | Standard Therapy | Germany | 17 |
7599 | Bone Marrow Family | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2008 | Standard Therapy | Germany | 53 |
7600 | Bone Marrow | Autologous | Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 46 |
7601 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 60 |
7602 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 44 |
7603 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 67 |
7604 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 58 |
7605 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 56 |
7606 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 72 |
7607 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 69 |
7608 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 53 |
7609 | Bone Marrow | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 70 |
7610 | Bone Marrow | Autologous | Peripheral Artery Disease | Hematology | 2008 | Standard Therapy | Germany | 76 |
7611 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 56 |
7612 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 58 |
7613 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 70 |
7614 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 56 |
7615 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 65 |
7616 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 38 |
7617 | Apheresis | Allogeneic | B-Cell Non-Hodgkin Lymphoma - Relapse | Hematology | 2008 | Standard Therapy | Germany | 49 |
7618 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2008 | Standard Therapy | Germany | 51 |
7619 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2008 | Standard Therapy | Germany | 49 |
7620 | Apheresis | Autologous | Diffuse Large B-Cell Non-Hodgkin-Lymphoma | Hematology | 2008 | Standard Therapy | Germany | 44 |
7621 | Apheresis | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 73 |
7622 | Apheresis | Autologous | Ischemic Cardiomyopathy | Hematology | 2008 | Standard Therapy | Germany | 46 |
7623 | Apheresis | Autologous | Mantle Cell Lymphoma | Hematology | 2008 | Standard Therapy | Germany | 64 |
7624 | Apheresis | Autologous | Morbus Hodgkin | Hematology | 2008 | Standard Therapy | Germany | 25 |
7625 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 52 |
7626 | Apheresis | Allogeneic | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 45 |
7627 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 61 |
7628 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 58 |
7629 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 67 |
7630 | Apheresis | Autologous | Multiple Myeloma | Hematology | 2008 | Standard Therapy | Germany | 57 |
7631 | Apheresis | Allogeneic | Myelodysplastic Syndrome | Hematology | 2008 | Standard Therapy | Germany | 58 |
7632 | Apheresis | Autologous | Myosarcoma | Hematology | 2008 | Standard Therapy | Germany | 56 |
7633 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2008 | Standard Therapy | Germany | 55 |
7634 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2008 | Standard Therapy | Germany | 65 |
7635 | Apheresis | Allogeneic | Osteomyelofibrosis | Hematology | 2008 | Standard Therapy | Germany | 62 |
7636 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 68 |
7637 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 52 |
7638 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 53 |
7639 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 67 |
7640 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 69 |
7641 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 56 |
7642 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 59 |
7643 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 52 |
7644 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 60 |
7645 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 67 |
7646 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 68 |
7647 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 57 |
7648 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 62 |
7649 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 63 |
7650 | Apheresis | Autologous | Plasmacytoma | Hematology | 2008 | Standard Therapy | Germany | 66 |
7651 | Apheresis | Allogeneic | Refractory Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 71 |
7652 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 53 |
7653 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 55 |
7654 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2008 | Standard Therapy | Germany | 65 |
7655 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2008 | Standard Therapy | Germany | 29 |
7656 | Apheresis | Allogeneic | T-Cell Lymphoblastic Leukemia | Hematology | 2008 | Standard Therapy | Germany | 38 |
7657 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2008 | Standard Therapy | Germany | 28 |
7658 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma Relapse | Hematology | 2008 | Standard Therapy | Germany | 21 |
7659 | Cord Blood | Allogeneic - Related | Neuroblastoma | Hematology | 2007 | Standard Therapy | Poland | 8 |
7660 | Cord Blood | Allogeneic - Related | Scid (Severe Combined Immunodeficiency) | Hematology | 2007 | Standard Therapy | Portugal | 1 |
7661 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2007 | Standard Therapy | UK | 7 |
7662 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2007 | Standard Therapy | Germany | 68 |
7663 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2007 | Standard Therapy | Germany | 38 |
7664 | Apheresis | Allogeneic | Aplastic Anemia | Hematology | 2007 | Standard Therapy | Germany | 49 |
7665 | Apheresis | Allogeneic | Chronic Lymphocytic Leukemia | Hematology | 2007 | Standard Therapy | Germany | 57 |
7666 | Apheresis | Autologous | Myocardial Infarction | Hematology | 2007 | Standard Therapy | Germany | 61 |
7667 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2007 | Standard Therapy | Germany | 57 |
7668 | Cord Blood | Allogeneic - Related | Aplastic Anemia | Hematology | 2005 | Standard Therapy | Germany | 5 |
7669 | Cord Blood | Autologous | Brain Damage | Neurology | 2005 | Experimental Therapy | Germany | 1 |
7670 | Cord Blood | Allogeneic - Related | Leukemia | Hematology | 2005 | Standard Therapy | UK | no data |
7671 | Cord Blood | Allogeneic - Related | Thalassemia | Hematology | 2005 | Standard Therapy | UK | 4 |
7672 | Cord Blood | Autologous | Acute Lymphoblastic Leukemia | Hematology | 2004 | Standard Therapy | Germany | 3 |